{
    "58a95c711978bbde22000001_000": [
        {
            "text": "Alzheimer's disease",
            "probability": 0.7668520362677568,
            "start_logit": 5.93485689163208,
            "end_logit": 5.336843967437744
        },
        {
            "text": "Alzheimer's disease. Alzheimer's disease",
            "probability": 0.20966737452154616,
            "start_logit": 5.93485689163208,
            "end_logit": 4.040072441101074
        },
        {
            "text": "Alzheimer's disease.",
            "probability": 0.007944853565345763,
            "start_logit": 5.93485689163208,
            "end_logit": 0.767074465751648
        },
        {
            "text": "AD",
            "probability": 0.004436222626808978,
            "start_logit": 3.13529372215271,
            "end_logit": 2.9839165210723877
        },
        {
            "text": "Alzheimer's disease. Alzheimer's disease (AD)",
            "probability": 0.002500681891544848,
            "start_logit": 5.93485689163208,
            "end_logit": -0.3888864517211914
        },
        {
            "text": "Alzheimer",
            "probability": 0.0016610323643995852,
            "start_logit": 5.93485689163208,
            "end_logit": -0.7980105876922607
        },
        {
            "text": "Alzheimer's disease. Alzheimer",
            "probability": 0.0009261289909102164,
            "start_logit": 5.93485689163208,
            "end_logit": -1.3821916580200195
        },
        {
            "text": "aducanumab reduces A\u03b2 plaques in Alzheimer's disease",
            "probability": 0.0009187583727879166,
            "start_logit": -0.7921690940856934,
            "end_logit": 5.336843967437744
        },
        {
            "text": "A\u03b2 plaques in Alzheimer's disease",
            "probability": 0.0007591546032402196,
            "start_logit": -0.9829868078231812,
            "end_logit": 5.336843967437744
        },
        {
            "text": "Alzheimer's disease. Alzheimer's disease (AD",
            "probability": 0.0007089922001450907,
            "start_logit": 5.93485689163208,
            "end_logit": -1.6493606567382812
        },
        {
            "text": "Alzheimer's disease (AD)",
            "probability": 0.0006770265777120147,
            "start_logit": 4.628248691558838,
            "end_logit": -0.3888864517211914
        },
        {
            "text": "Alzheimer's disease. Alzheimer's",
            "probability": 0.0004972800052279247,
            "start_logit": 5.93485689163208,
            "end_logit": -2.004051923751831
        },
        {
            "text": "Alzheimer's",
            "probability": 0.0004929816542866671,
            "start_logit": 5.93485689163208,
            "end_logit": -2.012733221054077
        },
        {
            "text": "in Alzheimer's disease",
            "probability": 0.00047561192750101384,
            "start_logit": -1.4505900144577026,
            "end_logit": 5.336843967437744
        },
        {
            "text": "Alzheimer's disease. Alzheimer's disease (AD) is characterized by deposition of amyloid-\u03b2 (A\u03b2",
            "probability": 0.00033950405219057865,
            "start_logit": 5.93485689163208,
            "end_logit": -2.3857192993164062
        },
        {
            "text": "disease",
            "probability": 0.00028748023632348027,
            "start_logit": -1.954038143157959,
            "end_logit": 5.336843967437744
        },
        {
            "text": "aducanumab reduces A\u03b2 plaques in Alzheimer's disease. Alzheimer's disease",
            "probability": 0.00025120055334230056,
            "start_logit": -0.7921690940856934,
            "end_logit": 4.040072441101074
        },
        {
            "text": "A\u03b2 plaques in Alzheimer's disease. Alzheimer's disease",
            "probability": 0.00020756279567567913,
            "start_logit": -0.9829868078231812,
            "end_logit": 4.040072441101074
        },
        {
            "text": "The antibody aducanumab reduces A\u03b2 plaques in Alzheimer's disease",
            "probability": 0.00020416652380553422,
            "start_logit": -2.2962563037872314,
            "end_logit": 5.336843967437744
        },
        {
            "text": "Alzheimer's disease (AD",
            "probability": 0.00019195026944918947,
            "start_logit": 4.628248691558838,
            "end_logit": -1.6493606567382812
        }
    ],
    "58a95c711978bbde22000001_001": [
        {
            "text": "Alzheimer's disease",
            "probability": 0.9400273256377161,
            "start_logit": 6.8271098136901855,
            "end_logit": 5.91442346572876
        },
        {
            "text": "Alzheimer's disease compared with amyloid burden alone. SIGNIFICANCE STATEMENT: Alzheimer's disease",
            "probability": 0.04549816878536838,
            "start_logit": 3.798872947692871,
            "end_logit": 5.91442346572876
        },
        {
            "text": "Alzheimer's disease (AD)",
            "probability": 0.005509787443157891,
            "start_logit": 6.8271098136901855,
            "end_logit": 0.7750405669212341
        },
        {
            "text": "amyloid burden alone. SIGNIFICANCE STATEMENT: Alzheimer's disease",
            "probability": 0.002961404065371146,
            "start_logit": 1.0668643712997437,
            "end_logit": 5.91442346572876
        },
        {
            "text": "Alzheimer's disease (AD",
            "probability": 0.0010115882117440556,
            "start_logit": 6.8271098136901855,
            "end_logit": -0.9199638962745667
        },
        {
            "text": "Alzheimer's",
            "probability": 0.0009049988352409924,
            "start_logit": 6.8271098136901855,
            "end_logit": -1.0313071012496948
        },
        {
            "text": "Alzheimer's disease (AD) is a progressive neurodegenerative",
            "probability": 0.0008381585971075398,
            "start_logit": 6.8271098136901855,
            "end_logit": -1.1080334186553955
        },
        {
            "text": "Alzheimer",
            "probability": 0.0007931315679279466,
            "start_logit": 6.8271098136901855,
            "end_logit": -1.1632516384124756
        },
        {
            "text": "amyloid-\u03b2",
            "probability": 0.0004141042074489204,
            "start_logit": 3.4755523204803467,
            "end_logit": 1.538434386253357
        },
        {
            "text": "Alzheimer's disease (AD) is",
            "probability": 0.0003446797797345433,
            "start_logit": 6.8271098136901855,
            "end_logit": -1.9966249465942383
        },
        {
            "text": "SIGNIFICANCE STATEMENT: Alzheimer's disease",
            "probability": 0.00032073991676682213,
            "start_logit": -1.155923843383789,
            "end_logit": 5.91442346572876
        },
        {
            "text": "Alzheimer's disease (AD) is a progressive neurodegenerative disorder that is currently without a cure. Aducanumab",
            "probability": 0.00026900035592204025,
            "start_logit": 6.8271098136901855,
            "end_logit": -2.24452805519104
        },
        {
            "text": ": Alzheimer's disease",
            "probability": 0.00026305301676561067,
            "start_logit": -1.3541988134384155,
            "end_logit": 5.91442346572876
        },
        {
            "text": "Alzheimer's disease (AD) is a progressive neurodegenerative disorder",
            "probability": 0.0002513199154789248,
            "start_logit": 6.8271098136901855,
            "end_logit": -2.312514066696167
        },
        {
            "text": "disease",
            "probability": 0.00017437773846411627,
            "start_logit": -1.7653305530548096,
            "end_logit": 5.91442346572876
        },
        {
            "text": "amyloid",
            "probability": 0.00011486951747408024,
            "start_logit": 3.4755523204803467,
            "end_logit": 0.25611358880996704
        },
        {
            "text": ". SIGNIFICANCE STATEMENT: Alzheimer's disease",
            "probability": 9.09657439024917e-05,
            "start_logit": -2.4160714149475098,
            "end_logit": 5.91442346572876
        },
        {
            "text": "disease compared with amyloid burden alone. SIGNIFICANCE STATEMENT: Alzheimer's disease",
            "probability": 8.066990401452423e-05,
            "start_logit": -2.536188840866089,
            "end_logit": 5.91442346572876
        },
        {
            "text": "of Alzheimer's disease compared with amyloid burden alone. SIGNIFICANCE STATEMENT: Alzheimer's disease",
            "probability": 7.543531504119483e-05,
            "start_logit": -2.603278875350952,
            "end_logit": 5.91442346572876
        },
        {
            "text": "Alzheimer's disease (AD) is a",
            "probability": 5.622144535280459e-05,
            "start_logit": 6.8271098136901855,
            "end_logit": -3.8099424839019775
        }
    ],
    "58a95c711978bbde22000001_002": [
        {
            "text": "Alzheimer's disease",
            "probability": 0.7369353421825993,
            "start_logit": 3.541926622390747,
            "end_logit": 2.845000743865967
        },
        {
            "text": "A\u03b2 dyshomeostasis",
            "probability": 0.061615375148986413,
            "start_logit": 2.1324522495269775,
            "end_logit": 1.7728863954544067
        },
        {
            "text": "Alzheimer's disease (AD)",
            "probability": 0.05026412331312367,
            "start_logit": 3.541926622390747,
            "end_logit": 0.15979215502738953
        },
        {
            "text": "Down's syndrome",
            "probability": 0.032206488089744606,
            "start_logit": 2.0691325664520264,
            "end_logit": 1.187462568283081
        },
        {
            "text": "A\u03b2",
            "probability": 0.022612922346913027,
            "start_logit": 1.9335460662841797,
            "end_logit": 0.9694026708602905
        },
        {
            "text": "Alzheimer's disease (AD).",
            "probability": 0.02255477748793751,
            "start_logit": 3.541926622390747,
            "end_logit": -0.6415525078773499
        },
        {
            "text": "amyloid hypothesis of Alzheimer's disease",
            "probability": 0.013801283848706878,
            "start_logit": -0.002095140516757965,
            "end_logit": 2.4112839698791504
        },
        {
            "text": "A\u03b242 and related A\u03b2 peptides is a very early, often initiating factor in Alzheimer's disease",
            "probability": 0.0109168933331774,
            "start_logit": -0.6702620983123779,
            "end_logit": 2.845000743865967
        },
        {
            "text": "A\u03b2 antibodies (solanezumab, crenezumab,",
            "probability": 0.009824821960734349,
            "start_logit": 1.9335460662841797,
            "end_logit": 0.13579317927360535
        },
        {
            "text": "Alzheimer's disease (AD",
            "probability": 0.008592826601035287,
            "start_logit": 3.541926622390747,
            "end_logit": -1.6065716743469238
        },
        {
            "text": "A\u03b2 antibodies (solanezumab,",
            "probability": 0.007751937610219851,
            "start_logit": 1.9335460662841797,
            "end_logit": -0.10117603093385696
        },
        {
            "text": "Alzheimer",
            "probability": 0.005362629976604411,
            "start_logit": 3.30515193939209,
            "end_logit": -1.8412702083587646
        },
        {
            "text": "Alzheimer's",
            "probability": 0.004795648412969922,
            "start_logit": 3.541926622390747,
            "end_logit": -2.1897904872894287
        },
        {
            "text": "neuritic dystrophy",
            "probability": 0.0028749371882848505,
            "start_logit": 0.6597005724906921,
            "end_logit": 0.18075746297836304
        },
        {
            "text": "A\u03b2 peptides is a very early, often initiating factor in Alzheimer's disease",
            "probability": 0.002284758398976418,
            "start_logit": -2.2343132495880127,
            "end_logit": 2.845000743865967
        },
        {
            "text": "dyshomeostasis",
            "probability": 0.0019959832657856936,
            "start_logit": -1.297322392463684,
            "end_logit": 1.7728863954544067
        },
        {
            "text": "The amyloid hypothesis of Alzheimer's disease",
            "probability": 0.0017868197769058778,
            "start_logit": -2.046419382095337,
            "end_logit": 2.4112839698791504
        },
        {
            "text": "Alzheimer's disease at 25\u00a0years. Despite continuing debate about the amyloid",
            "probability": 0.0016087157141669113,
            "start_logit": 3.30515193939209,
            "end_logit": -3.045288562774658
        },
        {
            "text": "Alzheimer's disease at 25\u00a0years.",
            "probability": 0.001133048988456131,
            "start_logit": 3.30515193939209,
            "end_logit": -3.395812511444092
        },
        {
            "text": "(solanezumab, crenezumab,",
            "probability": 0.0010806663546715895,
            "start_logit": -0.27378812432289124,
            "end_logit": 0.13579317927360535
        }
    ],
    "58a95c711978bbde22000001_003": [
        {
            "text": "Alzheimer's disease",
            "probability": 0.5247309798442306,
            "start_logit": 4.828514575958252,
            "end_logit": 4.12927770614624
        },
        {
            "text": "Alzheimer's disease. Despite the significant public health issue that it poses, only five medical treatments have been approved for Alzheimer's disease",
            "probability": 0.4269214322194142,
            "start_logit": 4.828514575958252,
            "end_logit": 3.922991991043091
        },
        {
            "text": "Alzheimer's disease.",
            "probability": 0.01798897206501961,
            "start_logit": 4.828514575958252,
            "end_logit": 0.7561509013175964
        },
        {
            "text": "dementia",
            "probability": 0.010849845984123032,
            "start_logit": 2.969190835952759,
            "end_logit": 2.1098666191101074
        },
        {
            "text": "Alzheimer",
            "probability": 0.0037963424913951874,
            "start_logit": 4.828514575958252,
            "end_logit": -0.7995699048042297
        },
        {
            "text": "Alzheimer's disease. Despite the significant public health issue that it poses, only five medical treatments have been approved for Alzheimer's disease (AD)",
            "probability": 0.0035950671664376293,
            "start_logit": 4.828514575958252,
            "end_logit": -0.8540453314781189
        },
        {
            "text": "Alzheimer's disease (AD)",
            "probability": 0.0028422226878359914,
            "start_logit": 4.593538284301758,
            "end_logit": -0.8540453314781189
        },
        {
            "text": "Alzheimer's disease. Despite the significant public health issue that it poses, only five medical treatments have been approved for Alzheimer",
            "probability": 0.0023347263531918946,
            "start_logit": 4.828514575958252,
            "end_logit": -1.2857133150100708
        },
        {
            "text": "Alzheimer's",
            "probability": 0.0013181107774538454,
            "start_logit": 4.828514575958252,
            "end_logit": -1.8574085235595703
        },
        {
            "text": "in Alzheimer's disease",
            "probability": 0.0010094284672366887,
            "start_logit": -1.4249868392944336,
            "end_logit": 4.12927770614624
        },
        {
            "text": "in Alzheimer's disease. Despite the significant public health issue that it poses, only five medical treatments have been approved for Alzheimer's disease",
            "probability": 0.0008212715915566186,
            "start_logit": -1.4249868392944336,
            "end_logit": 3.922991991043091
        },
        {
            "text": "Alzheimer's disease. Despite the significant public health issue that it poses, only five medical treatments have been approved for Alzheimer's",
            "probability": 0.0007591405477178024,
            "start_logit": 4.828514575958252,
            "end_logit": -2.4091763496398926
        },
        {
            "text": "Alzheimer's disease. Despite the significant public health issue that it poses, only five medical treatments have been approved for Alzheimer's disease (AD",
            "probability": 0.0007223322726378642,
            "start_logit": 4.828514575958252,
            "end_logit": -2.4588780403137207
        },
        {
            "text": "Alzheimer's disease (AD",
            "probability": 0.0005710683774183355,
            "start_logit": 4.593538284301758,
            "end_logit": -2.4588780403137207
        },
        {
            "text": "disease",
            "probability": 0.00039166282624966247,
            "start_logit": -2.371725082397461,
            "end_logit": 4.12927770614624
        },
        {
            "text": "disease. Despite the significant public health issue that it poses, only five medical treatments have been approved for Alzheimer's disease",
            "probability": 0.00031865710459719096,
            "start_logit": -2.371725082397461,
            "end_logit": 3.922991991043091
        },
        {
            "text": "for Alzheimer's disease",
            "probability": 0.00029370433626540874,
            "start_logit": -2.4532670974731445,
            "end_logit": 3.922991991043091
        },
        {
            "text": "only five medical treatments have been approved for Alzheimer's disease",
            "probability": 0.0002829445893587447,
            "start_logit": -2.4905896186828613,
            "end_logit": 3.922991991043091
        },
        {
            "text": ". Despite the significant public health issue that it poses, only five medical treatments have been approved for Alzheimer's disease",
            "probability": 0.00028231508638188537,
            "start_logit": -2.492816925048828,
            "end_logit": 3.922991991043091
        },
        {
            "text": "Alzheimer's disease. Despite the significant public health issue that it poses,",
            "probability": 0.00016977521147764547,
            "start_logit": 4.828514575958252,
            "end_logit": -3.906888008117676
        }
    ],
    "587f760792a5b8ad44000005_000": [
        {
            "text": "JAMM",
            "probability": 0.7943177873231031,
            "start_logit": 3.782411575317383,
            "end_logit": 2.7506649494171143
        },
        {
            "text": "JAMM is a universal peak finder that is applicable to different types of datasets. We show that JAMM",
            "probability": 0.1300423926860259,
            "start_logit": 3.2181472778320312,
            "end_logit": 1.5053061246871948
        },
        {
            "text": "RESULTS: We developed JAMM",
            "probability": 0.02329263625918965,
            "start_logit": 0.3320811986923218,
            "end_logit": 2.6716489791870117
        },
        {
            "text": "JAMM:",
            "probability": 0.020514572922312967,
            "start_logit": 3.782411575317383,
            "end_logit": -0.905683159828186
        },
        {
            "text": "JAMM (Joint Analysis of NGS replicates via Mixture Model",
            "probability": 0.012503619984502353,
            "start_logit": 3.467567205429077,
            "end_logit": -1.08595609664917
        },
        {
            "text": "JAMM: a peak finder for joint analysis of NGS replicates.",
            "probability": 0.003203646753298696,
            "start_logit": 3.782411575317383,
            "end_logit": -2.762528896331787
        },
        {
            "text": "J",
            "probability": 0.0024457959559884236,
            "start_logit": 3.782411575317383,
            "end_logit": -3.0324480533599854
        },
        {
            "text": "JAMM (",
            "probability": 0.002208952531990974,
            "start_logit": 3.467567205429077,
            "end_logit": -2.819455862045288
        },
        {
            "text": "We developed JAMM",
            "probability": 0.0020312843757659834,
            "start_logit": -2.1073877811431885,
            "end_logit": 2.6716489791870117
        },
        {
            "text": "JAMM (Joint Analysis of NGS replicates via Mixture",
            "probability": 0.001870623472670335,
            "start_logit": 3.467567205429077,
            "end_logit": -2.9857025146484375
        },
        {
            "text": "Mixture Model",
            "probability": 0.0012998942393355492,
            "start_logit": 1.2038319110870361,
            "end_logit": -1.08595609664917
        },
        {
            "text": "JAMM: a peak finder for joint analysis of NGS replicates. MOTIVATION",
            "probability": 0.0010947979142236215,
            "start_logit": 3.782411575317383,
            "end_logit": -3.8362488746643066
        },
        {
            "text": "developed JAMM",
            "probability": 0.0010359977009756288,
            "start_logit": -2.780691146850586,
            "end_logit": 2.6716489791870117
        },
        {
            "text": "JAMM (Joint",
            "probability": 0.0007141699362107227,
            "start_logit": 3.467567205429077,
            "end_logit": -3.948608636856079
        },
        {
            "text": "JAM",
            "probability": 0.000691973159134566,
            "start_logit": 3.782411575317383,
            "end_logit": -4.295026779174805
        },
        {
            "text": "JAMM (Joint Analysis",
            "probability": 0.0005823441392345659,
            "start_logit": 3.467567205429077,
            "end_logit": -4.152667999267578
        },
        {
            "text": "RESULTS",
            "probability": 0.000565630081222171,
            "start_logit": 0.3320811986923218,
            "end_logit": -1.0463032722473145
        },
        {
            "text": "RESULTS: We developed JAMM (Joint Analysis of NGS replicates via Mixture Model",
            "probability": 0.0005436401143280759,
            "start_logit": 0.3320811986923218,
            "end_logit": -1.08595609664917
        },
        {
            "text": "JAMM (Joint Analysis of NGS replicates",
            "probability": 0.0005302650119889742,
            "start_logit": 3.467567205429077,
            "end_logit": -4.246352672576904
        },
        {
            "text": ". JAMM",
            "probability": 0.0005099754384976893,
            "start_logit": -3.1457250118255615,
            "end_logit": 2.327925205230713
        }
    ],
    "58a9bbe81978bbde22000007_000": [
        {
            "text": "The intestinal",
            "probability": 0.37846151663527605,
            "start_logit": 5.682950019836426,
            "end_logit": 4.434502601623535
        },
        {
            "text": "intestinal",
            "probability": 0.3393803113381364,
            "start_logit": 5.5739569664001465,
            "end_logit": 4.434502601623535
        },
        {
            "text": "The intestinal stem cell niche",
            "probability": 0.13301507686238792,
            "start_logit": 5.682950019836426,
            "end_logit": 3.388850688934326
        },
        {
            "text": "intestinal stem cell niche",
            "probability": 0.11927949398809667,
            "start_logit": 5.5739569664001465,
            "end_logit": 3.388850688934326
        },
        {
            "text": "The intestinal stem cell niche comprises both epithelial cells, in particular the Paneth cell,",
            "probability": 0.005551249223634626,
            "start_logit": 5.682950019836426,
            "end_logit": 0.21241119503974915
        },
        {
            "text": "intestinal stem cell niche comprises both epithelial cells, in particular the Paneth cell,",
            "probability": 0.004978008613880566,
            "start_logit": 5.5739569664001465,
            "end_logit": 0.21241119503974915
        },
        {
            "text": "crypt base",
            "probability": 0.0035979246947504644,
            "start_logit": 2.701080560684204,
            "end_logit": 2.7606148719787598
        },
        {
            "text": "the crypt base",
            "probability": 0.002280292467934647,
            "start_logit": 2.2450270652770996,
            "end_logit": 2.7606148719787598
        },
        {
            "text": "The intestinal stem cell",
            "probability": 0.0022393016408759313,
            "start_logit": 5.682950019836426,
            "end_logit": -0.6954477429389954
        },
        {
            "text": "intestinal stem cell",
            "probability": 0.002008063844422159,
            "start_logit": 5.5739569664001465,
            "end_logit": -0.6954477429389954
        },
        {
            "text": "The intestinal stem cell niche comprises both epithelial cells,",
            "probability": 0.0018269543820277898,
            "start_logit": 5.682950019836426,
            "end_logit": -0.8989614844322205
        },
        {
            "text": "intestinal stem cell niche comprises both epithelial cells,",
            "probability": 0.0016382969462406134,
            "start_logit": 5.5739569664001465,
            "end_logit": -0.8989614844322205
        },
        {
            "text": "The intestinal stem",
            "probability": 0.0009567509717834818,
            "start_logit": 5.682950019836426,
            "end_logit": -1.5458239316940308
        },
        {
            "text": "The intestinal stem cell niche comprises both epithelial cells, in particular the Paneth cell, and the stromal compartment",
            "probability": 0.0009211414477724345,
            "start_logit": 5.682950019836426,
            "end_logit": -1.5837534666061401
        },
        {
            "text": "intestinal stem",
            "probability": 0.0008579536581783,
            "start_logit": 5.5739569664001465,
            "end_logit": -1.5458239316940308
        },
        {
            "text": "intestinal stem cell niche comprises both epithelial cells, in particular the Paneth cell, and the stromal compartment",
            "probability": 0.0008260212930255213,
            "start_logit": 5.5739569664001465,
            "end_logit": -1.5837534666061401
        },
        {
            "text": "The",
            "probability": 0.0006310642688188118,
            "start_logit": 5.682950019836426,
            "end_logit": -1.9619593620300293
        },
        {
            "text": "niche",
            "probability": 0.0005568634521066068,
            "start_logit": 0.2070523202419281,
            "end_logit": 3.388850688934326
        },
        {
            "text": "The intestinal stem cell niche comprises both epithelial cells, in particular the Paneth cell",
            "probability": 0.0005239073502229442,
            "start_logit": 5.682950019836426,
            "end_logit": -2.148052215576172
        },
        {
            "text": "intestinal stem cell niche comprises both epithelial cells, in particular the Paneth cell",
            "probability": 0.000469806920428189,
            "start_logit": 5.5739569664001465,
            "end_logit": -2.148052215576172
        }
    ],
    "58a9bbe81978bbde22000007_001": [
        {
            "text": "throughout the crypts",
            "probability": 0.3135386060708987,
            "start_logit": 4.643962860107422,
            "end_logit": 5.066554546356201
        },
        {
            "text": "crypts",
            "probability": 0.1923265922513897,
            "start_logit": 4.155235290527344,
            "end_logit": 5.066554546356201
        },
        {
            "text": "base of the crypts but aberrantly located throughout the crypts",
            "probability": 0.13315910052108493,
            "start_logit": 3.7875850200653076,
            "end_logit": 5.066554546356201
        },
        {
            "text": "the crypts",
            "probability": 0.09498521679905568,
            "start_logit": 3.4497616291046143,
            "end_logit": 5.066554546356201
        },
        {
            "text": "the base of the crypts but aberrantly located throughout the crypts",
            "probability": 0.060688528369082395,
            "start_logit": 3.0017950534820557,
            "end_logit": 5.066554546356201
        },
        {
            "text": "base of the crypts",
            "probability": 0.03397591900481011,
            "start_logit": 3.7875850200653076,
            "end_logit": 3.7006618976593018
        },
        {
            "text": "crypts but aberrantly located throughout the crypts",
            "probability": 0.03213773426285823,
            "start_logit": 2.3660712242126465,
            "end_logit": 5.066554546356201
        },
        {
            "text": "throughout the crypts.",
            "probability": 0.03205822982899134,
            "start_logit": 4.643962860107422,
            "end_logit": 2.7861859798431396
        },
        {
            "text": "crypts.",
            "probability": 0.019664723824241136,
            "start_logit": 4.155235290527344,
            "end_logit": 2.7861859798431396
        },
        {
            "text": "the base of the crypts",
            "probability": 0.015484848698437756,
            "start_logit": 3.0017950534820557,
            "end_logit": 3.7006618976593018
        },
        {
            "text": "base of the crypts but aberrantly located throughout the crypts.",
            "probability": 0.013615053985924185,
            "start_logit": 3.7875850200653076,
            "end_logit": 2.7861859798431396
        },
        {
            "text": "not limited to the base of the crypts but aberrantly located throughout the crypts",
            "probability": 0.01290968895681875,
            "start_logit": 1.454018473625183,
            "end_logit": 5.066554546356201
        },
        {
            "text": "the crypts.",
            "probability": 0.009711907406426802,
            "start_logit": 3.4497616291046143,
            "end_logit": 2.7861859798431396
        },
        {
            "text": "Paneth cells, which were not limited to the base of the crypts but aberrantly located throughout the crypts",
            "probability": 0.009691004766861645,
            "start_logit": 1.167238473892212,
            "end_logit": 5.066554546356201
        },
        {
            "text": "colonic adenomas",
            "probability": 0.0062864866196445145,
            "start_logit": 3.6272804737091064,
            "end_logit": 2.1737167835235596
        },
        {
            "text": "the base of the crypts but aberrantly located throughout the crypts.",
            "probability": 0.006205190534014701,
            "start_logit": 3.0017950534820557,
            "end_logit": 2.7861859798431396
        },
        {
            "text": "located throughout the crypts",
            "probability": 0.003861783419574113,
            "start_logit": 0.24716946482658386,
            "end_logit": 5.066554546356201
        },
        {
            "text": "not limited to the base of the crypts",
            "probability": 0.0032939434455305054,
            "start_logit": 1.454018473625183,
            "end_logit": 3.7006618976593018
        },
        {
            "text": "crypts but aberrantly located throughout the crypts.",
            "probability": 0.003285971332502472,
            "start_logit": 2.3660712242126465,
            "end_logit": 2.7861859798431396
        },
        {
            "text": "colonic",
            "probability": 0.0031194699018523577,
            "start_logit": 3.6272804737091064,
            "end_logit": 1.4729775190353394
        }
    ],
    "58a9bbe81978bbde22000007_002": [
        {
            "text": "crypt base columnar cells",
            "probability": 0.4997546378534735,
            "start_logit": 6.108155250549316,
            "end_logit": 3.3833680152893066
        },
        {
            "text": "crypt",
            "probability": 0.3645787731070815,
            "start_logit": 6.108155250549316,
            "end_logit": 3.067993402481079
        },
        {
            "text": "small intestinal crypts",
            "probability": 0.0343246447849502,
            "start_logit": 3.827002763748169,
            "end_logit": 2.986266851425171
        },
        {
            "text": "crypt base columnar",
            "probability": 0.03020926877172503,
            "start_logit": 6.108155250549316,
            "end_logit": 0.5773995518684387
        },
        {
            "text": "crypt base",
            "probability": 0.021104154417162707,
            "start_logit": 6.108155250549316,
            "end_logit": 0.2187206745147705
        },
        {
            "text": "crypt base columnar cells (CBCCs)),",
            "probability": 0.01634219028041041,
            "start_logit": 6.108155250549316,
            "end_logit": -0.036999113857746124
        },
        {
            "text": "crypt base columnar cells (CBCCs",
            "probability": 0.009011799298022271,
            "start_logit": 6.108155250549316,
            "end_logit": -0.6322144865989685
        },
        {
            "text": "crypt base columnar cells (CBCCs))",
            "probability": 0.0036784352489137953,
            "start_logit": 6.108155250549316,
            "end_logit": -1.5282617807388306
        },
        {
            "text": "crypt base columnar cells (CBCCs)",
            "probability": 0.003501532099086738,
            "start_logit": 6.108155250549316,
            "end_logit": -1.577548623085022
        },
        {
            "text": "base of the crypt",
            "probability": 0.0031483445565034436,
            "start_logit": 1.8535866737365723,
            "end_logit": 2.5706961154937744
        },
        {
            "text": "cry",
            "probability": 0.002867744322976684,
            "start_logit": 6.108155250549316,
            "end_logit": -1.7772234678268433
        },
        {
            "text": "crypts",
            "probability": 0.0021338334653057387,
            "start_logit": 1.049059271812439,
            "end_logit": 2.986266851425171
        },
        {
            "text": "(crypt base columnar cells",
            "probability": 0.002070622835189731,
            "start_logit": 0.6218874454498291,
            "end_logit": 3.3833680152893066
        },
        {
            "text": "(crypt",
            "probability": 0.0015105515299736237,
            "start_logit": 0.6218874454498291,
            "end_logit": 3.067993402481079
        },
        {
            "text": "the base of the crypt",
            "probability": 0.0013151293748013108,
            "start_logit": 0.980644941329956,
            "end_logit": 2.5706961154937744
        },
        {
            "text": "Paneth cells (crypt base columnar cells",
            "probability": 0.0011986979865243655,
            "start_logit": 0.07527395337820053,
            "end_logit": 3.3833680152893066
        },
        {
            "text": "base columnar cells",
            "probability": 0.0010244735744136444,
            "start_logit": -0.08178310841321945,
            "end_logit": 3.3833680152893066
        },
        {
            "text": "crypt base column",
            "probability": 0.0009031757217361751,
            "start_logit": 6.108155250549316,
            "end_logit": -2.9325873851776123
        },
        {
            "text": "Paneth cells (crypt",
            "probability": 0.0008744688055923854,
            "start_logit": 0.07527395337820053,
            "end_logit": 3.067993402481079
        },
        {
            "text": "the crypt",
            "probability": 0.0004475219661564561,
            "start_logit": -0.09731975942850113,
            "end_logit": 2.5706961154937744
        }
    ],
    "58a9bbe81978bbde22000007_003": [
        {
            "text": "intestinal crypts",
            "probability": 0.6544880962230645,
            "start_logit": 4.973837852478027,
            "end_logit": 4.347882270812988
        },
        {
            "text": "the intestinal crypts",
            "probability": 0.18764841591481457,
            "start_logit": 3.7245545387268066,
            "end_logit": 4.347882270812988
        },
        {
            "text": "in the intestinal crypts",
            "probability": 0.062358043292366466,
            "start_logit": 2.6228771209716797,
            "end_logit": 4.347882270812988
        },
        {
            "text": "intestinal crypts.",
            "probability": 0.040861715456534234,
            "start_logit": 4.973837852478027,
            "end_logit": 1.574222445487976
        },
        {
            "text": "crypts",
            "probability": 0.01229306066384992,
            "start_logit": 0.9990193843841553,
            "end_logit": 4.347882270812988
        },
        {
            "text": "the intestinal crypts.",
            "probability": 0.011715470795006237,
            "start_logit": 3.7245545387268066,
            "end_logit": 1.574222445487976
        },
        {
            "text": "intestinal crypts. PCs are specialized epithelia that protect intestinal",
            "probability": 0.011686067226959895,
            "start_logit": 4.973837852478027,
            "end_logit": 0.3224261701107025
        },
        {
            "text": "Paneth cells (PCs) in the intestinal crypts",
            "probability": 0.006687726670852204,
            "start_logit": 0.39025846123695374,
            "end_logit": 4.347882270812988
        },
        {
            "text": "in the intestinal crypts.",
            "probability": 0.003893205447346267,
            "start_logit": 2.6228771209716797,
            "end_logit": 1.574222445487976
        },
        {
            "text": "the intestinal crypts. PCs are specialized epithelia that protect intestinal",
            "probability": 0.003350514724511771,
            "start_logit": 3.7245545387268066,
            "end_logit": 0.3224261701107025
        },
        {
            "text": "in the intestinal crypts. PCs are specialized epithelia that protect intestinal",
            "probability": 0.001113420229125001,
            "start_logit": 2.6228771209716797,
            "end_logit": 0.3224261701107025
        },
        {
            "text": "intestinal",
            "probability": 0.0009400895363077776,
            "start_logit": 4.973837852478027,
            "end_logit": -2.19775128364563
        },
        {
            "text": "crypts.",
            "probability": 0.0007674937861130307,
            "start_logit": 0.9990193843841553,
            "end_logit": 1.574222445487976
        },
        {
            "text": "(PCs) in the intestinal crypts",
            "probability": 0.0006082236672217143,
            "start_logit": -2.007228136062622,
            "end_logit": 4.347882270812988
        },
        {
            "text": "Paneth cells (PCs) in the intestinal crypts.",
            "probability": 0.00041753545381870545,
            "start_logit": 0.39025846123695374,
            "end_logit": 1.574222445487976
        },
        {
            "text": "in",
            "probability": 0.00029759833685079714,
            "start_logit": 4.973837852478027,
            "end_logit": -3.3479816913604736
        },
        {
            "text": "the intestinal",
            "probability": 0.00026953326320869206,
            "start_logit": 3.7245545387268066,
            "end_logit": -2.19775128364563
        },
        {
            "text": "pts",
            "probability": 0.0002471739793199298,
            "start_logit": -2.9076783657073975,
            "end_logit": 4.347882270812988
        },
        {
            "text": "crypts. PCs are specialized epithelia that protect intestinal",
            "probability": 0.00021949602165703049,
            "start_logit": 0.9990193843841553,
            "end_logit": 0.3224261701107025
        },
        {
            "text": "NEC is caused by injury to Paneth cells (PCs) in the intestinal crypts",
            "probability": 0.00013711931107120504,
            "start_logit": -3.4969193935394287,
            "end_logit": 4.347882270812988
        }
    ],
    "58a9bbe81978bbde22000007_004": [
        {
            "text": "bottom of the crypts of Lieberk\u00fchn",
            "probability": 0.43772402859190235,
            "start_logit": 5.099753379821777,
            "end_logit": 4.824785232543945
        },
        {
            "text": "the bottom of the crypts of Lieberk\u00fchn",
            "probability": 0.13923943846654366,
            "start_logit": 3.954359769821167,
            "end_logit": 4.824785232543945
        },
        {
            "text": "crypts of Lieberk\u00fchn",
            "probability": 0.1326334238476833,
            "start_logit": 3.9057538509368896,
            "end_logit": 4.824785232543945
        },
        {
            "text": "the crypts of Lieberk\u00fchn",
            "probability": 0.06120167138688438,
            "start_logit": 3.1323392391204834,
            "end_logit": 4.824785232543945
        },
        {
            "text": "small intestinal host defense is the presence of Paneth cells at the bottom of the crypts of Lieberk\u00fchn",
            "probability": 0.05322742364623229,
            "start_logit": 2.9927384853363037,
            "end_logit": 4.824785232543945
        },
        {
            "text": "at the bottom of the crypts of Lieberk\u00fchn",
            "probability": 0.04577965588796053,
            "start_logit": 2.8420045375823975,
            "end_logit": 4.824785232543945
        },
        {
            "text": "bottom of the crypts of Lieberk\u00fchn.",
            "probability": 0.027986590712913983,
            "start_logit": 5.099753379821777,
            "end_logit": 2.0749220848083496
        },
        {
            "text": "Lieberk\u00fchn",
            "probability": 0.027208907908004835,
            "start_logit": 2.321709156036377,
            "end_logit": 4.824785232543945
        },
        {
            "text": "bottom of the crypts",
            "probability": 0.021859844410005956,
            "start_logit": 5.099753379821777,
            "end_logit": 1.827847957611084
        },
        {
            "text": "the bottom of the crypts of Lieberk\u00fchn.",
            "probability": 0.00890249774040213,
            "start_logit": 3.954359769821167,
            "end_logit": 2.0749220848083496
        },
        {
            "text": "crypts of Lieberk\u00fchn.",
            "probability": 0.008480131556904497,
            "start_logit": 3.9057538509368896,
            "end_logit": 2.0749220848083496
        },
        {
            "text": "the bottom of the crypts",
            "probability": 0.006953587790020514,
            "start_logit": 3.954359769821167,
            "end_logit": 1.827847957611084
        },
        {
            "text": "crypts",
            "probability": 0.0066236848322070085,
            "start_logit": 3.9057538509368896,
            "end_logit": 1.827847957611084
        },
        {
            "text": "the crypts of Lieberk\u00fchn.",
            "probability": 0.003913027424061951,
            "start_logit": 3.1323392391204834,
            "end_logit": 2.0749220848083496
        },
        {
            "text": "small intestinal host defense is the presence of Paneth cells at the bottom of the crypts of Lieberk\u00fchn.",
            "probability": 0.0034031810524133067,
            "start_logit": 2.9927384853363037,
            "end_logit": 2.0749220848083496
        },
        {
            "text": "Paneth cells at the bottom of the crypts of Lieberk\u00fchn",
            "probability": 0.003241659763711275,
            "start_logit": 0.1942502111196518,
            "end_logit": 4.824785232543945
        },
        {
            "text": "the crypts",
            "probability": 0.0030563983851956064,
            "start_logit": 3.1323392391204834,
            "end_logit": 1.827847957611084
        },
        {
            "text": "small intestinal",
            "probability": 0.0029796844128459144,
            "start_logit": 2.9927384853363037,
            "end_logit": 1.9420288801193237
        },
        {
            "text": "at the bottom of the crypts of Lieberk\u00fchn.",
            "probability": 0.0029269960263225447,
            "start_logit": 2.8420045375823975,
            "end_logit": 2.0749220848083496
        },
        {
            "text": "small intestinal host defense is the presence of Paneth cells at the bottom of the crypts",
            "probability": 0.002658166157784546,
            "start_logit": 2.9927384853363037,
            "end_logit": 1.827847957611084
        }
    ],
    "58a9bbe81978bbde22000007_005": [
        {
            "text": "crypt base",
            "probability": 0.6319400432195779,
            "start_logit": 5.097562313079834,
            "end_logit": 4.625097274780273
        },
        {
            "text": "the crypt base",
            "probability": 0.2941950202949404,
            "start_logit": 4.333010673522949,
            "end_logit": 4.625097274780273
        },
        {
            "text": "at the crypt base",
            "probability": 0.016046326581320148,
            "start_logit": 1.4242477416992188,
            "end_logit": 4.625097274780273
        },
        {
            "text": "crypt",
            "probability": 0.014214239184884294,
            "start_logit": 5.097562313079834,
            "end_logit": 0.8305469751358032
        },
        {
            "text": "crypt base were also increased and the epithelial proliferative zone was shifted up the crypt-villus",
            "probability": 0.008344963005424947,
            "start_logit": 5.097562313079834,
            "end_logit": 0.29796087741851807
        },
        {
            "text": "crypt base were also increased and the epithelial proliferative zone was shifted up the crypt",
            "probability": 0.00719436799802452,
            "start_logit": 5.097562313079834,
            "end_logit": 0.14960125088691711
        },
        {
            "text": "the crypt",
            "probability": 0.006617334081520059,
            "start_logit": 4.333010673522949,
            "end_logit": 0.8305469751358032
        },
        {
            "text": "Paneth cells at the crypt base",
            "probability": 0.004011268379734576,
            "start_logit": 0.03787528723478317,
            "end_logit": 4.625097274780273
        },
        {
            "text": "the crypt base were also increased and the epithelial proliferative zone was shifted up the crypt-villus",
            "probability": 0.0038849359003010242,
            "start_logit": 4.333010673522949,
            "end_logit": 0.29796087741851807
        },
        {
            "text": "the crypt base were also increased and the epithelial proliferative zone was shifted up the crypt",
            "probability": 0.0033492848916565087,
            "start_logit": 4.333010673522949,
            "end_logit": 0.14960125088691711
        },
        {
            "text": "crypt base were also increased and the epithelial proliferative zone was shifted up the crypt-villus axis",
            "probability": 0.0026229261268344243,
            "start_logit": 5.097562313079834,
            "end_logit": -0.8594067096710205
        },
        {
            "text": "crypt base causes the proliferative zone to move up the crypt-villus",
            "probability": 0.0018092449108164591,
            "start_logit": 3.555541753768921,
            "end_logit": 0.31123289465904236
        },
        {
            "text": "crypt base causes the proliferative zone to move up the crypt",
            "probability": 0.0012342336446975308,
            "start_logit": 3.555541753768921,
            "end_logit": -0.07122644037008286
        },
        {
            "text": "the crypt base were also increased and the epithelial proliferative zone was shifted up the crypt-villus axis",
            "probability": 0.001221083888251183,
            "start_logit": 4.333010673522949,
            "end_logit": -0.8594067096710205
        },
        {
            "text": "base",
            "probability": 0.0008979640823496282,
            "start_logit": -1.4588574171066284,
            "end_logit": 4.625097274780273
        },
        {
            "text": "the crypt base causes the proliferative zone to move up the crypt-villus",
            "probability": 0.0006859513393497395,
            "start_logit": 2.585683584213257,
            "end_logit": 0.31123289465904236
        },
        {
            "text": "crypt base causes the proliferative zone to move up the crypt-villus axis",
            "probability": 0.0005075045411794146,
            "start_logit": 3.555541753768921,
            "end_logit": -0.9599263072013855
        },
        {
            "text": "the crypt base causes the proliferative zone to move up the crypt",
            "probability": 0.00046794340367591536,
            "start_logit": 2.585683584213257,
            "end_logit": -0.07122644037008286
        },
        {
            "text": "crypt base were also increased and the epithelial proliferative zone was shifted up the crypt-villus axis.",
            "probability": 0.00039443420222454417,
            "start_logit": 5.097562313079834,
            "end_logit": -2.754000186920166
        },
        {
            "text": "at the crypt",
            "probability": 0.00036093032323700837,
            "start_logit": 1.4242477416992188,
            "end_logit": 0.8305469751358032
        }
    ],
    "58a2df9c60087bc10a000006_000": [
        {
            "text": "7.61%",
            "probability": 0.8613462155520705,
            "start_logit": 6.555797100067139,
            "end_logit": 6.175417423248291
        },
        {
            "text": "(7.61%",
            "probability": 0.08189857457696957,
            "start_logit": 4.202782154083252,
            "end_logit": 6.175417423248291
        },
        {
            "text": "7.61%)",
            "probability": 0.03573504393128422,
            "start_logit": 6.555797100067139,
            "end_logit": 2.9930527210235596
        },
        {
            "text": "7.61",
            "probability": 0.006496282789528719,
            "start_logit": 6.555797100067139,
            "end_logit": 1.2881510257720947
        },
        {
            "text": "(7.61%)",
            "probability": 0.0033977616753581032,
            "start_logit": 4.202782154083252,
            "end_logit": 2.9930527210235596
        },
        {
            "text": "7.61%) (p < 0.02)",
            "probability": 0.002319229091606142,
            "start_logit": 6.555797100067139,
            "end_logit": 0.2581557333469391
        },
        {
            "text": "8.49%",
            "probability": 0.0021981068639310188,
            "start_logit": 3.6665456295013428,
            "end_logit": 3.093768835067749
        },
        {
            "text": "7.61%) (p < 0.02",
            "probability": 0.001234402152494787,
            "start_logit": 6.555797100067139,
            "end_logit": -0.37249234318733215
        },
        {
            "text": "the mean incidence of heterozygosity for beta-thalassaemia in the whole Greek population (7.61%",
            "probability": 0.000952899329105535,
            "start_logit": -0.25094544887542725,
            "end_logit": 6.175417423248291
        },
        {
            "text": "mean incidence of heterozygosity for beta-thalassaemia in the whole Greek population (7.61%",
            "probability": 0.0007292427422743162,
            "start_logit": -0.5184480547904968,
            "end_logit": 6.175417423248291
        },
        {
            "text": "(7.61",
            "probability": 0.000617679965274241,
            "start_logit": 4.202782154083252,
            "end_logit": 1.2881510257720947
        },
        {
            "text": "7",
            "probability": 0.0005520353787162713,
            "start_logit": 6.555797100067139,
            "end_logit": -1.1772222518920898
        },
        {
            "text": "beta-thalassaemia in the whole Greek population (7.61%",
            "probability": 0.0005056577073490903,
            "start_logit": -0.884594738483429,
            "end_logit": 6.175417423248291
        },
        {
            "text": "7.61%) (p < 0.02).",
            "probability": 0.0004418029533334555,
            "start_logit": 6.555797100067139,
            "end_logit": -1.3999704122543335
        },
        {
            "text": "(8.49%",
            "probability": 0.00030299640790500506,
            "start_logit": 1.6849148273468018,
            "end_logit": 3.093768835067749
        },
        {
            "text": "8.49%)",
            "probability": 0.0002759964995518392,
            "start_logit": 3.6665456295013428,
            "end_logit": 1.0188052654266357
        },
        {
            "text": "61%",
            "probability": 0.00026602233944913155,
            "start_logit": -1.5268744230270386,
            "end_logit": 6.175417423248291
        },
        {
            "text": ".61%",
            "probability": 0.00026425245775033544,
            "start_logit": -1.5335497856140137,
            "end_logit": 6.175417423248291
        },
        {
            "text": "incidence of heterozygosity for beta-thalassaemia in the whole Greek population (7.61%",
            "probability": 0.000245280500942526,
            "start_logit": -1.6080522537231445,
            "end_logit": 6.175417423248291
        },
        {
            "text": "(7.61%) (p < 0.02)",
            "probability": 0.0002205170851052524,
            "start_logit": 4.202782154083252,
            "end_logit": 0.2581557333469391
        }
    ],
    "58a2df9c60087bc10a000006_001": [
        {
            "text": "8%",
            "probability": 0.9446506527197203,
            "start_logit": 5.661105632781982,
            "end_logit": 5.490985870361328
        },
        {
            "text": "8% and that of sickle cell trait ranging from 1 to 32%",
            "probability": 0.02667233899647553,
            "start_logit": 5.661105632781982,
            "end_logit": 1.9237977266311646
        },
        {
            "text": "beta-thalassemia trait being 8%",
            "probability": 0.007432221959392623,
            "start_logit": 0.8161153197288513,
            "end_logit": 5.490985870361328
        },
        {
            "text": "8",
            "probability": 0.006434289028922151,
            "start_logit": 5.661105632781982,
            "end_logit": 0.5018120408058167
        },
        {
            "text": "the incidence of beta-thalassemia trait being 8%",
            "probability": 0.005228597759653843,
            "start_logit": 0.46443358063697815,
            "end_logit": 5.490985870361328
        },
        {
            "text": "incidence of beta-thalassemia trait being 8%",
            "probability": 0.001934069221773106,
            "start_logit": -0.5300833582878113,
            "end_logit": 5.490985870361328
        },
        {
            "text": "Hemoglobinopathies are very common in Greece, the incidence of beta-thalassemia trait being 8%",
            "probability": 0.0011015852314842762,
            "start_logit": -1.0929592847824097,
            "end_logit": 5.490985870361328
        },
        {
            "text": "in Greece, the incidence of beta-thalassemia trait being 8%",
            "probability": 0.0009689087348828574,
            "start_logit": -1.2212944030761719,
            "end_logit": 5.490985870361328
        },
        {
            "text": "1 to 32%",
            "probability": 0.000662681211604784,
            "start_logit": 1.9660173654556274,
            "end_logit": 1.9237977266311646
        },
        {
            "text": "8% and that of sickle cell trait ranging from 1 to 32% in various districts. In Greek populations,",
            "probability": 0.0006361819799953066,
            "start_logit": 5.661105632781982,
            "end_logit": -1.8120999336242676
        },
        {
            "text": "being 8%",
            "probability": 0.0006314718635113635,
            "start_logit": -1.6494114398956299,
            "end_logit": 5.490985870361328
        },
        {
            "text": "%",
            "probability": 0.0005517141292321749,
            "start_logit": -1.7844347953796387,
            "end_logit": 5.490985870361328
        },
        {
            "text": "8% and that of sickle cell trait ranging from 1",
            "probability": 0.0005374653573611162,
            "start_logit": 5.661105632781982,
            "end_logit": -1.9807202816009521
        },
        {
            "text": "8% and that of sickle cell trait ranging from 1 to 32% in various districts",
            "probability": 0.0005062552718468294,
            "start_logit": 5.661105632781982,
            "end_logit": -2.040543556213379
        },
        {
            "text": "8% and",
            "probability": 0.00044383581972018345,
            "start_logit": 5.661105632781982,
            "end_logit": -2.1721298694610596
        },
        {
            "text": "8% and that of sickle cell trait ranging from 1 to 32% in various districts.",
            "probability": 0.00043250770060847575,
            "start_logit": 5.661105632781982,
            "end_logit": -2.197984457015991
        },
        {
            "text": "32%",
            "probability": 0.00042680444678871245,
            "start_logit": 1.526049256324768,
            "end_logit": 1.9237977266311646
        },
        {
            "text": "8% and that of sickle cell trait ranging from 1 to 32",
            "probability": 0.000366313620799267,
            "start_logit": 5.661105632781982,
            "end_logit": -2.3640947341918945
        },
        {
            "text": "beta-thalassemia trait being 8% and that of sickle cell trait ranging from 1 to 32%",
            "probability": 0.00020984979264793485,
            "start_logit": 0.8161153197288513,
            "end_logit": 1.9237977266311646
        },
        {
            "text": "8% and that of sickle cell trait ranging from 1 to 32% in",
            "probability": 0.0001722551535792033,
            "start_logit": 5.661105632781982,
            "end_logit": -3.118607759475708
        }
    ],
    "58a32edd60087bc10a000012_000": [
        {
            "text": "obesity",
            "probability": 0.7244468124967093,
            "start_logit": 4.919654369354248,
            "end_logit": 4.812379837036133
        },
        {
            "text": "treatment of obesity",
            "probability": 0.10176388621648483,
            "start_logit": 2.9569013118743896,
            "end_logit": 4.812379837036133
        },
        {
            "text": "the treatment of obesity",
            "probability": 0.07739385370086971,
            "start_logit": 2.6831533908843994,
            "end_logit": 4.812379837036133
        },
        {
            "text": "obesity,",
            "probability": 0.05222517375637781,
            "start_logit": 4.919654369354248,
            "end_logit": 2.1825361251831055
        },
        {
            "text": "for the treatment of obesity",
            "probability": 0.01991069151417511,
            "start_logit": 1.325502872467041,
            "end_logit": 4.812379837036133
        },
        {
            "text": "treatment of obesity,",
            "probability": 0.007336130890636395,
            "start_logit": 2.9569013118743896,
            "end_logit": 2.1825361251831055
        },
        {
            "text": "the treatment of obesity,",
            "probability": 0.005579301872105296,
            "start_logit": 2.6831533908843994,
            "end_logit": 2.1825361251831055
        },
        {
            "text": "obesity and obesity with Type 2 diabetes",
            "probability": 0.003794823758054392,
            "start_logit": 2.6174569129943848,
            "end_logit": 1.8628069162368774
        },
        {
            "text": "for the treatment of obesity,",
            "probability": 0.0014353563381054363,
            "start_logit": 1.325502872467041,
            "end_logit": 2.1825361251831055
        },
        {
            "text": "naltrexone hydrochloride extended release and bupropion hydrochloride extended release for the treatment of obesity",
            "probability": 0.0011619901971626691,
            "start_logit": -1.5156197547912598,
            "end_logit": 4.812379837036133
        },
        {
            "text": "besity",
            "probability": 0.0008652778896710897,
            "start_logit": -1.8104585409164429,
            "end_logit": 4.812379837036133
        },
        {
            "text": "obesity and obesity",
            "probability": 0.0008070391659585168,
            "start_logit": 2.6174569129943848,
            "end_logit": 0.3147858679294586
        },
        {
            "text": "Type 2 diabetes",
            "probability": 0.00071903209320332,
            "start_logit": 0.9539696574211121,
            "end_logit": 1.8628069162368774
        },
        {
            "text": "obesity, and is used with lifestyle modification",
            "probability": 0.0005836637008456569,
            "start_logit": 4.919654369354248,
            "end_logit": -2.3114588260650635
        },
        {
            "text": "weight loss",
            "probability": 0.0004937648972706577,
            "start_logit": 1.630751371383667,
            "end_logit": 0.8101786971092224
        },
        {
            "text": "o",
            "probability": 0.00042022823843444165,
            "start_logit": 4.919654369354248,
            "end_logit": -2.6399857997894287
        },
        {
            "text": "treatment of obesity and obesity with Type 2 diabetes",
            "probability": 0.00032201523135767476,
            "start_logit": 0.15066251158714294,
            "end_logit": 1.8628069162368774
        },
        {
            "text": "diabetes",
            "probability": 0.000310332661532462,
            "start_logit": 0.1137084886431694,
            "end_logit": 1.8628069162368774
        },
        {
            "text": "obesity, and is used with lifestyle modification.",
            "probability": 0.0002525587530954597,
            "start_logit": 4.919654369354248,
            "end_logit": -3.149139881134033
        },
        {
            "text": "obesity and obesity with Type 2 diabetes. Contrave",
            "probability": 0.00017806662795009025,
            "start_logit": 2.6174569129943848,
            "end_logit": -1.1964285373687744
        }
    ],
    "5880a8ec0a76a87357000001_000": [
        {
            "text": "CAFE",
            "probability": 0.9349616583881657,
            "start_logit": 5.365468502044678,
            "end_logit": 4.209254741668701
        },
        {
            "text": "CAFE:",
            "probability": 0.04083002596977174,
            "start_logit": 5.365468502044678,
            "end_logit": 1.0781669616699219
        },
        {
            "text": "SUMMARY",
            "probability": 0.012680059472401172,
            "start_logit": 2.995593786239624,
            "end_logit": 2.2786545753479004
        },
        {
            "text": "CAFE: an R package for the detection of gross chromosomal abnormalities from gene expression microarray data.",
            "probability": 0.0030237965668758514,
            "start_logit": 5.365468502044678,
            "end_logit": -1.5247375965118408
        },
        {
            "text": "CAF",
            "probability": 0.0018101676643952002,
            "start_logit": 5.365468502044678,
            "end_logit": -2.0378313064575195
        },
        {
            "text": "CA",
            "probability": 0.0015472534590259897,
            "start_logit": 5.365468502044678,
            "end_logit": -2.1947693824768066
        },
        {
            "text": "CAFE: an R package for the detection of gross chromosomal abnormalities from gene expression microarray data",
            "probability": 0.0009351709066966424,
            "start_logit": 5.365468502044678,
            "end_logit": -2.6982767581939697
        },
        {
            "text": "CAFE: an R package for the detection of gross chromosomal abnormalities from gene expression microarray data. S",
            "probability": 0.0008124254790078012,
            "start_logit": 5.365468502044678,
            "end_logit": -2.838981866836548
        },
        {
            "text": "SUMMARY:",
            "probability": 0.0006794354095156844,
            "start_logit": 2.995593786239624,
            "end_logit": -0.6478691697120667
        },
        {
            "text": "CAFE: an R package for the detection of gross chromosomal abnormalities from gene expression microarray data. SUMMA",
            "probability": 0.00046854316236258657,
            "start_logit": 5.365468502044678,
            "end_logit": -3.3893778324127197
        },
        {
            "text": "CAFE: an R package for the detection of gross chromosomal abnormalities",
            "probability": 0.00042100162638087426,
            "start_logit": 5.365468502044678,
            "end_logit": -3.4963693618774414
        },
        {
            "text": "CAFE: an R package for the detection of gross chromosomal abnormalities from gene expression microarray",
            "probability": 0.00037695475065090996,
            "start_logit": 5.365468502044678,
            "end_logit": -3.6068809032440186
        },
        {
            "text": "CAFE has been developed to alleviate these issues. It is implemented as an R package that analyzes Affymetrix *.CEL",
            "probability": 0.0003641231862787174,
            "start_logit": 3.9293620586395264,
            "end_logit": -2.2054073810577393
        },
        {
            "text": "CAFE: an R package for the detection of gross chromosomal abnormalities from gene expression microarray data. SUMMAR",
            "probability": 0.0003609880272833904,
            "start_logit": 5.365468502044678,
            "end_logit": -3.6501612663269043
        },
        {
            "text": "E",
            "probability": 0.00019133722441560267,
            "start_logit": -3.1287548542022705,
            "end_logit": 4.209254741668701
        },
        {
            "text": "CAFE has been developed to alleviate these issues. It is implemented as an R package that analyzes Affymetrix *",
            "probability": 0.0001390233164834246,
            "start_logit": 3.9293620586395264,
            "end_logit": -3.16825795173645
        },
        {
            "text": ". SUMMARY",
            "probability": 0.00011340945654417242,
            "start_logit": -1.7211873531341553,
            "end_logit": 2.2786545753479004
        },
        {
            "text": "CAFE has",
            "probability": 0.00011033617106372648,
            "start_logit": 3.9293620586395264,
            "end_logit": -3.3993678092956543
        },
        {
            "text": ". CAFE",
            "probability": 9.833412341123584e-05,
            "start_logit": -2.353158950805664,
            "end_logit": 2.7679924964904785
        },
        {
            "text": "S",
            "probability": 7.595563926948643e-05,
            "start_logit": 2.995593786239624,
            "end_logit": -2.838981866836548
        }
    ],
    "58a877cf38c171fb5b000004_000": [
        {
            "text": "transposable element",
            "probability": 0.8933541847139598,
            "start_logit": 4.198267936706543,
            "end_logit": 3.149644613265991
        },
        {
            "text": "a transposable element",
            "probability": 0.06069316709802047,
            "start_logit": 1.5091159343719482,
            "end_logit": 3.149644613265991
        },
        {
            "text": "transposable element.",
            "probability": 0.013617846160506675,
            "start_logit": 4.198267936706543,
            "end_logit": -1.0339573621749878
        },
        {
            "text": "industrial melanism mutation in British peppered moths is a transposable element",
            "probability": 0.00772779495660679,
            "start_logit": -0.5518916249275208,
            "end_logit": 3.149644613265991
        },
        {
            "text": "transposable",
            "probability": 0.00658648927626854,
            "start_logit": 4.198267936706543,
            "end_logit": -1.7603180408477783
        },
        {
            "text": "melanism mutation in British peppered moths is a transposable element",
            "probability": 0.003937898826522571,
            "start_logit": -1.2260679006576538,
            "end_logit": 3.149644613265991
        },
        {
            "text": "The industrial melanism mutation in British peppered moths is a transposable element",
            "probability": 0.0030803375863702118,
            "start_logit": -1.471675992012024,
            "end_logit": 3.149644613265991
        },
        {
            "text": "mutation in British peppered moths is a transposable element",
            "probability": 0.0025773453014740003,
            "start_logit": -1.6499552726745605,
            "end_logit": 3.149644613265991
        },
        {
            "text": "trans",
            "probability": 0.0020674351886194094,
            "start_logit": 4.198267936706543,
            "end_logit": -2.919029712677002
        },
        {
            "text": "carbonaria",
            "probability": 0.001236524508717931,
            "start_logit": 1.149269938468933,
            "end_logit": -0.3840358853340149
        },
        {
            "text": "carbonaria-typica",
            "probability": 0.001010852546490717,
            "start_logit": 1.149269938468933,
            "end_logit": -0.5855464339256287
        },
        {
            "text": "transposable element. Discovering the mutational events that fuel adaptation to environmental change remains an important challenge for evolutionary biology. The classroom",
            "probability": 0.0009859168034641738,
            "start_logit": 4.198267936706543,
            "end_logit": -3.6595218181610107
        },
        {
            "text": "a transposable element.",
            "probability": 0.0009251764044732223,
            "start_logit": 1.5091159343719482,
            "end_logit": -1.0339573621749878
        },
        {
            "text": "peppered moths is a transposable element",
            "probability": 0.0008446871703071647,
            "start_logit": -2.7655041217803955,
            "end_logit": 3.149644613265991
        },
        {
            "text": "transposable element. Discovering the mutational events that fuel adaptation to environmental change remains an important challenge for evolutionary biology. The classroom example",
            "probability": 0.0004751576193297191,
            "start_logit": 4.198267936706543,
            "end_logit": -4.389447212219238
        },
        {
            "text": "a transposable",
            "probability": 0.00044747637731375574,
            "start_logit": 1.5091159343719482,
            "end_logit": -1.7603180408477783
        },
        {
            "text": "a trans",
            "probability": 0.0001404585006868044,
            "start_logit": 1.5091159343719482,
            "end_logit": -2.919029712677002
        },
        {
            "text": "industrial melanism mutation in British peppered moths is a transposable element.",
            "probability": 0.00011779865665789184,
            "start_logit": -0.5518916249275208,
            "end_logit": -1.0339573621749878
        },
        {
            "text": "industrial melanism",
            "probability": 0.0001046748063851234,
            "start_logit": -0.5518916249275208,
            "end_logit": -1.1520757675170898
        },
        {
            "text": "transposable element into the first intron of the gene cortex. Statistical inference based on the distribution of recombined carbonaria",
            "probability": 6.877749782569912e-05,
            "start_logit": -1.3899765014648438,
            "end_logit": -0.7339727282524109
        }
    ],
    "5880aef4c872c95565000001_000": [
        {
            "text": "CD38",
            "probability": 0.9282483915651756,
            "start_logit": 6.484390735626221,
            "end_logit": 5.799618721008301
        },
        {
            "text": "CD38 and SLAMF7",
            "probability": 0.034273526885676794,
            "start_logit": 6.484390735626221,
            "end_logit": 2.50069260597229
        },
        {
            "text": "daratumumab and elotuzumab, two monoclonal antibodies that target CD38",
            "probability": 0.01079245289750954,
            "start_logit": 2.0299384593963623,
            "end_logit": 5.799618721008301
        },
        {
            "text": "CD38 and SLAMF7,",
            "probability": 0.009841195391920998,
            "start_logit": 6.484390735626221,
            "end_logit": 1.2528965473175049
        },
        {
            "text": "proteasome inhibitor; and daratumumab and elotuzumab, two monoclonal antibodies that target CD38",
            "probability": 0.009289645515543066,
            "start_logit": 1.8799917697906494,
            "end_logit": 5.799618721008301
        },
        {
            "text": "elotuzumab, two monoclonal antibodies that target CD38",
            "probability": 0.0019041395086436333,
            "start_logit": 0.29512158036231995,
            "end_logit": 5.799618721008301
        },
        {
            "text": "SLAMF7",
            "probability": 0.0016014738144837814,
            "start_logit": 3.4209418296813965,
            "end_logit": 2.50069260597229
        },
        {
            "text": "CD",
            "probability": 0.0007126173202290587,
            "start_logit": 6.484390735626221,
            "end_logit": -1.3724913597106934
        },
        {
            "text": "CD38 and SLAMF",
            "probability": 0.0004999480074373753,
            "start_logit": 6.484390735626221,
            "end_logit": -1.7269318103790283
        },
        {
            "text": "target CD38",
            "probability": 0.0004770578728069899,
            "start_logit": -1.0890260934829712,
            "end_logit": 5.799618721008301
        },
        {
            "text": "SLAMF7,",
            "probability": 0.0004598422793181039,
            "start_logit": 3.4209418296813965,
            "end_logit": 1.2528965473175049
        },
        {
            "text": "38",
            "probability": 0.0004168795460735617,
            "start_logit": -1.223866581916809,
            "end_logit": 5.799618721008301
        },
        {
            "text": "daratumumab and elotuzumab, two monoclonal antibodies that target CD38 and SLAMF7",
            "probability": 0.00039848754698243064,
            "start_logit": 2.0299384593963623,
            "end_logit": 2.50069260597229
        },
        {
            "text": "and daratumumab and elotuzumab, two monoclonal antibodies that target CD38",
            "probability": 0.0002144424195677193,
            "start_logit": -1.8886226415634155,
            "end_logit": 5.799618721008301
        },
        {
            "text": "; and daratumumab and elotuzumab, two monoclonal antibodies that target CD38",
            "probability": 0.00019137756303171338,
            "start_logit": -2.002415657043457,
            "end_logit": 5.799618721008301
        },
        {
            "text": "CD38 and SLAMF7, respectively.",
            "probability": 0.00016549578273097375,
            "start_logit": 6.484390735626221,
            "end_logit": -2.8324902057647705
        },
        {
            "text": "CD38 and SL",
            "probability": 0.00016384071411688135,
            "start_logit": 6.484390735626221,
            "end_logit": -2.842541217803955
        },
        {
            "text": "two monoclonal antibodies that target CD38",
            "probability": 0.00013266912634784665,
            "start_logit": -2.3688056468963623,
            "end_logit": 5.799618721008301
        },
        {
            "text": "daratumumab and elotuzumab, two monoclonal antibodies that target CD38 and SLAMF7,",
            "probability": 0.0001144204920661453,
            "start_logit": 2.0299384593963623,
            "end_logit": 1.2528965473175049
        },
        {
            "text": "and elotuzumab, two monoclonal antibodies that target CD38",
            "probability": 0.00010209575033781894,
            "start_logit": -2.6307528018951416,
            "end_logit": 5.799618721008301
        }
    ],
    "5880aef4c872c95565000001_001": [
        {
            "text": "CD38",
            "probability": 0.7588925223915921,
            "start_logit": 4.730888843536377,
            "end_logit": 3.862600326538086
        },
        {
            "text": "SLAMF7",
            "probability": 0.11629528414382799,
            "start_logit": 3.771590232849121,
            "end_logit": 2.946171283721924
        },
        {
            "text": "CD38 antibody or CD38",
            "probability": 0.08630325295116391,
            "start_logit": 3.833751678466797,
            "end_logit": 2.585744619369507
        },
        {
            "text": "CD38-targeting antibodies,",
            "probability": 0.016451325353459573,
            "start_logit": 4.730888843536377,
            "end_logit": 0.031146205961704254
        },
        {
            "text": "SLAMF7)",
            "probability": 0.00920267680464789,
            "start_logit": 3.771590232849121,
            "end_logit": 0.40953317284584045
        },
        {
            "text": "daratumumab, and probably also other CD38",
            "probability": 0.002213017498843931,
            "start_logit": -1.106614351272583,
            "end_logit": 3.862600326538086
        },
        {
            "text": "CD38 and SLAMF7",
            "probability": 0.002124919331308289,
            "start_logit": 3.0097906589508057,
            "end_logit": -0.2944278120994568
        },
        {
            "text": "CD",
            "probability": 0.0013016921946866732,
            "start_logit": 4.730888843536377,
            "end_logit": -2.5055947303771973
        },
        {
            "text": "(anti-SLAMF7",
            "probability": 0.0012138392332662921,
            "start_logit": -0.7907540202140808,
            "end_logit": 2.946171283721924
        },
        {
            "text": "SLAMF",
            "probability": 0.00091062598901388,
            "start_logit": 3.771590232849121,
            "end_logit": -1.9035842418670654
        },
        {
            "text": "elotuzumab (anti-SLAMF7",
            "probability": 0.0008363342833206404,
            "start_logit": -1.1632691621780396,
            "end_logit": 2.946171283721924
        },
        {
            "text": "CD38-",
            "probability": 0.000756226015448025,
            "start_logit": 4.730888843536377,
            "end_logit": -3.0486748218536377
        },
        {
            "text": "CD38-targeting antibodies, interfere with blood compatibility testing and thereby complicate the safe release of blood products. Neutralization of the therapeutic CD",
            "probability": 0.0007197840020257182,
            "start_logit": 4.730888843536377,
            "end_logit": -3.0980639457702637
        },
        {
            "text": "38",
            "probability": 0.0005557984736612897,
            "start_logit": -2.488320827484131,
            "end_logit": 3.862600326538086
        },
        {
            "text": "other CD38",
            "probability": 0.0005292634546441218,
            "start_logit": -2.5372402667999268,
            "end_logit": 3.862600326538086
        },
        {
            "text": "anti-SLAMF7",
            "probability": 0.00036110138911608344,
            "start_logit": -2.003138780593872,
            "end_logit": 2.946171283721924
        },
        {
            "text": "CD38 antibody or",
            "probability": 0.00035459659422244826,
            "start_logit": 3.833751678466797,
            "end_logit": -2.9088971614837646
        },
        {
            "text": "CD38 and SLAMF7 in multiple myeloma.",
            "probability": 0.00033993469336187276,
            "start_logit": 3.0097906589508057,
            "end_logit": -2.1271634101867676
        },
        {
            "text": "CD38-targeting antibodies have marked single agent activity in extensively pretreated MM,",
            "probability": 0.0003233180471883713,
            "start_logit": 2.837425470352173,
            "end_logit": -2.004915237426758
        },
        {
            "text": "CD38-targeting",
            "probability": 0.0003144871552008566,
            "start_logit": 4.730888843536377,
            "end_logit": -3.926071882247925
        }
    ],
    "5880aef4c872c95565000001_002": [
        {
            "text": "CD38",
            "probability": 0.7430913390867754,
            "start_logit": 6.590532302856445,
            "end_logit": 6.423523426055908
        },
        {
            "text": "RANKL",
            "probability": 0.16170829744436543,
            "start_logit": 6.1883931159973145,
            "end_logit": 5.300637722015381
        },
        {
            "text": "RANKL) or BHQ880 (anti-DKK-1",
            "probability": 0.02444203579148298,
            "start_logit": 6.1883931159973145,
            "end_logit": 3.4111480712890625
        },
        {
            "text": "CD38) and elotuzumab (anti-CS1",
            "probability": 0.012648322134852912,
            "start_logit": 6.590532302856445,
            "end_logit": 2.350229024887085
        },
        {
            "text": "RANKL) or BHQ880 (anti-DKK",
            "probability": 0.011583641525353308,
            "start_logit": 6.1883931159973145,
            "end_logit": 2.6644375324249268
        },
        {
            "text": "CD38)",
            "probability": 0.008469349757186858,
            "start_logit": 6.590532302856445,
            "end_logit": 1.9491581916809082
        },
        {
            "text": "daratumumab (anti-CD38",
            "probability": 0.008395542520929304,
            "start_logit": 2.1074142456054688,
            "end_logit": 6.423523426055908
        },
        {
            "text": "(anti-CD38",
            "probability": 0.005883012526882248,
            "start_logit": 1.7517822980880737,
            "end_logit": 6.423523426055908
        },
        {
            "text": "DKK-1",
            "probability": 0.005209061952110186,
            "start_logit": 4.642488479614258,
            "end_logit": 3.4111480712890625
        },
        {
            "text": "RANKL) or BHQ880 (anti-DKK-1)",
            "probability": 0.0043887117060835415,
            "start_logit": 6.1883931159973145,
            "end_logit": 1.6938793659210205
        },
        {
            "text": "CD38) and elotuzumab (anti-CS1)",
            "probability": 0.0029684597059194324,
            "start_logit": 6.590532302856445,
            "end_logit": 0.9007476568222046
        },
        {
            "text": "RANKL)",
            "probability": 0.002812496787809851,
            "start_logit": 6.1883931159973145,
            "end_logit": 1.2489162683486938
        },
        {
            "text": "DKK",
            "probability": 0.0024686939685125337,
            "start_logit": 4.642488479614258,
            "end_logit": 2.6644375324249268
        },
        {
            "text": "anti-CD38",
            "probability": 0.001527225685863875,
            "start_logit": 0.40316614508628845,
            "end_logit": 6.423523426055908
        },
        {
            "text": "denosumab (anti-RANKL",
            "probability": 0.001022180238658001,
            "start_logit": 1.1245368719100952,
            "end_logit": 5.300637722015381
        },
        {
            "text": "DKK-1)",
            "probability": 0.0009353178009381065,
            "start_logit": 4.642488479614258,
            "end_logit": 1.6938793659210205
        },
        {
            "text": "Dominantly daratumumab (anti-CD38",
            "probability": 0.0008429250275811506,
            "start_logit": -0.19116392731666565,
            "end_logit": 6.423523426055908
        },
        {
            "text": "(anti-RANKL",
            "probability": 0.0007164214780254399,
            "start_logit": 0.7691124081611633,
            "end_logit": 5.300637722015381
        },
        {
            "text": "anti-RANKL",
            "probability": 0.0005155180733780057,
            "start_logit": 0.44001612067222595,
            "end_logit": 5.300637722015381
        },
        {
            "text": "CD38) and elotuzumab",
            "probability": 0.00037144678729127747,
            "start_logit": 6.590532302856445,
            "end_logit": -1.177645206451416
        }
    ],
    "5880aef4c872c95565000001_003": [
        {
            "text": "CD38",
            "probability": 0.7653205166689852,
            "start_logit": 6.0152974128723145,
            "end_logit": 5.171952724456787
        },
        {
            "text": "CD38 IgG1-\u03ba",
            "probability": 0.19292699773553493,
            "start_logit": 6.0152974128723145,
            "end_logit": 3.7939698696136475
        },
        {
            "text": "CD38 IgG1",
            "probability": 0.024835418204924967,
            "start_logit": 6.0152974128723145,
            "end_logit": 1.7439287900924683
        },
        {
            "text": "Daratumumab is a fully human anti-CD38",
            "probability": 0.008233357790100404,
            "start_logit": 1.4831966161727905,
            "end_logit": 5.171952724456787
        },
        {
            "text": "Daratumumab is a fully human anti-CD38 IgG1-\u03ba",
            "probability": 0.0020755186423593256,
            "start_logit": 1.4831966161727905,
            "end_logit": 3.7939698696136475
        },
        {
            "text": "anti-CD38",
            "probability": 0.0018116409196980202,
            "start_logit": -0.03076428920030594,
            "end_logit": 5.171952724456787
        },
        {
            "text": "IgG1-\u03ba",
            "probability": 0.0006293496745369968,
            "start_logit": 0.2899172902107239,
            "end_logit": 3.7939698696136475
        },
        {
            "text": "38",
            "probability": 0.0005857177249339015,
            "start_logit": -1.1599146127700806,
            "end_logit": 5.171952724456787
        },
        {
            "text": "CD",
            "probability": 0.00056935842275084,
            "start_logit": 6.0152974128723145,
            "end_logit": -2.0315871238708496
        },
        {
            "text": "anti-CD38 IgG1-\u03ba",
            "probability": 0.0004566902833513787,
            "start_logit": -0.03076428920030594,
            "end_logit": 3.7939698696136475
        },
        {
            "text": "CD38 IgG1-",
            "probability": 0.00041428244815556943,
            "start_logit": 6.0152974128723145,
            "end_logit": -2.3495492935180664
        },
        {
            "text": "daratumumab IFE reflex assay (DIRA). Daratumumab is a fully human anti-CD38",
            "probability": 0.0003183990214969163,
            "start_logit": -1.7694472074508667,
            "end_logit": 5.171952724456787
        },
        {
            "text": ". Daratumumab is a fully human anti-CD38",
            "probability": 0.00030173302017810804,
            "start_logit": -1.8232100009918213,
            "end_logit": 5.171952724456787
        },
        {
            "text": "human anti-CD38",
            "probability": 0.0002837619653161623,
            "start_logit": -1.8846168518066406,
            "end_logit": 5.171952724456787
        },
        {
            "text": "Daratumumab is a fully human anti-CD38 IgG1",
            "probability": 0.0002671807164374781,
            "start_logit": 1.4831966161727905,
            "end_logit": 1.7439287900924683
        },
        {
            "text": "fully human anti-CD38",
            "probability": 0.0002336161532007508,
            "start_logit": -2.079073190689087,
            "end_logit": 5.171952724456787
        },
        {
            "text": "CD38 IgG1-\u03ba monoclonal antibody",
            "probability": 0.0002331620958278595,
            "start_logit": 6.0152974128723145,
            "end_logit": -2.924363374710083
        },
        {
            "text": "-CD38",
            "probability": 0.00020026155336251835,
            "start_logit": -2.233128309249878,
            "end_logit": 5.171952724456787
        },
        {
            "text": "\u03ba",
            "probability": 0.00015538540668113792,
            "start_logit": -1.1088612079620361,
            "end_logit": 3.7939698696136475
        },
        {
            "text": "38 IgG1-\u03ba",
            "probability": 0.00014765155216773097,
            "start_logit": -1.1599146127700806,
            "end_logit": 3.7939698696136475
        }
    ],
    "5884c72fe56acf517600000f_000": [
        {
            "text": "PD-L1",
            "probability": 0.9635939911292513,
            "start_logit": 5.946115016937256,
            "end_logit": 4.683319568634033
        },
        {
            "text": "PD-L1 mAb would potentially be able to block PD-1/PD-L1",
            "probability": 0.007394439681940803,
            "start_logit": 4.180846691131592,
            "end_logit": 1.578646183013916
        },
        {
            "text": "avelumab) is a fully human IgG1 anti-PD-L1",
            "probability": 0.005791567173974056,
            "start_logit": 1.510674238204956,
            "end_logit": 4.004493236541748
        },
        {
            "text": "PD-L1 Antibody Avelumab",
            "probability": 0.0034758225158593864,
            "start_logit": 5.946115016937256,
            "end_logit": -0.9415193200111389
        },
        {
            "text": "PD-L",
            "probability": 0.0033911800219199838,
            "start_logit": 5.946115016937256,
            "end_logit": -0.9661725163459778
        },
        {
            "text": "MSB0010718C (designated avelumab) is a fully human IgG1 anti-PD-L1",
            "probability": 0.0027088367029917573,
            "start_logit": 0.7507905960083008,
            "end_logit": 4.004493236541748
        },
        {
            "text": "Anti-PD-L1",
            "probability": 0.002123891305720727,
            "start_logit": -0.1713050901889801,
            "end_logit": 4.683319568634033
        },
        {
            "text": "IgG1 anti-PD-L1",
            "probability": 0.0020079987754321282,
            "start_logit": 0.4514099061489105,
            "end_logit": 4.004493236541748
        },
        {
            "text": "PD",
            "probability": 0.0015427645085169498,
            "start_logit": 5.946115016937256,
            "end_logit": -1.7537745237350464
        },
        {
            "text": "PD-1/PD-L1",
            "probability": 0.0015179845579269117,
            "start_logit": 1.9808863401412964,
            "end_logit": 2.1952617168426514
        },
        {
            "text": "PD-L1 mAb would potentially be able to block PD-1",
            "probability": 0.0009894783772541964,
            "start_logit": 4.180846691131592,
            "end_logit": -0.4326595067977905
        },
        {
            "text": "PD-L1 Antibody Avelumab (MSB0010718C) on Human Tumor Cells.",
            "probability": 0.0009083332009715334,
            "start_logit": 5.946115016937256,
            "end_logit": -2.283494472503662
        },
        {
            "text": "-PD-L1",
            "probability": 0.0007227200754971961,
            "start_logit": -1.2492883205413818,
            "end_logit": 4.683319568634033
        },
        {
            "text": "PD-1 on immune cells interacting with PD-L1",
            "probability": 0.0006969743546049169,
            "start_logit": 1.4578251838684082,
            "end_logit": 1.9399327039718628
        },
        {
            "text": "PD-L1 m",
            "probability": 0.0005643828287493789,
            "start_logit": 5.133265972137451,
            "end_logit": -1.946523904800415
        },
        {
            "text": "PD-L1 Antibody Avelumab (MSB0010718C)",
            "probability": 0.0005630950869436999,
            "start_logit": 5.946115016937256,
            "end_logit": -2.761657238006592
        },
        {
            "text": "(designated avelumab) is a fully human IgG1 anti-PD-L1",
            "probability": 0.0005486437799636328,
            "start_logit": -0.846034586429596,
            "end_logit": 4.004493236541748
        },
        {
            "text": "PD-1",
            "probability": 0.0005357704522093211,
            "start_logit": 1.9808863401412964,
            "end_logit": 1.153828740119934
        },
        {
            "text": "human IgG1 anti-PD-L1",
            "probability": 0.00047098910574528704,
            "start_logit": -0.998649001121521,
            "end_logit": 4.004493236541748
        },
        {
            "text": "anti-PD-L1",
            "probability": 0.00045113636452728275,
            "start_logit": -1.0417143106460571,
            "end_logit": 4.004493236541748
        }
    ],
    "5884c72fe56acf517600000f_001": [
        {
            "text": "programmed death-ligand 1",
            "probability": 0.48156805417255844,
            "start_logit": 6.380879878997803,
            "end_logit": 4.831722259521484
        },
        {
            "text": "PD-L1",
            "probability": 0.268079768933147,
            "start_logit": 5.888984203338623,
            "end_logit": 4.737854957580566
        },
        {
            "text": "programmed death-ligand 1 (PD-L1",
            "probability": 0.1492342995031276,
            "start_logit": 6.380879878997803,
            "end_logit": 3.6601922512054443
        },
        {
            "text": "programmed death-ligand 1 (PD-L1)",
            "probability": 0.06640323496054401,
            "start_logit": 6.380879878997803,
            "end_logit": 2.8504204750061035
        },
        {
            "text": "PD-L1)",
            "probability": 0.009202398270569774,
            "start_logit": 4.404598236083984,
            "end_logit": 2.8504204750061035
        },
        {
            "text": "programmed death-ligand",
            "probability": 0.006856093959291533,
            "start_logit": 6.380879878997803,
            "end_logit": 0.5798125863075256
        },
        {
            "text": "(PD-L1",
            "probability": 0.003062851086646953,
            "start_logit": 2.49470853805542,
            "end_logit": 3.6601922512054443
        },
        {
            "text": "avelumab, an anti-programmed death-ligand 1",
            "probability": 0.0026745251993337276,
            "start_logit": 1.1876041889190674,
            "end_logit": 4.831722259521484
        },
        {
            "text": "PD-L",
            "probability": 0.0024422567252388146,
            "start_logit": 5.888984203338623,
            "end_logit": 0.03949287533760071
        },
        {
            "text": "programmed death",
            "probability": 0.0016174828577967726,
            "start_logit": 6.380879878997803,
            "end_logit": -0.8644541501998901
        },
        {
            "text": "(PD-L1)",
            "probability": 0.0013628450097124803,
            "start_logit": 2.49470853805542,
            "end_logit": 2.8504204750061035
        },
        {
            "text": "death-ligand 1",
            "probability": 0.0011515116871528817,
            "start_logit": 0.3449079096317291,
            "end_logit": 4.831722259521484
        },
        {
            "text": "programmed death-ligand 1 (PD-L1) antibody.",
            "probability": 0.0011008025254930387,
            "start_logit": 6.380879878997803,
            "end_logit": -1.2492858171463013
        },
        {
            "text": "Programmed cell death protein-1",
            "probability": 0.0008563847350817896,
            "start_logit": 3.0559957027435303,
            "end_logit": 1.8245233297348022
        },
        {
            "text": "avelumab, an anti-programmed death-ligand 1 (PD-L1",
            "probability": 0.0008288151408046109,
            "start_logit": 1.1876041889190674,
            "end_logit": 3.6601922512054443
        },
        {
            "text": "programmed death-ligand 1 (PD-L",
            "probability": 0.0007432025078430697,
            "start_logit": 6.380879878997803,
            "end_logit": -1.6421120166778564
        },
        {
            "text": "PD-L1 monoclonal antibody (mAb), avelumab,",
            "probability": 0.0007410631047193036,
            "start_logit": 5.191319465637207,
            "end_logit": -0.4554343819618225
        },
        {
            "text": "PD",
            "probability": 0.0007243499764288132,
            "start_logit": 5.888984203338623,
            "end_logit": -1.175910234451294
        },
        {
            "text": "PD-L1 antibody, avelumab,",
            "probability": 0.000681389767892014,
            "start_logit": 5.888984203338623,
            "end_logit": -1.2370504140853882
        },
        {
            "text": "Programmed cell death protein-1 ligand (PD-L1",
            "probability": 0.0006686698766173295,
            "start_logit": 3.0559957027435303,
            "end_logit": 1.5770940780639648
        }
    ],
    "5884c72fe56acf517600000f_002": [
        {
            "text": "PD-L1",
            "probability": 0.4537200791730384,
            "start_logit": 5.206395149230957,
            "end_logit": 3.9370505809783936
        },
        {
            "text": "PD-1 (pembrolizumab and nivolumab) or PD-L1",
            "probability": 0.23071116612783454,
            "start_logit": 4.530081272125244,
            "end_logit": 3.9370505809783936
        },
        {
            "text": "PD-1",
            "probability": 0.11206178076265846,
            "start_logit": 4.530081272125244,
            "end_logit": 3.2149343490600586
        },
        {
            "text": "PD-L1 (atezolizumab,",
            "probability": 0.04399076908938154,
            "start_logit": 5.206395149230957,
            "end_logit": 1.6035499572753906
        },
        {
            "text": "PD-L1). Several drugs targeting PD-1",
            "probability": 0.02717789210642803,
            "start_logit": 3.1134347915649414,
            "end_logit": 3.2149343490600586
        },
        {
            "text": "PD-1) and its ligand programmed death ligand 1 (PD-L1). Several drugs targeting PD-1",
            "probability": 0.02675511540787828,
            "start_logit": 3.0977566242218018,
            "end_logit": 3.2149343490600586
        },
        {
            "text": "PD-1 (pembrolizumab and nivolumab) or PD-L1 (atezolizumab,",
            "probability": 0.02236877339431314,
            "start_logit": 4.530081272125244,
            "end_logit": 1.6035499572753906
        },
        {
            "text": "programmed death receptor 1",
            "probability": 0.021599870368658465,
            "start_logit": 3.3897769451141357,
            "end_logit": 2.7088756561279297
        },
        {
            "text": "programmed death receptor 1 (PD-1",
            "probability": 0.010157343462171472,
            "start_logit": 3.3897769451141357,
            "end_logit": 1.9543852806091309
        },
        {
            "text": "programmed death receptor 1 (PD-1) and its ligand programmed death ligand 1 (PD-L1",
            "probability": 0.009514261909898231,
            "start_logit": 3.3897769451141357,
            "end_logit": 1.8889802694320679
        },
        {
            "text": "programmed death ligand 1 (PD-L1). Several drugs targeting PD-1",
            "probability": 0.008249955786010501,
            "start_logit": 1.9212387800216675,
            "end_logit": 3.2149343490600586
        },
        {
            "text": "PD-1 (pembrolizumab and nivolumab)",
            "probability": 0.008155669452355572,
            "start_logit": 4.530081272125244,
            "end_logit": 0.594597339630127
        },
        {
            "text": "PD-1) and its ligand programmed death ligand 1 (PD-L1",
            "probability": 0.007104807059835526,
            "start_logit": 3.0977566242218018,
            "end_logit": 1.8889802694320679
        },
        {
            "text": "(PD-1) and its ligand programmed death ligand 1 (PD-L1). Several drugs targeting PD-1",
            "probability": 0.0032801648295272576,
            "start_logit": 0.9989246129989624,
            "end_logit": 3.2149343490600586
        },
        {
            "text": "programmed death receptor 1 (PD-1)",
            "probability": 0.0031659907636250755,
            "start_logit": 3.3897769451141357,
            "end_logit": 0.7886543869972229
        },
        {
            "text": "programmed death receptor 1 (PD-1) and its ligand programmed death ligand 1",
            "probability": 0.0031220280117488534,
            "start_logit": 3.3897769451141357,
            "end_logit": 0.7746711373329163
        },
        {
            "text": "PD-1)",
            "probability": 0.00236421424402622,
            "start_logit": 3.0977566242218018,
            "end_logit": 0.7886543869972229
        },
        {
            "text": "PD-1) and its ligand programmed death ligand 1",
            "probability": 0.002331384911298368,
            "start_logit": 3.0977566242218018,
            "end_logit": 0.7746711373329163
        },
        {
            "text": "programmed death ligand 1 (PD-L1",
            "probability": 0.002190771492412208,
            "start_logit": 1.9212387800216675,
            "end_logit": 1.8889802694320679
        },
        {
            "text": "PD-L1). Several drugs targeting PD-1 (pembrolizumab and nivolumab)",
            "probability": 0.0019779616468996084,
            "start_logit": 3.1134347915649414,
            "end_logit": 0.594597339630127
        }
    ],
    "5884c72fe56acf517600000f_003": [
        {
            "text": "PD-L1",
            "probability": 0.9302479861488014,
            "start_logit": 5.236781120300293,
            "end_logit": 4.323395729064941
        },
        {
            "text": "PD-L1/PD-1 pathway. We assessed treatment with avelumab, an anti-PD-L1",
            "probability": 0.041907783077665836,
            "start_logit": 2.1368014812469482,
            "end_logit": 4.323395729064941
        },
        {
            "text": "avelumab, an anti-PD-L1",
            "probability": 0.012998553323580195,
            "start_logit": 0.9661679863929749,
            "end_logit": 4.323395729064941
        },
        {
            "text": "PD-L",
            "probability": 0.003256107721919524,
            "start_logit": 5.236781120300293,
            "end_logit": -1.3315229415893555
        },
        {
            "text": "PD-L1 monoclonal antibody,",
            "probability": 0.003114280685905647,
            "start_logit": 5.236781120300293,
            "end_logit": -1.3760572671890259
        },
        {
            "text": "PD",
            "probability": 0.0023295821020812013,
            "start_logit": 5.236781120300293,
            "end_logit": -1.6663665771484375
        },
        {
            "text": "PD-1 pathway. We assessed treatment with avelumab, an anti-PD-L1",
            "probability": 0.001366765050353386,
            "start_logit": -1.2862234115600586,
            "end_logit": 4.323395729064941
        },
        {
            "text": "L1",
            "probability": 0.0008881209148457262,
            "start_logit": -1.7173174619674683,
            "end_logit": 4.323395729064941
        },
        {
            "text": "anti-PD-L1",
            "probability": 0.0007217639595392397,
            "start_logit": -1.924727201461792,
            "end_logit": 4.323395729064941
        },
        {
            "text": "1",
            "probability": 0.0007030687704908916,
            "start_logit": -1.9509706497192383,
            "end_logit": 4.323395729064941
        },
        {
            "text": "PD-L1/PD-1",
            "probability": 0.0003423133070912977,
            "start_logit": 2.1368014812469482,
            "end_logit": -0.4841046929359436
        },
        {
            "text": "the PD-L1/PD-1 pathway. We assessed treatment with avelumab, an anti-PD-L1",
            "probability": 0.00028827431661798697,
            "start_logit": -2.842512845993042,
            "end_logit": 4.323395729064941
        },
        {
            "text": "1/PD-1 pathway. We assessed treatment with avelumab, an anti-PD-L1",
            "probability": 0.00026752502495880207,
            "start_logit": -2.9172122478485107,
            "end_logit": 4.323395729064941
        },
        {
            "text": "-L1",
            "probability": 0.00025822549803603716,
            "start_logit": -2.952592134475708,
            "end_logit": 4.323395729064941
        },
        {
            "text": ". We assessed treatment with avelumab, an anti-PD-L1",
            "probability": 0.0002513100319585679,
            "start_logit": -2.9797379970550537,
            "end_logit": 4.323395729064941
        },
        {
            "text": "-PD-L1",
            "probability": 0.0002450385903742534,
            "start_logit": -3.005009651184082,
            "end_logit": 4.323395729064941
        },
        {
            "text": "an anti-PD-L1",
            "probability": 0.00023914095448003685,
            "start_logit": -3.029372215270996,
            "end_logit": 4.323395729064941
        },
        {
            "text": "We assessed treatment with avelumab, an anti-PD-L1",
            "probability": 0.00021348251553784137,
            "start_logit": -3.1428704261779785,
            "end_logit": 4.323395729064941
        },
        {
            "text": "L1/PD-1 pathway. We assessed treatment with avelumab, an anti-PD-L1",
            "probability": 0.00019669275543113076,
            "start_logit": -3.2247824668884277,
            "end_logit": 4.323395729064941
        },
        {
            "text": ", an anti-PD-L1",
            "probability": 0.00016398525033106925,
            "start_logit": -3.406648874282837,
            "end_logit": 4.323395729064941
        }
    ],
    "5884c72fe56acf517600000f_004": [
        {
            "text": "PD-L1",
            "probability": 0.8656759503881368,
            "start_logit": 5.927375316619873,
            "end_logit": 4.786815643310547
        },
        {
            "text": "programed death-ligand 1",
            "probability": 0.07039511484991695,
            "start_logit": 4.362257480621338,
            "end_logit": 3.8425467014312744
        },
        {
            "text": "death-ligand 1",
            "probability": 0.04039604331884931,
            "start_logit": 3.8068654537200928,
            "end_logit": 3.8425467014312744
        },
        {
            "text": "PD-L",
            "probability": 0.004411644175654914,
            "start_logit": 5.927375316619873,
            "end_logit": -0.49244755506515503
        },
        {
            "text": "programed death-ligand 1 (Avelumab).",
            "probability": 0.003092102737299022,
            "start_logit": 4.362257480621338,
            "end_logit": 0.7172741889953613
        },
        {
            "text": "PD-L1 antibody (Avelumab",
            "probability": 0.002393161465231834,
            "start_logit": 5.927375316619873,
            "end_logit": -1.1040797233581543
        },
        {
            "text": "death-ligand 1 (Avelumab).",
            "probability": 0.0017743946634446207,
            "start_logit": 3.8068654537200928,
            "end_logit": 0.7172741889953613
        },
        {
            "text": "PD-L1 antibody (Avelumab)",
            "probability": 0.0017560777262502427,
            "start_logit": 5.927375316619873,
            "end_logit": -1.4136122465133667
        },
        {
            "text": "programed death-ligand 1 (Avelumab). OBJECTIVE: The programed death-1",
            "probability": 0.0014405940724553773,
            "start_logit": 4.362257480621338,
            "end_logit": -0.046521589159965515
        },
        {
            "text": "PD",
            "probability": 0.0011846063551041242,
            "start_logit": 5.927375316619873,
            "end_logit": -1.8072844743728638
        },
        {
            "text": "PD-L1 antibody (Avelumab) in chronically SIV-infected rhesus macaques.",
            "probability": 0.0009865201208576612,
            "start_logit": 5.927375316619873,
            "end_logit": -1.9902665615081787
        },
        {
            "text": "programed death-ligand",
            "probability": 0.0009485156605420715,
            "start_logit": 4.362257480621338,
            "end_logit": -0.4644341468811035
        },
        {
            "text": "anti-programed death-ligand 1",
            "probability": 0.0009412252031009396,
            "start_logit": 0.04756076633930206,
            "end_logit": 3.8425467014312744
        },
        {
            "text": "programed death-ligand 1 (Avelumab)",
            "probability": 0.0008799612982309066,
            "start_logit": 4.362257480621338,
            "end_logit": -0.5394545197486877
        },
        {
            "text": "death-ligand 1 (Avelumab). OBJECTIVE: The programed death-1",
            "probability": 0.0008266809519361642,
            "start_logit": 3.8068654537200928,
            "end_logit": -0.046521589159965515
        },
        {
            "text": "programed death-ligand 1 (Avelumab",
            "probability": 0.0007740195784031707,
            "start_logit": 4.362257480621338,
            "end_logit": -0.6677352786064148
        },
        {
            "text": "L1",
            "probability": 0.000568443899617717,
            "start_logit": -1.400987982749939,
            "end_logit": 4.786815643310547
        },
        {
            "text": "death-ligand",
            "probability": 0.0005443031067362436,
            "start_logit": 3.8068654537200928,
            "end_logit": -0.4644341468811035
        },
        {
            "text": "anti-PD-L1",
            "probability": 0.0005056770540254905,
            "start_logit": -1.517992377281189,
            "end_logit": 4.786815643310547
        },
        {
            "text": "death-ligand 1 (Avelumab)",
            "probability": 0.0005049633742061935,
            "start_logit": 3.8068654537200928,
            "end_logit": -0.5394545197486877
        }
    ],
    "5884c72fe56acf517600000f_005": [
        {
            "text": "PD-L1",
            "probability": 0.8303338452495945,
            "start_logit": 4.926914691925049,
            "end_logit": 3.808574914932251
        },
        {
            "text": "PD-1 and avelumab targeting PD-L1",
            "probability": 0.0981234443848921,
            "start_logit": 2.7913131713867188,
            "end_logit": 3.808574914932251
        },
        {
            "text": "avelumab targeting PD-L1",
            "probability": 0.025370658348452254,
            "start_logit": 1.4386801719665527,
            "end_logit": 3.808574914932251
        },
        {
            "text": "PD-1",
            "probability": 0.011105951902117361,
            "start_logit": 2.7913131713867188,
            "end_logit": 1.62982976436615
        },
        {
            "text": "pembrolizumab targeting PD-1 and avelumab targeting PD-L1",
            "probability": 0.0106950886524885,
            "start_logit": 0.5748714804649353,
            "end_logit": 3.808574914932251
        },
        {
            "text": "PD-L",
            "probability": 0.00501152713902134,
            "start_logit": 4.926914691925049,
            "end_logit": -1.3015122413635254
        },
        {
            "text": "PD-L1 blockade therapies are briefly summarized. We then focus on the recent breakthrough work concerning the structural basis of the PD-1",
            "probability": 0.003942560017948,
            "start_logit": 2.8664443492889404,
            "end_logit": 0.5190476775169373
        },
        {
            "text": "PD",
            "probability": 0.002466072026421093,
            "start_logit": 4.926914691925049,
            "end_logit": -2.0106263160705566
        },
        {
            "text": "PD-1/PD-L1",
            "probability": 0.002425532087934588,
            "start_logit": 0.9234217405319214,
            "end_logit": 1.9762909412384033
        },
        {
            "text": "PD-Ls interaction and how therapeutic antibodies, pembrolizumab targeting PD-1",
            "probability": 0.001848512555785494,
            "start_logit": 0.9982132911682129,
            "end_logit": 1.62982976436615
        },
        {
            "text": "PD-1 and the present understanding of antibody-based PD-1/PD-L1",
            "probability": 0.0014755426869068513,
            "start_logit": 0.4263966679573059,
            "end_logit": 1.9762909412384033
        },
        {
            "text": "targeting PD-L1",
            "probability": 0.0013632657337921462,
            "start_logit": -1.4850300550460815,
            "end_logit": 3.808574914932251
        },
        {
            "text": "PD-1/PD-Ls interaction and how therapeutic antibodies, pembrolizumab targeting PD-1",
            "probability": 0.0012168526162268539,
            "start_logit": 0.5800997018814087,
            "end_logit": 1.62982976436615
        },
        {
            "text": "pembrolizumab targeting PD-1",
            "probability": 0.001210507243279229,
            "start_logit": 0.5748714804649353,
            "end_logit": 1.62982976436615
        },
        {
            "text": "1",
            "probability": 0.0007234352739248436,
            "start_logit": -2.118657350540161,
            "end_logit": 3.808574914932251
        },
        {
            "text": "L1",
            "probability": 0.000621183370921994,
            "start_logit": -2.2710421085357666,
            "end_logit": 3.808574914932251
        },
        {
            "text": "PD-1 and avelumab targeting PD-L",
            "probability": 0.0005922296282663516,
            "start_logit": 2.7913131713867188,
            "end_logit": -1.3015122413635254
        },
        {
            "text": "and avelumab targeting PD-L1",
            "probability": 0.0005645846499986627,
            "start_logit": -2.3665781021118164,
            "end_logit": 3.808574914932251
        },
        {
            "text": "targeting PD-1 and avelumab targeting PD-L1",
            "probability": 0.0004937740904293529,
            "start_logit": -2.5005903244018555,
            "end_logit": 3.808574914932251
        },
        {
            "text": "1 and avelumab targeting PD-L1",
            "probability": 0.0004154323415988955,
            "start_logit": -2.6733486652374268,
            "end_logit": 3.808574914932251
        }
    ],
    "5891f9e549702f2e01000002_000": [
        {
            "text": "restless legs syndrome",
            "probability": 0.5954500421047934,
            "start_logit": 6.537150859832764,
            "end_logit": 6.034178733825684
        },
        {
            "text": "Restless Legs Syndrome",
            "probability": 0.37269614872880574,
            "start_logit": 6.550633430480957,
            "end_logit": 5.552142143249512
        },
        {
            "text": "restless legs syndrome (WED/RLS",
            "probability": 0.01773280825694534,
            "start_logit": 6.537150859832764,
            "end_logit": 2.520277738571167
        },
        {
            "text": "restless legs syndrome (WED/RLS)",
            "probability": 0.006223028632652351,
            "start_logit": 6.537150859832764,
            "end_logit": 1.4731179475784302
        },
        {
            "text": "Willis-Ekbom disease/restless legs syndrome",
            "probability": 0.0017722147249319147,
            "start_logit": 0.7200633883476257,
            "end_logit": 6.034178733825684
        },
        {
            "text": "Restless Legs",
            "probability": 0.0010956985554773158,
            "start_logit": 6.550633430480957,
            "end_logit": -0.2772292196750641
        },
        {
            "text": "RLS",
            "probability": 0.0009071820530819477,
            "start_logit": 3.5643222332000732,
            "end_logit": 2.520277738571167
        },
        {
            "text": "Restless Legs Syndrome in",
            "probability": 0.0005632844626200515,
            "start_logit": 6.550633430480957,
            "end_logit": -0.9425918459892273
        },
        {
            "text": "Restless Legs Syndrome in Children with Neurodevelopmental Conditions.",
            "probability": 0.000528332239037666,
            "start_logit": 6.550633430480957,
            "end_logit": -1.0066512823104858
        },
        {
            "text": "Restless Legs Syndrome in Children",
            "probability": 0.0005124802161995888,
            "start_logit": 6.550633430480957,
            "end_logit": -1.0371145009994507
        },
        {
            "text": "Willis-Ekbom Disease/Restless Legs Syndrome",
            "probability": 0.00046151692005934385,
            "start_logit": -0.14336660504341125,
            "end_logit": 5.552142143249512
        },
        {
            "text": "restless legs syndrome (WED",
            "probability": 0.00041584582076420245,
            "start_logit": 6.537150859832764,
            "end_logit": -1.2325794696807861
        },
        {
            "text": "RLS)",
            "probability": 0.0003183601722612765,
            "start_logit": 3.5643222332000732,
            "end_logit": 1.4731179475784302
        },
        {
            "text": "Syndrome",
            "probability": 0.00024975628532117723,
            "start_logit": -0.7573997378349304,
            "end_logit": 5.552142143249512
        },
        {
            "text": "restless legs",
            "probability": 0.00020742886162637524,
            "start_logit": 6.537150859832764,
            "end_logit": -1.9281055927276611
        },
        {
            "text": "BACKGROUND: Willis-Ekbom disease/restless legs syndrome",
            "probability": 0.00020148901756737313,
            "start_logit": -1.454187035560608,
            "end_logit": 6.034178733825684
        },
        {
            "text": "restless legs syndrome (WED/RLS) seems to be a frequent cause of intractable chronic insomnia",
            "probability": 0.00018122072024761362,
            "start_logit": 6.537150859832764,
            "end_logit": -2.063178300857544
        },
        {
            "text": "/restless legs syndrome",
            "probability": 0.00017366608737286892,
            "start_logit": -1.6027874946594238,
            "end_logit": 6.034178733825684
        },
        {
            "text": "syndrome",
            "probability": 0.0001702353889504658,
            "start_logit": -1.6227397918701172,
            "end_logit": 6.034178733825684
        },
        {
            "text": "Restless Legs Syndrome in Children with Neurodevelopmental Conditions",
            "probability": 0.0001392607512841479,
            "start_logit": 6.550633430480957,
            "end_logit": -2.3400285243988037
        }
    ],
    "5891f9e549702f2e01000002_001": [
        {
            "text": "restless legs syndrome",
            "probability": 0.8278924277166932,
            "start_logit": 6.03363561630249,
            "end_logit": 5.582534313201904
        },
        {
            "text": "restless legs syndrome/Willis-Ekbom disease (RLS/WED",
            "probability": 0.10939681379172458,
            "start_logit": 6.03363561630249,
            "end_logit": 3.5586328506469727
        },
        {
            "text": "restless legs syndrome/Willis-Ekbom disease (RLS/WED)",
            "probability": 0.01837495361978771,
            "start_logit": 6.03363561630249,
            "end_logit": 1.77463960647583
        },
        {
            "text": "RLS/WED",
            "probability": 0.014802919264363727,
            "start_logit": 4.033478260040283,
            "end_logit": 3.5586328506469727
        },
        {
            "text": "restless legs syndrome/Willis-Ekbom disease",
            "probability": 0.008968931464008236,
            "start_logit": 5.954909801483154,
            "end_logit": 1.136143445968628
        },
        {
            "text": "restless legs syndrome/Willis-Ekbom disease (RLS/WED):",
            "probability": 0.0034173041937703365,
            "start_logit": 6.03363561630249,
            "end_logit": 0.09250307828187943
        },
        {
            "text": "restless legs syndrome/Willis-Ekbom",
            "probability": 0.0034106483810283695,
            "start_logit": 6.03363561630249,
            "end_logit": 0.09055349975824356
        },
        {
            "text": "restless legs syndrome/",
            "probability": 0.0030284271472509573,
            "start_logit": 6.03363561630249,
            "end_logit": -0.028305523097515106
        },
        {
            "text": "restless legs syndrome/Willis-Ekbom disease (RLS",
            "probability": 0.0029504947588317727,
            "start_logit": 6.03363561630249,
            "end_logit": -0.05437604337930679
        },
        {
            "text": "RLS/WED)",
            "probability": 0.002486388273044213,
            "start_logit": 4.033478260040283,
            "end_logit": 1.77463960647583
        },
        {
            "text": "(RLS/WED",
            "probability": 0.0008809809427796831,
            "start_logit": 1.2119345664978027,
            "end_logit": 3.5586328506469727
        },
        {
            "text": "Willis-Ekbom disease (RLS/WED",
            "probability": 0.0007933854768579008,
            "start_logit": 1.1072077751159668,
            "end_logit": 3.5586328506469727
        },
        {
            "text": "restless legs",
            "probability": 0.0005871526782419829,
            "start_logit": 6.03363561630249,
            "end_logit": -1.6688193082809448
        },
        {
            "text": "sporadic restless legs syndrome",
            "probability": 0.0005179674260444096,
            "start_logit": -1.2343559265136719,
            "end_logit": 5.473799705505371
        },
        {
            "text": "legs syndrome",
            "probability": 0.0005072669426258528,
            "start_logit": -1.3639655113220215,
            "end_logit": 5.582534313201904
        },
        {
            "text": "RLS/WED):",
            "probability": 0.0004624090622827672,
            "start_logit": 4.033478260040283,
            "end_logit": 0.09250307828187943
        },
        {
            "text": "familial and sporadic restless legs syndrome",
            "probability": 0.0004479606119232248,
            "start_logit": -1.3795629739761353,
            "end_logit": 5.473799705505371
        },
        {
            "text": "WED): a clinical and polysomnographic study. Clinical features variability between familial and sporadic restless legs syndrome",
            "probability": 0.000408888202884421,
            "start_logit": -1.470826506614685,
            "end_logit": 5.473799705505371
        },
        {
            "text": "RLS",
            "probability": 0.0003992432155114463,
            "start_logit": 4.033478260040283,
            "end_logit": -0.05437604337930679
        },
        {
            "text": "syndrome",
            "probability": 0.0002654368303450412,
            "start_logit": -2.0116260051727295,
            "end_logit": 5.582534313201904
        }
    ],
    "5891f9e549702f2e01000002_002": [
        {
            "text": "Restless legs syndrome",
            "probability": 0.6468908298673951,
            "start_logit": 6.760941982269287,
            "end_logit": 6.027970314025879
        },
        {
            "text": "Restless legs syndrome (RLS)",
            "probability": 0.18201128719155937,
            "start_logit": 6.760941982269287,
            "end_logit": 4.759861469268799
        },
        {
            "text": "Restless legs syndrome (RLS",
            "probability": 0.08181149792599497,
            "start_logit": 6.760941982269287,
            "end_logit": 3.9602105617523193
        },
        {
            "text": "Restless legs syndrome. Restless legs syndrome",
            "probability": 0.02450259204415971,
            "start_logit": 3.4875433444976807,
            "end_logit": 6.027970314025879
        },
        {
            "text": "RLS)",
            "probability": 0.015885824243385926,
            "start_logit": 4.322300434112549,
            "end_logit": 4.759861469268799
        },
        {
            "text": "Restless legs syndrome (RLS),",
            "probability": 0.009003505454955695,
            "start_logit": 6.760941982269287,
            "end_logit": 1.7534067630767822
        },
        {
            "text": "RLS",
            "probability": 0.007140453194931077,
            "start_logit": 4.322300434112549,
            "end_logit": 3.9602105617523193
        },
        {
            "text": "Restless legs syndrome. Restless legs syndrome (RLS)",
            "probability": 0.006894128207693665,
            "start_logit": 3.4875433444976807,
            "end_logit": 4.759861469268799
        },
        {
            "text": "Restless legs syndrome (RLS), also known as Willis-Ekbom disease",
            "probability": 0.004735747511617247,
            "start_logit": 6.760941982269287,
            "end_logit": 1.1109323501586914
        },
        {
            "text": "Restless legs syndrome (RLS), also known as Willis-Ekbom disease (WED)",
            "probability": 0.00379796398002906,
            "start_logit": 6.760941982269287,
            "end_logit": 0.8902578949928284
        },
        {
            "text": "Restless legs syndrome (RLS), also known as Willis-Ekbom disease (WED),",
            "probability": 0.003352524020061086,
            "start_logit": 6.760941982269287,
            "end_logit": 0.7655062675476074
        },
        {
            "text": "Restless legs syndrome (RLS), also known as Willis-Ekbom disease (WED",
            "probability": 0.0031505599178604025,
            "start_logit": 6.760941982269287,
            "end_logit": 0.7033729553222656
        },
        {
            "text": "Restless legs syndrome. Restless legs syndrome (RLS",
            "probability": 0.0030988130696074185,
            "start_logit": 3.4875433444976807,
            "end_logit": 3.9602105617523193
        },
        {
            "text": "Restless legs",
            "probability": 0.0022241575142114152,
            "start_logit": 6.760941982269287,
            "end_logit": 0.35517096519470215
        },
        {
            "text": "(RLS)",
            "probability": 0.0017323817044425942,
            "start_logit": 2.106370449066162,
            "end_logit": 4.759861469268799
        },
        {
            "text": "Restless legs syndrome (RLS), also known as Willis-Ekbom",
            "probability": 0.0014488701545931283,
            "start_logit": 6.760941982269287,
            "end_logit": -0.07342318445444107
        },
        {
            "text": "RLS),",
            "probability": 0.0007858199754461458,
            "start_logit": 4.322300434112549,
            "end_logit": 1.7534067630767822
        },
        {
            "text": "(RLS",
            "probability": 0.0007786810609765824,
            "start_logit": 2.106370449066162,
            "end_logit": 3.9602105617523193
        },
        {
            "text": "RLS), also known as Willis-Ekbom disease",
            "probability": 0.00041333289704954416,
            "start_logit": 4.322300434112549,
            "end_logit": 1.1109323501586914
        },
        {
            "text": "Restless legs syndrome. Restless legs syndrome (RLS),",
            "probability": 0.0003410300640300748,
            "start_logit": 3.4875433444976807,
            "end_logit": 1.7534067630767822
        }
    ],
    "5880be1dc872c95565000007_000": [
        {
            "text": "PARP",
            "probability": 0.4162238343749543,
            "start_logit": 3.4399805068969727,
            "end_logit": 2.514331817626953
        },
        {
            "text": "Poly(ADP-ribose) polymerase",
            "probability": 0.17028824134055343,
            "start_logit": 2.9747402667999268,
            "end_logit": 2.085841417312622
        },
        {
            "text": "PARP inhibitors (rucaparib,",
            "probability": 0.08947950059675826,
            "start_logit": 3.4399805068969727,
            "end_logit": 0.977118194103241
        },
        {
            "text": "Poly(ADP-ribose) polymerase (PARP)",
            "probability": 0.058447341448190644,
            "start_logit": 2.9747402667999268,
            "end_logit": 1.0164750814437866
        },
        {
            "text": "ADP-ribose) polymerase",
            "probability": 0.05568817143090699,
            "start_logit": 1.8570154905319214,
            "end_logit": 2.085841417312622
        },
        {
            "text": "Poly(ADP-ribose) polymerase (PARP",
            "probability": 0.05045131573050689,
            "start_logit": 2.9747402667999268,
            "end_logit": 0.869357705116272
        },
        {
            "text": "PARP inhibitors (rucaparib, niraparib and veliparib) are in progress and include non-BRCA",
            "probability": 0.029381037642626714,
            "start_logit": 3.4399805068969727,
            "end_logit": -0.13654187321662903
        },
        {
            "text": "(ADP-ribose) polymerase",
            "probability": 0.0236970695279713,
            "start_logit": 1.0025991201400757,
            "end_logit": 2.085841417312622
        },
        {
            "text": "ADP-ribose) polymerase (PARP)",
            "probability": 0.019113624902252567,
            "start_logit": 1.8570154905319214,
            "end_logit": 1.0164750814437866
        },
        {
            "text": "PARP)",
            "probability": 0.018374472629735537,
            "start_logit": 1.8175764083862305,
            "end_logit": 1.0164750814437866
        },
        {
            "text": "PARP inhibitors (rucaparib, niraparib and",
            "probability": 0.017449103575377996,
            "start_logit": 3.4399805068969727,
            "end_logit": -0.6576030850410461
        },
        {
            "text": "ADP-ribose) polymerase (PARP",
            "probability": 0.016498740589472528,
            "start_logit": 1.8570154905319214,
            "end_logit": 0.869357705116272
        },
        {
            "text": "(ADP-ribose) polymerase (PARP)",
            "probability": 0.008133448928237967,
            "start_logit": 1.0025991201400757,
            "end_logit": 1.0164750814437866
        },
        {
            "text": "(ADP-ribose) polymerase (PARP",
            "probability": 0.007020733359107979,
            "start_logit": 1.0025991201400757,
            "end_logit": 0.869357705116272
        },
        {
            "text": "(rucaparib,",
            "probability": 0.006520071366833331,
            "start_logit": 0.8208562731742859,
            "end_logit": 0.977118194103241
        },
        {
            "text": "Olaparib can be given for a prolonged period with few significant side-effects in most patients. Similar trials with other PARP",
            "probability": 0.0034683316410779983,
            "start_logit": -1.3475689888000488,
            "end_logit": 2.514331817626953
        },
        {
            "text": "PARP inhibitors (rucaparib, niraparib",
            "probability": 0.0026777582971026473,
            "start_logit": 3.4399805068969727,
            "end_logit": -2.5319113731384277
        },
        {
            "text": "rucaparib,",
            "probability": 0.0025816381881430908,
            "start_logit": -0.10560489445924759,
            "end_logit": 0.977118194103241
        },
        {
            "text": "PARP inhibitors (rucaparib, niraparib and veliparib)",
            "probability": 0.002364666671664841,
            "start_logit": 3.4399805068969727,
            "end_logit": -2.656254291534424
        },
        {
            "text": "(rucaparib, niraparib and veliparib) are in progress and include non-BRCA",
            "probability": 0.002140897758525073,
            "start_logit": 0.8208562731742859,
            "end_logit": -0.13654187321662903
        }
    ],
    "5880be1dc872c95565000007_001": [
        {
            "text": "poly (ADP) ribose polymerase",
            "probability": 0.34397580964071395,
            "start_logit": 4.746969223022461,
            "end_logit": 3.3453900814056396
        },
        {
            "text": "poly (ADP) ribose polymerase (PARP)",
            "probability": 0.2684506326113904,
            "start_logit": 4.746969223022461,
            "end_logit": 3.0974857807159424
        },
        {
            "text": "poly (ADP) ribose polymerase (PARP",
            "probability": 0.19154980718563355,
            "start_logit": 4.746969223022461,
            "end_logit": 2.7599666118621826
        },
        {
            "text": "PARP)",
            "probability": 0.08557667462437098,
            "start_logit": 3.603714942932129,
            "end_logit": 3.0974857807159424
        },
        {
            "text": "PARP",
            "probability": 0.06106223466277068,
            "start_logit": 3.603714942932129,
            "end_logit": 2.7599666118621826
        },
        {
            "text": "poly (ADP) ribose polymerase (PARP),",
            "probability": 0.015615797754224742,
            "start_logit": 4.746969223022461,
            "end_logit": 0.25310182571411133
        },
        {
            "text": "PARP),",
            "probability": 0.0049780029587331,
            "start_logit": 3.603714942932129,
            "end_logit": 0.25310182571411133
        },
        {
            "text": "(PARP)",
            "probability": 0.0033795423046746316,
            "start_logit": 0.3720424771308899,
            "end_logit": 3.0974857807159424
        },
        {
            "text": "ribose polymerase",
            "probability": 0.003376957001502665,
            "start_logit": 0.12337289750576019,
            "end_logit": 3.3453900814056396
        },
        {
            "text": "the enzyme poly (ADP) ribose polymerase",
            "probability": 0.0027640332549899852,
            "start_logit": -0.07691117376089096,
            "end_logit": 3.3453900814056396
        },
        {
            "text": "ribose polymerase (PARP)",
            "probability": 0.0026354941770520167,
            "start_logit": 0.12337289750576019,
            "end_logit": 3.0974857807159424
        },
        {
            "text": "(PARP",
            "probability": 0.002411432860257861,
            "start_logit": 0.3720424771308899,
            "end_logit": 2.7599666118621826
        },
        {
            "text": "(ADP) ribose polymerase",
            "probability": 0.0021610284564996455,
            "start_logit": -0.3230178654193878,
            "end_logit": 3.3453900814056396
        },
        {
            "text": "the enzyme poly (ADP) ribose polymerase (PARP)",
            "probability": 0.002157147261710104,
            "start_logit": -0.07691117376089096,
            "end_logit": 3.0974857807159424
        },
        {
            "text": "PARP inhibitors will certainly emerge as the next challenge. While olaparib is the first PARP",
            "probability": 0.0021179386270824027,
            "start_logit": 1.2368476390838623,
            "end_logit": 1.7653836011886597
        },
        {
            "text": "ribose polymerase (PARP",
            "probability": 0.0018805260264890646,
            "start_logit": 0.12337289750576019,
            "end_logit": 2.7599666118621826
        },
        {
            "text": "(ADP) ribose polymerase (PARP)",
            "probability": 0.001686541436865858,
            "start_logit": -0.3230178654193878,
            "end_logit": 3.0974857807159424
        },
        {
            "text": "the enzyme poly (ADP) ribose polymerase (PARP",
            "probability": 0.0015392071832057794,
            "start_logit": -0.07691117376089096,
            "end_logit": 2.7599666118621826
        },
        {
            "text": "ADP) ribose polymerase",
            "probability": 0.0014777800673806776,
            "start_logit": -0.7030611038208008,
            "end_logit": 3.3453900814056396
        },
        {
            "text": "(ADP) ribose polymerase (PARP",
            "probability": 0.0012034119044520705,
            "start_logit": -0.3230178654193878,
            "end_logit": 2.7599666118621826
        }
    ],
    "5880be1dc872c95565000007_002": [
        {
            "text": "PARP-1/2",
            "probability": 0.19681473926604245,
            "start_logit": 4.763739585876465,
            "end_logit": 3.1648330688476562
        },
        {
            "text": "Poly(ADP-ribose) Polymerase",
            "probability": 0.1901111186071596,
            "start_logit": 4.4183526039123535,
            "end_logit": 3.4755659103393555
        },
        {
            "text": "Poly(ADP-ribose) Polymerase (PARP",
            "probability": 0.15497395528734398,
            "start_logit": 4.4183526039123535,
            "end_logit": 3.271214246749878
        },
        {
            "text": "Poly(ADP-ribose) Polymerase (PARP)",
            "probability": 0.14420141404032769,
            "start_logit": 4.4183526039123535,
            "end_logit": 3.1991682052612305
        },
        {
            "text": "PARP",
            "probability": 0.12243722219717984,
            "start_logit": 4.182693958282471,
            "end_logit": 3.271214246749878
        },
        {
            "text": "PARP)",
            "probability": 0.1139263725912336,
            "start_logit": 4.182693958282471,
            "end_logit": 3.1991682052612305
        },
        {
            "text": "(PARP",
            "probability": 0.01787618140710172,
            "start_logit": 2.2585647106170654,
            "end_logit": 3.271214246749878
        },
        {
            "text": "(PARP)",
            "probability": 0.016633573246329844,
            "start_logit": 2.2585647106170654,
            "end_logit": 3.1991682052612305
        },
        {
            "text": "(ADP-ribose) Polymerase",
            "probability": 0.005858919217399751,
            "start_logit": 0.938709020614624,
            "end_logit": 3.4755659103393555
        },
        {
            "text": "(ADP-ribose) Polymerase (PARP",
            "probability": 0.00477604829997184,
            "start_logit": 0.938709020614624,
            "end_logit": 3.271214246749878
        },
        {
            "text": "PARP-1",
            "probability": 0.004461630527620139,
            "start_logit": 4.763739585876465,
            "end_logit": -0.6219155192375183
        },
        {
            "text": "(ADP-ribose) Polymerase (PARP)",
            "probability": 0.0044440558873513275,
            "start_logit": 0.938709020614624,
            "end_logit": 3.1991682052612305
        },
        {
            "text": "Poly(ADP-ribose) polymerases",
            "probability": 0.004439932461134371,
            "start_logit": 2.624753713607788,
            "end_logit": 1.5121952295303345
        },
        {
            "text": "Polymerase",
            "probability": 0.004145942653754802,
            "start_logit": 0.5928740501403809,
            "end_logit": 3.4755659103393555
        },
        {
            "text": "Polymerase (PARP",
            "probability": 0.0033796715108207866,
            "start_logit": 0.5928740501403809,
            "end_logit": 3.271214246749878
        },
        {
            "text": "Polymerase (PARP)",
            "probability": 0.003144743966484851,
            "start_logit": 0.5928740501403809,
            "end_logit": 3.1991682052612305
        },
        {
            "text": "ADP-ribose) Polymerase",
            "probability": 0.0026176081377013638,
            "start_logit": 0.13300484418869019,
            "end_logit": 3.4755659103393555
        },
        {
            "text": "ADP-ribose) Polymerase (PARP",
            "probability": 0.00213381042341961,
            "start_logit": 0.13300484418869019,
            "end_logit": 3.271214246749878
        },
        {
            "text": "ADP-ribose) Polymerase (PARP)",
            "probability": 0.0019854851080014116,
            "start_logit": 0.13300484418869019,
            "end_logit": 3.1991682052612305
        },
        {
            "text": "Poly(ADP-ribose) polymerases (PARP",
            "probability": 0.0016375751636207104,
            "start_logit": 2.624753713607788,
            "end_logit": 0.5147726535797119
        }
    ],
    "5880be1dc872c95565000007_003": [
        {
            "text": "PARP",
            "probability": 0.7413492942206478,
            "start_logit": 4.818524360656738,
            "end_logit": 3.8635904788970947
        },
        {
            "text": "Poly(ADP-ribose) polymerase",
            "probability": 0.1265900122613953,
            "start_logit": 3.951716661453247,
            "end_logit": 2.9628798961639404
        },
        {
            "text": "Poly(ADP-ribose) polymerase (PARP",
            "probability": 0.07655552523465252,
            "start_logit": 3.951716661453247,
            "end_logit": 2.459942579269409
        },
        {
            "text": "Poly(ADP-ribose) polymerase (PARP)",
            "probability": 0.016458673830620288,
            "start_logit": 3.951716661453247,
            "end_logit": 0.9227789044380188
        },
        {
            "text": "PARP)",
            "probability": 0.008829553845903082,
            "start_logit": 3.3289685249328613,
            "end_logit": 0.9227789044380188
        },
        {
            "text": "BRCA2",
            "probability": 0.006233539309741052,
            "start_logit": 2.4301559925079346,
            "end_logit": 1.4734312295913696
        },
        {
            "text": "(ADP-ribose) polymerase",
            "probability": 0.004002171867529064,
            "start_logit": 0.4976002275943756,
            "end_logit": 2.9628798961639404
        },
        {
            "text": "ADP-ribose) polymerase",
            "probability": 0.0031033051258101347,
            "start_logit": 0.24323076009750366,
            "end_logit": 2.9628798961639404
        },
        {
            "text": "(PARP",
            "probability": 0.00274625148469741,
            "start_logit": 0.6239372491836548,
            "end_logit": 2.459942579269409
        },
        {
            "text": "polymerase",
            "probability": 0.0026764156291641077,
            "start_logit": 0.0952414944767952,
            "end_logit": 2.9628798961639404
        },
        {
            "text": "(ADP-ribose) polymerase (PARP",
            "probability": 0.002420320244265222,
            "start_logit": 0.4976002275943756,
            "end_logit": 2.459942579269409
        },
        {
            "text": "ADP-ribose) polymerase (PARP",
            "probability": 0.0018767290533096418,
            "start_logit": 0.24323076009750366,
            "end_logit": 2.459942579269409
        },
        {
            "text": "PARP inhibitor niraparib in homologous recombination deficient and proficient ovarian carcinoma.",
            "probability": 0.0018741187860949042,
            "start_logit": 4.818524360656738,
            "end_logit": -2.1167428493499756
        },
        {
            "text": "polymerase (PARP",
            "probability": 0.00161856690410777,
            "start_logit": 0.0952414944767952,
            "end_logit": 2.459942579269409
        },
        {
            "text": "PA",
            "probability": 0.0011654860225150654,
            "start_logit": 4.818524360656738,
            "end_logit": -2.591743230819702
        },
        {
            "text": "(PARP)",
            "probability": 0.0005904166590843524,
            "start_logit": 0.6239372491836548,
            "end_logit": 0.9227789044380188
        },
        {
            "text": "Poly(ADP-ribose",
            "probability": 0.0005853900528258051,
            "start_logit": 3.951716661453247,
            "end_logit": -2.413550615310669
        },
        {
            "text": "(ADP-ribose) polymerase (PARP)",
            "probability": 0.0005203446954861625,
            "start_logit": 0.4976002275943756,
            "end_logit": 0.9227789044380188
        },
        {
            "text": "ADP-ribose) polymerase (PARP)",
            "probability": 0.00040347801497272795,
            "start_logit": 0.24323076009750366,
            "end_logit": 0.9227789044380188
        },
        {
            "text": "PARP inhibitor niraparib in homologous recombination",
            "probability": 0.0004004067571776377,
            "start_logit": 4.818524360656738,
            "end_logit": -3.660155773162842
        }
    ],
    "5880be1dc872c95565000007_004": [
        {
            "text": "poly(adenosine diphosphate [ADP]-ribose) polymerase",
            "probability": 0.48785045673975724,
            "start_logit": 5.576469421386719,
            "end_logit": 4.923405647277832
        },
        {
            "text": "adenosine diphosphate [ADP]-ribose) polymerase",
            "probability": 0.2421514279448719,
            "start_logit": 4.876023769378662,
            "end_logit": 4.923405647277832
        },
        {
            "text": "poly(adenosine diphosphate [ADP]-ribose) polymerase (PARP) 1/2",
            "probability": 0.0975799289568881,
            "start_logit": 5.576469421386719,
            "end_logit": 3.314068555831909
        },
        {
            "text": "adenosine diphosphate [ADP]-ribose) polymerase (PARP) 1/2",
            "probability": 0.04843516862437727,
            "start_logit": 4.876023769378662,
            "end_logit": 3.314068555831909
        },
        {
            "text": "poly(adenosine diphosphate [ADP]-ribose) polymerase (PARP)",
            "probability": 0.018072271827125726,
            "start_logit": 5.576469421386719,
            "end_logit": 1.6277755498886108
        },
        {
            "text": "poly(adenosine diphosphate [ADP]-ribose) polymerase (PARP",
            "probability": 0.015280998119809779,
            "start_logit": 5.576469421386719,
            "end_logit": 1.460006833076477
        },
        {
            "text": "(adenosine diphosphate [ADP]-ribose) polymerase",
            "probability": 0.015237314068376575,
            "start_logit": 2.1102077960968018,
            "end_logit": 4.923405647277832
        },
        {
            "text": "PARP) 1/2",
            "probability": 0.010605252352290713,
            "start_logit": 3.357146978378296,
            "end_logit": 3.314068555831909
        },
        {
            "text": "poly(adenosine diphosphate [ADP]-ribose) polymerase (PARP) 1",
            "probability": 0.010128045638055324,
            "start_logit": 5.576469421386719,
            "end_logit": 1.0487051010131836
        },
        {
            "text": "polymerase",
            "probability": 0.010114547936127156,
            "start_logit": 1.7004352807998657,
            "end_logit": 4.923405647277832
        },
        {
            "text": "adenosine diphosphate [ADP]-ribose) polymerase (PARP)",
            "probability": 0.008970426016185657,
            "start_logit": 4.876023769378662,
            "end_logit": 1.6277755498886108
        },
        {
            "text": "adenosine diphosphate [ADP]-ribose) polymerase (PARP",
            "probability": 0.00758493809734971,
            "start_logit": 4.876023769378662,
            "end_logit": 1.460006833076477
        },
        {
            "text": "[ADP]-ribose) polymerase",
            "probability": 0.005413758287461502,
            "start_logit": 1.0754040479660034,
            "end_logit": 4.923405647277832
        },
        {
            "text": "adenosine diphosphate [ADP]-ribose) polymerase (PARP) 1",
            "probability": 0.005027197739930005,
            "start_logit": 4.876023769378662,
            "end_logit": 1.0487051010131836
        },
        {
            "text": "(PARP) 1/2",
            "probability": 0.004741087715972273,
            "start_logit": 2.5520641803741455,
            "end_logit": 3.314068555831909
        },
        {
            "text": "Niraparib is an oral poly(adenosine diphosphate [ADP]-ribose) polymerase",
            "probability": 0.0031716154524130758,
            "start_logit": 0.5407015681266785,
            "end_logit": 4.923405647277832
        },
        {
            "text": "(adenosine diphosphate [ADP]-ribose) polymerase (PARP) 1/2",
            "probability": 0.003047770077376679,
            "start_logit": 2.1102077960968018,
            "end_logit": 3.314068555831909
        },
        {
            "text": "poly(adenosine diphosphate [ADP]-ribose",
            "probability": 0.002600537150244357,
            "start_logit": 5.576469421386719,
            "end_logit": -0.3108852505683899
        },
        {
            "text": "polymerase (PARP) 1/2",
            "probability": 0.0020231135492506623,
            "start_logit": 1.7004352807998657,
            "end_logit": 3.314068555831909
        },
        {
            "text": "PARP)",
            "probability": 0.001964143706135923,
            "start_logit": 3.357146978378296,
            "end_logit": 1.6277755498886108
        }
    ],
    "5880be1dc872c95565000007_005": [
        {
            "text": "sirtuin",
            "probability": 0.5438944496480879,
            "start_logit": 2.9452273845672607,
            "end_logit": 2.1008801460266113
        },
        {
            "text": "tankyrase",
            "probability": 0.08200793237249518,
            "start_logit": 2.182894468307495,
            "end_logit": 0.9712738394737244
        },
        {
            "text": "PARP-family ADP-ribosyltransferases",
            "probability": 0.0621649324686771,
            "start_logit": 1.769536018371582,
            "end_logit": 1.107607364654541
        },
        {
            "text": "SIRT1, SIRT2, SIRT3 and SIRT6 are blocked by sirtuin",
            "probability": 0.05687827712391244,
            "start_logit": 1.4547336101531982,
            "end_logit": 1.3335322141647339
        },
        {
            "text": "ADP-ribosyltransferases",
            "probability": 0.03523633916192909,
            "start_logit": 1.2018228769302368,
            "end_logit": 1.107607364654541
        },
        {
            "text": "human sirtuin",
            "probability": 0.03461708817952621,
            "start_logit": 0.1908196210861206,
            "end_logit": 2.1008801460266113
        },
        {
            "text": "sirtuin isoforms",
            "probability": 0.02848663937101084,
            "start_logit": 2.9452273845672607,
            "end_logit": -0.8484398722648621
        },
        {
            "text": "sirtuin deacetylase",
            "probability": 0.023787087818677107,
            "start_logit": 1.9450997114181519,
            "end_logit": -0.028604477643966675
        },
        {
            "text": "PARP-family ADP-ribosyltransferases (PARPs) and sirtuin deacetylase",
            "probability": 0.01995698508805719,
            "start_logit": 1.769536018371582,
            "end_logit": -0.028604477643966675
        },
        {
            "text": "sirtuin isoforms SIRT",
            "probability": 0.016222192375584914,
            "start_logit": 2.9452273845672607,
            "end_logit": -1.4114948511123657
        },
        {
            "text": "sirtuin isoforms SIRT1",
            "probability": 0.01300746648962683,
            "start_logit": 2.9452273845672607,
            "end_logit": -1.6323515176773071
        },
        {
            "text": "ADP-ribosyltransferases (PARPs) and sirtuin deacetylase",
            "probability": 0.01131202218496207,
            "start_logit": 1.2018228769302368,
            "end_logit": -0.028604477643966675
        },
        {
            "text": "sirtuin isoforms SIRT1, SIRT2,",
            "probability": 0.011022267183155026,
            "start_logit": 2.9452273845672607,
            "end_logit": -1.7979575395584106
        },
        {
            "text": "PARP-family ADP-ribosyltransferases (PARP",
            "probability": 0.010743538521939808,
            "start_logit": 1.769536018371582,
            "end_logit": -0.6478791832923889
        },
        {
            "text": "sirtuin isoforms SIRT1,",
            "probability": 0.009885677029693181,
            "start_logit": 2.9452273845672607,
            "end_logit": -1.9067881107330322
        },
        {
            "text": "PARP",
            "probability": 0.009165438360337036,
            "start_logit": 1.769536018371582,
            "end_logit": -0.8067439794540405
        },
        {
            "text": "PARP-family ADP-ribosyltransferases (PARPs)",
            "probability": 0.009009308435765811,
            "start_logit": 1.769536018371582,
            "end_logit": -0.8239253759384155
        },
        {
            "text": "PARP-family ADP-ribosyltransferases (PARPs",
            "probability": 0.008869355035475894,
            "start_logit": 1.769536018371582,
            "end_logit": -0.8395816087722778
        },
        {
            "text": "sirtuin inhibitor Ex527 in vitro, they are unaffected by the seven clinical and commonly used PARP",
            "probability": 0.007346533976577496,
            "start_logit": 2.2495744228363037,
            "end_logit": -1.507993459701538
        },
        {
            "text": "sirtuin isoforms SIRT1, SIRT2, SIRT3 and SIRT6",
            "probability": 0.006386469174509005,
            "start_logit": 2.9452273845672607,
            "end_logit": -2.343693494796753
        }
    ],
    "5880be1dc872c95565000007_006": [
        {
            "text": "PARP",
            "probability": 0.9718224230461434,
            "start_logit": 1.5183308124542236,
            "end_logit": 1.1852320432662964
        },
        {
            "text": "PA",
            "probability": 0.005305434249097179,
            "start_logit": 1.5183308124542236,
            "end_logit": -4.025209426879883
        },
        {
            "text": "the PARP",
            "probability": 0.004214491026303176,
            "start_logit": -3.9223134517669678,
            "end_logit": 1.1852320432662964
        },
        {
            "text": "Results from a phase III trial indicate that maintenance therapy with the PARP",
            "probability": 0.0025292487044609588,
            "start_logit": -4.432919979095459,
            "end_logit": 1.1852320432662964
        },
        {
            "text": "PARP inhibitor niraparib",
            "probability": 0.0023557466180137926,
            "start_logit": 1.5183308124542236,
            "end_logit": -4.837083339691162
        },
        {
            "text": "PARP inhibitor",
            "probability": 0.0018047749770914085,
            "start_logit": 1.5183308124542236,
            "end_logit": -5.1035051345825195
        },
        {
            "text": "RP",
            "probability": 0.0014927492617334427,
            "start_logit": -4.9602227210998535,
            "end_logit": 1.1852320432662964
        },
        {
            "text": "Niraparib Slows Ovarian Cancer Progression. Results from a phase III trial indicate that maintenance therapy with the PARP",
            "probability": 0.0013135529621764238,
            "start_logit": -5.088106632232666,
            "end_logit": 1.1852320432662964
        },
        {
            "text": "with the PARP",
            "probability": 0.0012765372906313717,
            "start_logit": -5.1166911125183105,
            "end_logit": 1.1852320432662964
        },
        {
            "text": "Slows Ovarian Cancer Progression. Results from a phase III trial indicate that maintenance therapy with the PARP",
            "probability": 0.001091154142754922,
            "start_logit": -5.273606300354004,
            "end_logit": 1.1852320432662964
        },
        {
            "text": "therapy with the PARP",
            "probability": 0.0009850158337538527,
            "start_logit": -5.375939846038818,
            "end_logit": 1.1852320432662964
        },
        {
            "text": "Ovarian Cancer Progression. Results from a phase III trial indicate that maintenance therapy with the PARP",
            "probability": 0.0009145387981221139,
            "start_logit": -5.4501776695251465,
            "end_logit": 1.1852320432662964
        },
        {
            "text": "PARP inhibitor niraparib is more effective than placebo in slowing the progression of recurrent platinum-sensitive ovarian cancer.",
            "probability": 0.0008882426574322081,
            "start_logit": 1.5183308124542236,
            "end_logit": -5.812451362609863
        },
        {
            "text": "maintenance therapy with the PARP",
            "probability": 0.0008216932000143519,
            "start_logit": -5.557230472564697,
            "end_logit": 1.1852320432662964
        },
        {
            "text": "PARP inhibitor niraparib is more effective than placebo in slowing the progression of recurrent platinum-sensitive ovarian cancer",
            "probability": 0.0006318494499635903,
            "start_logit": 1.5183308124542236,
            "end_logit": -6.153045177459717
        },
        {
            "text": "PARP inhibitor niraparib is",
            "probability": 0.0006244968165562155,
            "start_logit": 1.5183308124542236,
            "end_logit": -6.164750099182129
        },
        {
            "text": ". Results from a phase III trial indicate that maintenance therapy with the PARP",
            "probability": 0.0006218913773297306,
            "start_logit": -5.835832118988037,
            "end_logit": 1.1852320432662964
        },
        {
            "text": "Progression. Results from a phase III trial indicate that maintenance therapy with the PARP",
            "probability": 0.0006033075836314942,
            "start_logit": -5.866170406341553,
            "end_logit": 1.1852320432662964
        },
        {
            "text": "PARP inhibitor niraparib is more effective than placebo",
            "probability": 0.0005690241816865139,
            "start_logit": 1.5183308124542236,
            "end_logit": -6.257773399353027
        },
        {
            "text": "BRCA",
            "probability": 0.00013382782310420702,
            "start_logit": -3.136533737182617,
            "end_logit": -3.0502777099609375
        }
    ],
    "5880be1dc872c95565000007_007": [
        {
            "text": "PARP",
            "probability": 0.29828019239562353,
            "start_logit": 3.682752847671509,
            "end_logit": 2.563377857208252
        },
        {
            "text": "poly(ADP-ribose) polymerase",
            "probability": 0.17667604327815603,
            "start_logit": 3.4582512378692627,
            "end_logit": 2.2641639709472656
        },
        {
            "text": "poly(ADP-ribose) polymerase (PARP",
            "probability": 0.14746087578064293,
            "start_logit": 3.4582512378692627,
            "end_logit": 2.083409070968628
        },
        {
            "text": "PARP) inhibitors kill cancer cells is by trapping PARP1 and PARP2 to the sites of DNA damage. The PARP",
            "probability": 0.0928659311409499,
            "start_logit": 3.1656110286712646,
            "end_logit": 1.91364324092865
        },
        {
            "text": "PARP inhibitors, including veliparib,",
            "probability": 0.04554901595051314,
            "start_logit": 3.682752847671509,
            "end_logit": 0.6841335892677307
        },
        {
            "text": "poly(ADP-ribose) polymerase (PARP)",
            "probability": 0.031088511422804367,
            "start_logit": 3.4582512378692627,
            "end_logit": 0.5266845226287842
        },
        {
            "text": "PARP)",
            "probability": 0.023201063870605776,
            "start_logit": 3.1656110286712646,
            "end_logit": 0.5266845226287842
        },
        {
            "text": "PARP inhibitors, including veliparib, rucaparib,",
            "probability": 0.020101004892346414,
            "start_logit": 3.682752847671509,
            "end_logit": -0.13388562202453613
        },
        {
            "text": "PARP-trapping activity. Although they display similar capacity to inhibit PARP",
            "probability": 0.019696020502874823,
            "start_logit": 1.9297634363174438,
            "end_logit": 1.5987505912780762
        },
        {
            "text": "PARP1 and PARP2 to the sites of DNA damage. The PARP",
            "probability": 0.017888174468489056,
            "start_logit": 1.5185940265655518,
            "end_logit": 1.91364324092865
        },
        {
            "text": "poly(ADP-ribose) polymerase (PARP) inhibitors kill cancer cells is by trapping PARP",
            "probability": 0.01722744431320681,
            "start_logit": 3.4582512378692627,
            "end_logit": -0.06365010887384415
        },
        {
            "text": "PARP2 to the sites of DNA damage. The PARP",
            "probability": 0.01719317353405041,
            "start_logit": 1.4789665937423706,
            "end_logit": 1.91364324092865
        },
        {
            "text": "poly(ADP-ribose) polymerase (PARP) inhibitors kill cancer cells is by trapping PARP1 and PARP2",
            "probability": 0.01675100541135914,
            "start_logit": 3.4582512378692627,
            "end_logit": -0.09169553965330124
        },
        {
            "text": "poly(ADP-ribose) polymerase (PARP) inhibitors kill cancer cells is by trapping PARP1",
            "probability": 0.014624702235750985,
            "start_logit": 3.4582512378692627,
            "end_logit": -0.22744178771972656
        },
        {
            "text": "PARP) inhibitors kill cancer cells is by trapping PARP",
            "probability": 0.01285667976836057,
            "start_logit": 3.1656110286712646,
            "end_logit": -0.06365010887384415
        },
        {
            "text": "PARP) inhibitors kill cancer cells is by trapping PARP1 and PARP2",
            "probability": 0.012501117894011687,
            "start_logit": 3.1656110286712646,
            "end_logit": -0.09169553965330124
        },
        {
            "text": "PARP) inhibitors kill cancer cells is by trapping PARP1",
            "probability": 0.010914277819405547,
            "start_logit": 3.1656110286712646,
            "end_logit": -0.22744178771972656
        },
        {
            "text": "PARP catalytic activity, their relative abilities to trap PARP",
            "probability": 0.009199459353735239,
            "start_logit": 2.0836963653564453,
            "end_logit": 0.6835457682609558
        },
        {
            "text": "(PARP",
            "probability": 0.008038337885935404,
            "start_logit": 0.5489106774330139,
            "end_logit": 2.083409070968628
        },
        {
            "text": "PARP-trapping activity. Although they display similar capacity to inhibit PARP catalytic activity, their relative abilities to trap PARP",
            "probability": 0.007886968081178513,
            "start_logit": 1.9297634363174438,
            "end_logit": 0.6835457682609558
        }
    ],
    "5880be1dc872c95565000007_008": [
        {
            "text": "PARP",
            "probability": 0.5356680445432005,
            "start_logit": 4.160313606262207,
            "end_logit": 2.9120655059814453
        },
        {
            "text": "PARP inhibitors in late phase clinical development in ovarian cancer including rucaparib, niraparib,",
            "probability": 0.14473627161776273,
            "start_logit": 4.160313606262207,
            "end_logit": 1.603464126586914
        },
        {
            "text": "poly-ADP-ribose polymerase",
            "probability": 0.10128380318071778,
            "start_logit": 3.2543997764587402,
            "end_logit": 2.152391195297241
        },
        {
            "text": "PARP inhibitors in late phase clinical development in ovarian cancer including rucaparib, niraparib, veliparib,",
            "probability": 0.06479462920114694,
            "start_logit": 4.160313606262207,
            "end_logit": 0.7997735738754272
        },
        {
            "text": "PARP inhibitors in late phase clinical development in ovarian cancer including rucaparib,",
            "probability": 0.05326378859916859,
            "start_logit": 4.160313606262207,
            "end_logit": 0.6038075685501099
        },
        {
            "text": "poly-ADP-ribose polymerase (PARP)",
            "probability": 0.033698910338914465,
            "start_logit": 3.2543997764587402,
            "end_logit": 1.0519301891326904
        },
        {
            "text": "poly-ADP-ribose polymerase (PARP",
            "probability": 0.026406769493947605,
            "start_logit": 3.2543997764587402,
            "end_logit": 0.8080850839614868
        },
        {
            "text": "poly-ADP-ribose polymerase (PARP) inhibitors. PARP",
            "probability": 0.011019738328046126,
            "start_logit": 3.2543997764587402,
            "end_logit": -0.0658472552895546
        },
        {
            "text": "BRCA-mutated ovarian cancer who have received 3 or more lines of chemotherapy. There are a number of other PARP",
            "probability": 0.005550488951364436,
            "start_logit": -0.4093150198459625,
            "end_logit": 2.9120655059814453
        },
        {
            "text": "PARP)",
            "probability": 0.005245288814388187,
            "start_logit": 1.394264578819275,
            "end_logit": 1.0519301891326904
        },
        {
            "text": "niraparib,",
            "probability": 0.0031611778972329392,
            "start_logit": 0.33634504675865173,
            "end_logit": 1.603464126586914
        },
        {
            "text": "rucaparib, niraparib,",
            "probability": 0.003027675819620349,
            "start_logit": 0.29319560527801514,
            "end_logit": 1.603464126586914
        },
        {
            "text": "poly-ADP-ribose polymerase (PARP) inhibitors.",
            "probability": 0.0025770305336598564,
            "start_logit": 3.2543997764587402,
            "end_logit": -1.518897533416748
        },
        {
            "text": "PARP inhibitors in late phase clinical development in ovarian cancer including rucaparib, niraparib",
            "probability": 0.001857390386081395,
            "start_logit": 4.160313606262207,
            "end_logit": -2.752276659011841
        },
        {
            "text": "PARP) inhibitors. PARP",
            "probability": 0.001715239739453459,
            "start_logit": 1.394264578819275,
            "end_logit": -0.0658472552895546
        },
        {
            "text": "niraparib, veliparib,",
            "probability": 0.001415176357665222,
            "start_logit": 0.33634504675865173,
            "end_logit": 0.7997735738754272
        },
        {
            "text": "rucaparib, niraparib, veliparib,",
            "probability": 0.0013554109822012535,
            "start_logit": 0.29319560527801514,
            "end_logit": 0.7997735738754272
        },
        {
            "text": "PA",
            "probability": 0.0012295728807541295,
            "start_logit": 4.160313606262207,
            "end_logit": -3.1647822856903076
        },
        {
            "text": "rucaparib,",
            "probability": 0.0011142022866870748,
            "start_logit": 0.29319560527801514,
            "end_logit": 0.6038075685501099
        },
        {
            "text": "PARP inhibition. Olaparib, the first and most extensively investigated PARP",
            "probability": 0.000879390047987038,
            "start_logit": -0.049031637609004974,
            "end_logit": 0.7093693614006042
        }
    ],
    "5880be1dc872c95565000007_009": [
        {
            "text": "PARP",
            "probability": 0.5385227967138204,
            "start_logit": 5.3775248527526855,
            "end_logit": 4.052242755889893
        },
        {
            "text": "PARP-1/PARP-2",
            "probability": 0.23815855663700405,
            "start_logit": 4.615510940551758,
            "end_logit": 3.998363494873047
        },
        {
            "text": "PARP-2",
            "probability": 0.14509177502525206,
            "start_logit": 4.119940757751465,
            "end_logit": 3.998363494873047
        },
        {
            "text": "PARP-1",
            "probability": 0.06014002903486358,
            "start_logit": 4.615510940551758,
            "end_logit": 2.6221024990081787
        },
        {
            "text": "PARP inhibitor, niraparib,",
            "probability": 0.006665611815967399,
            "start_logit": 5.3775248527526855,
            "end_logit": -0.3396253287792206
        },
        {
            "text": "PARP-1/PARP",
            "probability": 0.003442356141415733,
            "start_logit": 4.615510940551758,
            "end_logit": -0.23841699957847595
        },
        {
            "text": "PARP inhibitor,",
            "probability": 0.0027779967969056513,
            "start_logit": 5.3775248527526855,
            "end_logit": -1.2148569822311401
        },
        {
            "text": "PA",
            "probability": 0.0008290664975214578,
            "start_logit": 5.3775248527526855,
            "end_logit": -2.424041986465454
        },
        {
            "text": "PARP inhibitor, niraparib",
            "probability": 0.0007884830194945708,
            "start_logit": 5.3775248527526855,
            "end_logit": -2.474231481552124
        },
        {
            "text": "PARP-1/",
            "probability": 0.0006568245349268321,
            "start_logit": 4.615510940551758,
            "end_logit": -1.894911527633667
        },
        {
            "text": "niraparib, a potent PARP-1/PARP-2",
            "probability": 0.0005065025390384399,
            "start_logit": -1.5376516580581665,
            "end_logit": 3.998363494873047
        },
        {
            "text": "/PARP-2",
            "probability": 0.0004599488863099147,
            "start_logit": -1.6340656280517578,
            "end_logit": 3.998363494873047
        },
        {
            "text": "PARP-",
            "probability": 0.00042151610324969285,
            "start_logit": 4.615510940551758,
            "end_logit": -2.338470458984375
        },
        {
            "text": "the PARP",
            "probability": 0.00041455924171469134,
            "start_logit": -1.791844367980957,
            "end_logit": 4.052242755889893
        },
        {
            "text": "2",
            "probability": 0.0003020230291119449,
            "start_logit": -2.054677724838257,
            "end_logit": 3.998363494873047
        },
        {
            "text": "PARP-1/PARP-2 inhibitor currently under clinical evaluation,",
            "probability": 0.000212190460662742,
            "start_logit": 4.615510940551758,
            "end_logit": -3.024844169616699
        },
        {
            "text": "PARP-1/PARP-",
            "probability": 0.0001672451585473615,
            "start_logit": 4.615510940551758,
            "end_logit": -3.2628676891326904
        },
        {
            "text": "1/PARP-2",
            "probability": 0.00015712955594375988,
            "start_logit": -2.7081103324890137,
            "end_logit": 3.998363494873047
        },
        {
            "text": "RP",
            "probability": 0.00015611740597150806,
            "start_logit": -2.7684519290924072,
            "end_logit": 4.052242755889893
        },
        {
            "text": "PARP-2 inhibitor currently under clinical evaluation,",
            "probability": 0.00012927140227805527,
            "start_logit": 4.119940757751465,
            "end_logit": -3.024844169616699
        }
    ],
    "58a8903b38c171fb5b000006_000": [
        {
            "text": "mitosis",
            "probability": 0.564297665002764,
            "start_logit": 3.7386581897735596,
            "end_logit": 3.273195505142212
        },
        {
            "text": "enriched in mitosis",
            "probability": 0.3337731694140454,
            "start_logit": 3.2135379314422607,
            "end_logit": 3.273195505142212
        },
        {
            "text": "Cells can also be enriched in mitosis",
            "probability": 0.04547388401380559,
            "start_logit": 1.2202144861221313,
            "end_logit": 3.273195505142212
        },
        {
            "text": "can also be enriched in mitosis",
            "probability": 0.011858645109566643,
            "start_logit": -0.12386655062437057,
            "end_logit": 3.273195505142212
        },
        {
            "text": "CDK1 inhibitor RO-3306. Cells can also be enriched in mitosis",
            "probability": 0.009857118649846385,
            "start_logit": -0.30872979760169983,
            "end_logit": 3.273195505142212
        },
        {
            "text": "mitosis using nocodazole",
            "probability": 0.006459409275959763,
            "start_logit": 3.7386581897735596,
            "end_logit": -1.1968485116958618
        },
        {
            "text": "in mitosis",
            "probability": 0.005670037573123002,
            "start_logit": -0.8617279529571533,
            "end_logit": 3.273195505142212
        },
        {
            "text": "enriched",
            "probability": 0.0055494961366121184,
            "start_logit": 3.2135379314422607,
            "end_logit": -0.8235589861869812
        },
        {
            "text": "enriched in mitosis using nocodazole",
            "probability": 0.0038206387165699396,
            "start_logit": 3.2135379314422607,
            "end_logit": -1.1968485116958618
        },
        {
            "text": "mitosis using nocodazole and mechanical shake-off. Releasing the cells from these blocks enables researchers to follow gene expression",
            "probability": 0.0027087370143839247,
            "start_logit": 3.7386581897735596,
            "end_logit": -2.065903902053833
        },
        {
            "text": "G phase with the CDK1 inhibitor RO-3306. Cells can also be enriched in mitosis",
            "probability": 0.0019708036302581115,
            "start_logit": -1.9184823036193848,
            "end_logit": 3.273195505142212
        },
        {
            "text": "be enriched in mitosis",
            "probability": 0.0015249089635829233,
            "start_logit": -2.1749889850616455,
            "end_logit": 3.273195505142212
        },
        {
            "text": "RO-3306. Cells can also be enriched in mitosis",
            "probability": 0.0013694051683091643,
            "start_logit": -2.2825472354888916,
            "end_logit": 3.273195505142212
        },
        {
            "text": "mit",
            "probability": 0.0009701793928004582,
            "start_logit": 3.7386581897735596,
            "end_logit": -3.092660665512085
        },
        {
            "text": ". Cells can also be enriched in mitosis",
            "probability": 0.0009249289581360097,
            "start_logit": -2.674962043762207,
            "end_logit": 3.273195505142212
        },
        {
            "text": "mitosis using nocodazole and",
            "probability": 0.0008399708731051506,
            "start_logit": 3.7386581897735596,
            "end_logit": -3.236774444580078
        },
        {
            "text": "Cells can also be enriched",
            "probability": 0.000756073785362636,
            "start_logit": 1.2202144861221313,
            "end_logit": -0.8235589861869812
        },
        {
            "text": "also be enriched in mitosis",
            "probability": 0.0007327669835405963,
            "start_logit": -2.907851219177246,
            "end_logit": 3.273195505142212
        },
        {
            "text": "ed in mitosis",
            "probability": 0.0007222227262656241,
            "start_logit": -2.9223453998565674,
            "end_logit": 3.273195505142212
        },
        {
            "text": "mitosis using nocodazole and mechanical shake-off.",
            "probability": 0.0007199386119622149,
            "start_logit": 3.7386581897735596,
            "end_logit": -3.3909757137298584
        }
    ],
    "58a8903b38c171fb5b000006_001": [
        {
            "text": "desynchronization",
            "probability": 0.16380223952200956,
            "start_logit": 3.4344663619995117,
            "end_logit": 3.0276577472686768
        },
        {
            "text": "cell synchronization and desynchronization",
            "probability": 0.12606156338481833,
            "start_logit": 3.172576904296875,
            "end_logit": 3.0276577472686768
        },
        {
            "text": "SAC",
            "probability": 0.11281621434018681,
            "start_logit": 3.5500948429107666,
            "end_logit": 2.5391294956207275
        },
        {
            "text": "desynchronization employing antimitotic SAC",
            "probability": 0.10049737341395724,
            "start_logit": 3.4344663619995117,
            "end_logit": 2.5391294956207275
        },
        {
            "text": "antimitotic SAC",
            "probability": 0.08549374917311911,
            "start_logit": 3.272778034210205,
            "end_logit": 2.5391294956207275
        },
        {
            "text": "cell synchronization and desynchronization employing antimitotic SAC",
            "probability": 0.07734238582818068,
            "start_logit": 3.172576904296875,
            "end_logit": 2.5391294956207275
        },
        {
            "text": "cell synchronization",
            "probability": 0.06651576885084594,
            "start_logit": 3.172576904296875,
            "end_logit": 2.388326406478882
        },
        {
            "text": "synchronization and desynchronization",
            "probability": 0.05905250289316055,
            "start_logit": 2.414233446121216,
            "end_logit": 3.0276577472686768
        },
        {
            "text": "synchronization and desynchronization employing antimitotic SAC",
            "probability": 0.036230404734395164,
            "start_logit": 2.414233446121216,
            "end_logit": 2.5391294956207275
        },
        {
            "text": "synchronization",
            "probability": 0.031158765027488305,
            "start_logit": 2.414233446121216,
            "end_logit": 2.388326406478882
        },
        {
            "text": "sequential cell synchronization and desynchronization",
            "probability": 0.018176358727359544,
            "start_logit": 1.2359282970428467,
            "end_logit": 3.0276577472686768
        },
        {
            "text": "SAC-inducing agents",
            "probability": 0.017375807177500882,
            "start_logit": 3.5500948429107666,
            "end_logit": 0.668448269367218
        },
        {
            "text": "SAC-inducing",
            "probability": 0.016125956331903276,
            "start_logit": 3.5500948429107666,
            "end_logit": 0.5937995910644531
        },
        {
            "text": "desynchronization employing antimitotic SAC-inducing agents",
            "probability": 0.015478475257294589,
            "start_logit": 3.4344663619995117,
            "end_logit": 0.668448269367218
        },
        {
            "text": "desynchronization employing antimitotic SAC-inducing",
            "probability": 0.014365100483319125,
            "start_logit": 3.4344663619995117,
            "end_logit": 0.5937995910644531
        },
        {
            "text": "antimitotic SAC-inducing agents",
            "probability": 0.01316763648915117,
            "start_logit": 3.272778034210205,
            "end_logit": 0.668448269367218
        },
        {
            "text": "antimitotic SAC-inducing",
            "probability": 0.012220481549391152,
            "start_logit": 3.272778034210205,
            "end_logit": 0.5937995910644531
        },
        {
            "text": "cell synchronization and desynchronization employing antimitotic SAC-inducing agents",
            "probability": 0.01191217406698278,
            "start_logit": 3.172576904296875,
            "end_logit": 0.668448269367218
        },
        {
            "text": "sequential cell synchronization and desynchronization employing antimitotic SAC",
            "probability": 0.011151717556853355,
            "start_logit": 1.2359282970428467,
            "end_logit": 2.5391294956207275
        },
        {
            "text": "cell synchronization and desynchronization employing antimitotic SAC-inducing",
            "probability": 0.011055325192082589,
            "start_logit": 3.172576904296875,
            "end_logit": 0.5937995910644531
        }
    ],
    "58a8903b38c171fb5b000006_002": [
        {
            "text": "mitotic arrest",
            "probability": 0.8473635284594583,
            "start_logit": 4.155694484710693,
            "end_logit": 3.2567105293273926
        },
        {
            "text": "mitotic arrest.",
            "probability": 0.07783008126530926,
            "start_logit": 4.155694484710693,
            "end_logit": 0.8691087365150452
        },
        {
            "text": "shortening of pro-metaphase and challenged the nocodazole-triggered mitotic arrest",
            "probability": 0.02350711940093529,
            "start_logit": 0.5708680152893066,
            "end_logit": 3.2567105293273926
        },
        {
            "text": "nocodazole-triggered mitotic arrest",
            "probability": 0.023352773664652833,
            "start_logit": 0.5642804503440857,
            "end_logit": 3.2567105293273926
        },
        {
            "text": "challenged the nocodazole-triggered mitotic arrest",
            "probability": 0.0038381111374613426,
            "start_logit": -1.2414549589157104,
            "end_logit": 3.2567105293273926
        },
        {
            "text": "a shortening of pro-metaphase and challenged the nocodazole-triggered mitotic arrest",
            "probability": 0.0029911147325626594,
            "start_logit": -1.4907891750335693,
            "end_logit": 3.2567105293273926
        },
        {
            "text": "arrest",
            "probability": 0.0025540159620957292,
            "start_logit": -1.6487683057785034,
            "end_logit": 3.2567105293273926
        },
        {
            "text": "Deficient PML p409 caused a shortening of pro-metaphase and challenged the nocodazole-triggered mitotic arrest",
            "probability": 0.002365459748069047,
            "start_logit": -1.7254629135131836,
            "end_logit": 3.2567105293273926
        },
        {
            "text": "shortening of pro-metaphase and challenged the nocodazole-triggered mitotic arrest.",
            "probability": 0.002159121736823319,
            "start_logit": 0.5708680152893066,
            "end_logit": 0.8691087365150452
        },
        {
            "text": "nocodazole-triggered mitotic arrest.",
            "probability": 0.0021449451280900434,
            "start_logit": 0.5642804503440857,
            "end_logit": 0.8691087365150452
        },
        {
            "text": "PML p409 caused a shortening of pro-metaphase and challenged the nocodazole-triggered mitotic arrest",
            "probability": 0.0018911774707646041,
            "start_logit": -1.9492356777191162,
            "end_logit": 3.2567105293273926
        },
        {
            "text": "triggered mitotic arrest",
            "probability": 0.0016638092970726848,
            "start_logit": -2.0773255825042725,
            "end_logit": 3.2567105293273926
        },
        {
            "text": "metaphase and challenged the nocodazole-triggered mitotic arrest",
            "probability": 0.0015173613475968906,
            "start_logit": -2.1694624423980713,
            "end_logit": 3.2567105293273926
        },
        {
            "text": "mitotic arrest. T409A mutation led to a higher frequency of misaligned chromosomes",
            "probability": 0.001496422649223771,
            "start_logit": 4.155694484710693,
            "end_logit": -3.0823419094085693
        },
        {
            "text": "the nocodazole-triggered mitotic arrest",
            "probability": 0.001237379998251008,
            "start_logit": -2.373439073562622,
            "end_logit": 3.2567105293273926
        },
        {
            "text": "mitotic arrest. T409A mutation led to a higher frequency of misaligned chromosomes on metaphase plate,",
            "probability": 0.0008845766604883089,
            "start_logit": 4.155694484710693,
            "end_logit": -3.608065366744995
        },
        {
            "text": "pro-metaphase and challenged the nocodazole-triggered mitotic arrest",
            "probability": 0.0008672953416429546,
            "start_logit": -2.728811025619507,
            "end_logit": 3.2567105293273926
        },
        {
            "text": "mitotic arrest. T409A mutation led to a higher frequency of misaligned chromosomes on metaphase plate",
            "probability": 0.0008470861092400129,
            "start_logit": 4.155694484710693,
            "end_logit": -3.651372194290161
        },
        {
            "text": "shortening of pro-metaphase",
            "probability": 0.0007981207771104545,
            "start_logit": 0.5708680152893066,
            "end_logit": -0.12608814239501953
        },
        {
            "text": "mit",
            "probability": 0.0006904991131513979,
            "start_logit": 4.155694484710693,
            "end_logit": -3.855759859085083
        }
    ],
    "58a8903b38c171fb5b000006_003": [
        {
            "text": "disrupts the microtubular network",
            "probability": 0.7665298486175339,
            "start_logit": 5.543104648590088,
            "end_logit": 4.554847717285156
        },
        {
            "text": "disrupts the microtubular network, also blocked the formation of RACK1-Lck complexes",
            "probability": 0.09283588763348295,
            "start_logit": 5.543104648590088,
            "end_logit": 2.443807363510132
        },
        {
            "text": "disrupts the microtubular network,",
            "probability": 0.03257865766007054,
            "start_logit": 5.543104648590088,
            "end_logit": 1.3966314792633057
        },
        {
            "text": "nocodazole, which disrupts the microtubular network",
            "probability": 0.029370551595387092,
            "start_logit": 2.2812235355377197,
            "end_logit": 4.554847717285156
        },
        {
            "text": "microtubular network",
            "probability": 0.01891038748028243,
            "start_logit": 1.8409423828125,
            "end_logit": 4.554847717285156
        },
        {
            "text": "disrupts the microtubular network, also blocked the formation of RACK1-Lck",
            "probability": 0.018177526859316524,
            "start_logit": 5.543104648590088,
            "end_logit": 0.8131601214408875
        },
        {
            "text": "disrupts the microtubular network, also blocked the formation of RACK1-Lck complexes.",
            "probability": 0.012769176556381203,
            "start_logit": 5.543104648590088,
            "end_logit": 0.46000826358795166
        },
        {
            "text": "blocked the formation of RACK1-Lck complexes",
            "probability": 0.008157023850223434,
            "start_logit": 3.1111507415771484,
            "end_logit": 2.443807363510132
        },
        {
            "text": "nocodazole, which disrupts the microtubular network, also blocked the formation of RACK1-Lck complexes",
            "probability": 0.003557123356070703,
            "start_logit": 2.2812235355377197,
            "end_logit": 2.443807363510132
        },
        {
            "text": "which disrupts the microtubular network",
            "probability": 0.0026081899399406244,
            "start_logit": -0.1401125192642212,
            "end_logit": 4.554847717285156
        },
        {
            "text": "microtubular network, also blocked the formation of RACK1-Lck complexes",
            "probability": 0.0022902729885748707,
            "start_logit": 1.8409423828125,
            "end_logit": 2.443807363510132
        },
        {
            "text": "disrupts the microtubular network, also blocked the formation of RACK1",
            "probability": 0.002207093655869932,
            "start_logit": 5.543104648590088,
            "end_logit": -1.295349359512329
        },
        {
            "text": "RACK1-Lck complexes",
            "probability": 0.001601093692335818,
            "start_logit": 1.4829583168029785,
            "end_logit": 2.443807363510132
        },
        {
            "text": "blocked the formation of RACK1-Lck",
            "probability": 0.0015971681201014773,
            "start_logit": 3.1111507415771484,
            "end_logit": 0.8131601214408875
        },
        {
            "text": "nocodazole, which disrupts the microtubular network,",
            "probability": 0.0012482920886111297,
            "start_logit": 2.2812235355377197,
            "end_logit": 1.3966314792633057
        },
        {
            "text": "disrupt",
            "probability": 0.0012194114835543286,
            "start_logit": 5.543104648590088,
            "end_logit": -1.888657569885254
        },
        {
            "text": "the microtubular network",
            "probability": 0.001203192889364573,
            "start_logit": -0.913790225982666,
            "end_logit": 4.554847717285156
        },
        {
            "text": "blocked the formation of RACK1-Lck complexes.",
            "probability": 0.0011219635032664757,
            "start_logit": 3.1111507415771484,
            "end_logit": 0.46000826358795166
        },
        {
            "text": "disrupts the microtubular network, also blocked",
            "probability": 0.0010482499323659197,
            "start_logit": 5.543104648590088,
            "end_logit": -2.0399038791656494
        },
        {
            "text": "disrupts the microtubular",
            "probability": 0.0009688880972662894,
            "start_logit": 5.543104648590088,
            "end_logit": -2.1186320781707764
        }
    ],
    "58a8903b38c171fb5b000006_004": [
        {
            "text": "polar body extrusion and escape of metaphase I arrest",
            "probability": 0.31257480603520627,
            "start_logit": 3.518536329269409,
            "end_logit": 3.3991904258728027
        },
        {
            "text": "precocious polar body extrusion and escape of metaphase I arrest",
            "probability": 0.27988752610996626,
            "start_logit": 3.4080803394317627,
            "end_logit": 3.3991904258728027
        },
        {
            "text": "metaphase I arrest",
            "probability": 0.16166369492157956,
            "start_logit": 2.859210729598999,
            "end_logit": 3.3991904258728027
        },
        {
            "text": "escape of metaphase I arrest",
            "probability": 0.10920326243882086,
            "start_logit": 2.4669034481048584,
            "end_logit": 3.3991904258728027
        },
        {
            "text": "polar body extrusion",
            "probability": 0.0402861968321048,
            "start_logit": 3.518536329269409,
            "end_logit": 1.3503555059432983
        },
        {
            "text": "precocious polar body extrusion",
            "probability": 0.03607329749553445,
            "start_logit": 3.4080803394317627,
            "end_logit": 1.3503555059432983
        },
        {
            "text": "The precocious polar body extrusion and escape of metaphase I arrest",
            "probability": 0.013244200132510209,
            "start_logit": 0.35725224018096924,
            "end_logit": 3.3991904258728027
        },
        {
            "text": "aneuploid metaphase II eggs. The precocious polar body extrusion and escape of metaphase I arrest",
            "probability": 0.006104807020954254,
            "start_logit": -0.4172309935092926,
            "end_logit": 3.3991904258728027
        },
        {
            "text": "increasing incidence of aneuploid metaphase II eggs. The precocious polar body extrusion and escape of metaphase I arrest",
            "probability": 0.005933960534779023,
            "start_logit": -0.44561561942100525,
            "end_logit": 3.3991904258728027
        },
        {
            "text": "polar body extrusion and escape of metaphase I",
            "probability": 0.005906293865386656,
            "start_logit": 3.518536329269409,
            "end_logit": -0.5696348547935486
        },
        {
            "text": "extrusion and escape of metaphase I arrest",
            "probability": 0.005482217288226366,
            "start_logit": -0.5247978568077087,
            "end_logit": 3.3991904258728027
        },
        {
            "text": "precocious polar body extrusion and escape of metaphase I",
            "probability": 0.005288647538264322,
            "start_logit": 3.4080803394317627,
            "end_logit": -0.5696348547935486
        },
        {
            "text": "arrest",
            "probability": 0.0034662206814259945,
            "start_logit": -0.9832426309585571,
            "end_logit": 3.3991904258728027
        },
        {
            "text": "metaphase I",
            "probability": 0.0030547352861942413,
            "start_logit": 2.859210729598999,
            "end_logit": -0.5696348547935486
        },
        {
            "text": "polar body extrusion and escape",
            "probability": 0.0021730078141395377,
            "start_logit": 3.518536329269409,
            "end_logit": -1.569541096687317
        },
        {
            "text": "polar body extrusion and escape of metaphase I arrest induced by nocodazole treatment in Zfp207-depleted oocytes",
            "probability": 0.002132251120723492,
            "start_logit": 3.518536329269409,
            "end_logit": -1.5884751081466675
        },
        {
            "text": "escape of metaphase I",
            "probability": 0.002063463038508516,
            "start_logit": 2.4669034481048584,
            "end_logit": -0.5696348547935486
        },
        {
            "text": "precocious polar body extrusion and escape",
            "probability": 0.0019457671238181538,
            "start_logit": 3.4080803394317627,
            "end_logit": -1.569541096687317
        },
        {
            "text": "polar body extrusion and escape of metaphase I arrest induced by nocodazole treatment in Zfp207",
            "probability": 0.0018086662862309858,
            "start_logit": 3.518536329269409,
            "end_logit": -1.753063678741455
        },
        {
            "text": "The precocious polar body extrusion",
            "probability": 0.0017069784356260576,
            "start_logit": 0.35725224018096924,
            "end_logit": 1.3503555059432983
        }
    ],
    "587e07023ec846c24f000001_000": [
        {
            "text": "PHYLUCE",
            "probability": 0.9218400532537935,
            "start_logit": 4.727943420410156,
            "end_logit": 4.021187782287598
        },
        {
            "text": "PHYLUCE is also available as a package (https://binstar.org/faircloth-lab/phyluce",
            "probability": 0.02535171952746353,
            "start_logit": 2.8408737182617188,
            "end_logit": 2.314732313156128
        },
        {
            "text": "phyluce",
            "probability": 0.01315659237411388,
            "start_logit": 2.184950113296509,
            "end_logit": 2.314732313156128
        },
        {
            "text": "faircloth-lab/phyluce",
            "probability": 0.009926002716987398,
            "start_logit": 1.9031850099563599,
            "end_logit": 2.314732313156128
        },
        {
            "text": "PHYLUCE is a software package for the analysis of conserved genomic loci.",
            "probability": 0.005415158393713076,
            "start_logit": 5.076155662536621,
            "end_logit": -1.4641940593719482
        },
        {
            "text": "PHYLUC",
            "probability": 0.004996876954150104,
            "start_logit": 5.076155662536621,
            "end_logit": -1.5445830821990967
        },
        {
            "text": "phyluce/ PHYLUCE",
            "probability": 0.0040023345801295206,
            "start_logit": 1.73860764503479,
            "end_logit": 1.5710296630859375
        },
        {
            "text": "PHYLUCE is a software package for the analysis of conserved genomic loci",
            "probability": 0.0031148305089528545,
            "start_logit": 5.076155662536621,
            "end_logit": -2.017221450805664
        },
        {
            "text": "faircloth-lab/phyluce/ PHYLUCE",
            "probability": 0.0026150943975747614,
            "start_logit": 1.3130300045013428,
            "end_logit": 1.5710296630859375
        },
        {
            "text": "P",
            "probability": 0.0021645047560853335,
            "start_logit": 5.076155662536621,
            "end_logit": -2.381204605102539
        },
        {
            "text": "PHYLUCE is",
            "probability": 0.0010558887842169811,
            "start_logit": 5.076155662536621,
            "end_logit": -3.099013328552246
        },
        {
            "text": ". PHYLUCE",
            "probability": 0.0009757534175604248,
            "start_logit": -2.122973680496216,
            "end_logit": 4.021187782287598
        },
        {
            "text": "binstar.org/faircloth-lab/phyluce",
            "probability": 0.0008490550453210886,
            "start_logit": -0.555604100227356,
            "end_logit": 2.314732313156128
        },
        {
            "text": "PHYL",
            "probability": 0.0008193466580503641,
            "start_logit": 5.076155662536621,
            "end_logit": -3.352644205093384
        },
        {
            "text": "PHYLUCE is a software package for the analysis of conserved genomic loci. UNLABELLED",
            "probability": 0.0007696759592012985,
            "start_logit": 5.076155662536621,
            "end_logit": -3.415181875228882
        },
        {
            "text": "phylogenomic inference. PHYLUCE",
            "probability": 0.0006558599893583802,
            "start_logit": -2.5202362537384033,
            "end_logit": 4.021187782287598
        },
        {
            "text": "PHYLUCE is an efficient and easy-to-install software package",
            "probability": 0.0006380358622667435,
            "start_logit": 4.727943420410156,
            "end_logit": -3.254544734954834
        },
        {
            "text": "(https://binstar.org/faircloth-lab/phyluce",
            "probability": 0.0006279275531288268,
            "start_logit": -0.8573033213615417,
            "end_logit": 2.314732313156128
        },
        {
            "text": "PHYLUCE is also available as a package (https://binstar",
            "probability": 0.0005228581535164013,
            "start_logit": 2.8408737182617188,
            "end_logit": -1.5665593147277832
        },
        {
            "text": "AVAILABILITY AND IMPLEMENTATION: PHYLUCE",
            "probability": 0.0005024311144157243,
            "start_logit": -1.767045259475708,
            "end_logit": 3.0015079975128174
        }
    ],
    "58a2e5f760087bc10a000007_000": [
        {
            "text": "alpha-synuclein",
            "probability": 0.8205535531430866,
            "start_logit": 7.447835922241211,
            "end_logit": 6.890844821929932
        },
        {
            "text": "alpha-synuclein (AS)",
            "probability": 0.09067782996470374,
            "start_logit": 7.447835922241211,
            "end_logit": 4.688178539276123
        },
        {
            "text": "alpha-synuclein fibrils. The protein alpha-synuclein",
            "probability": 0.06772640653429941,
            "start_logit": 4.953332901000977,
            "end_logit": 6.890844821929932
        },
        {
            "text": "alpha-synuclein fibrils. The protein alpha-synuclein (AS)",
            "probability": 0.007484317814862593,
            "start_logit": 4.953332901000977,
            "end_logit": 4.688178539276123
        },
        {
            "text": "alpha-synuclein (AS",
            "probability": 0.005561179246691514,
            "start_logit": 7.447835922241211,
            "end_logit": 1.8966758251190186
        },
        {
            "text": "synuclein",
            "probability": 0.002837340879955736,
            "start_logit": 1.780724048614502,
            "end_logit": 6.890844821929932
        },
        {
            "text": "The protein alpha-synuclein",
            "probability": 0.0008738381031332087,
            "start_logit": 0.6029965877532959,
            "end_logit": 6.890844821929932
        },
        {
            "text": "alpha-synuclein (AS) is the primary fibrillar component of Lewy bodies",
            "probability": 0.0006521968124335087,
            "start_logit": 7.447835922241211,
            "end_logit": -0.2465432584285736
        },
        {
            "text": "alpha-synuclein (AS) is the primary fibrillar component of Lewy bodies,",
            "probability": 0.0004829075131712487,
            "start_logit": 7.447835922241211,
            "end_logit": -0.547064483165741
        },
        {
            "text": "alpha-synuclein fibrils. The protein alpha-synuclein (AS",
            "probability": 0.0004590056127706034,
            "start_logit": 4.953332901000977,
            "end_logit": 1.8966758251190186
        },
        {
            "text": "protein alpha-synuclein",
            "probability": 0.00041173995181170676,
            "start_logit": -0.1495065689086914,
            "end_logit": 6.890844821929932
        },
        {
            "text": "alpha-synuclein (AS) is the primary fibrillar",
            "probability": 0.0003379586548743094,
            "start_logit": 7.447835922241211,
            "end_logit": -0.9039660692214966
        },
        {
            "text": "synuclein (AS)",
            "probability": 0.0003135492045327411,
            "start_logit": 1.780724048614502,
            "end_logit": 4.688178539276123
        },
        {
            "text": "-synuclein",
            "probability": 0.000312788729491411,
            "start_logit": -0.42437055706977844,
            "end_logit": 6.890844821929932
        },
        {
            "text": "synuclein fibrils. The protein alpha-synuclein",
            "probability": 0.00028822625662728197,
            "start_logit": -0.5061527490615845,
            "end_logit": 6.890844821929932
        },
        {
            "text": "alpha-synuclein (AS) is the primary fibrillar component",
            "probability": 0.0002447564697122245,
            "start_logit": 7.447835922241211,
            "end_logit": -1.226625919342041
        },
        {
            "text": "AS)",
            "probability": 0.00023568300940814526,
            "start_logit": 1.495255470275879,
            "end_logit": 4.688178539276123
        },
        {
            "text": "alpha",
            "probability": 0.00022020570875729914,
            "start_logit": 7.447835922241211,
            "end_logit": -1.3323274850845337
        },
        {
            "text": ". The protein alpha-synuclein",
            "probability": 0.00018935729469333484,
            "start_logit": -0.9262628555297852,
            "end_logit": 6.890844821929932
        },
        {
            "text": "(AS)",
            "probability": 0.00013715909498311204,
            "start_logit": 0.9539092779159546,
            "end_logit": 4.688178539276123
        }
    ],
    "58a2e5f760087bc10a000007_001": [
        {
            "text": "alpha-synuclein",
            "probability": 0.9771331367538246,
            "start_logit": 7.209346771240234,
            "end_logit": 6.564753532409668
        },
        {
            "text": "alpha-synuclein,",
            "probability": 0.019365773917413613,
            "start_logit": 7.209346771240234,
            "end_logit": 2.6436378955841064
        },
        {
            "text": "synuclein",
            "probability": 0.0009042276631715132,
            "start_logit": 0.22404974699020386,
            "end_logit": 6.564753532409668
        },
        {
            "text": "The primary structural component of Lewy bodies are fibrils composed primarily of alpha-synuclein",
            "probability": 0.00044443860589899327,
            "start_logit": -0.48621949553489685,
            "end_logit": 6.564753532409668
        },
        {
            "text": "Lewy bodies. The primary structural component of Lewy bodies are fibrils composed primarily of alpha-synuclein",
            "probability": 0.00034051262723699933,
            "start_logit": -0.7525792121887207,
            "end_logit": 6.564753532409668
        },
        {
            "text": "fibrils composed primarily of alpha-synuclein",
            "probability": 0.0003404972431148172,
            "start_logit": -0.7526243925094604,
            "end_logit": 6.564753532409668
        },
        {
            "text": "Lewy bodies are fibrils composed primarily of alpha-synuclein",
            "probability": 0.0002226613864324683,
            "start_logit": -1.1773792505264282,
            "end_logit": 6.564753532409668
        },
        {
            "text": "alpha",
            "probability": 0.00022191965095792672,
            "start_logit": 7.209346771240234,
            "end_logit": -1.8253092765808105
        },
        {
            "text": "-synuclein",
            "probability": 0.00015235797401674507,
            "start_logit": -1.5567985773086548,
            "end_logit": 6.564753532409668
        },
        {
            "text": "primary structural component of Lewy bodies are fibrils composed primarily of alpha-synuclein",
            "probability": 0.00014301072084663027,
            "start_logit": -1.6201118230819702,
            "end_logit": 6.564753532409668
        },
        {
            "text": ". The primary structural component of Lewy bodies are fibrils composed primarily of alpha-synuclein",
            "probability": 0.0001419215539880077,
            "start_logit": -1.627756953239441,
            "end_logit": 6.564753532409668
        },
        {
            "text": "lein",
            "probability": 9.432122135425831e-05,
            "start_logit": -2.036325216293335,
            "end_logit": 6.564753532409668
        },
        {
            "text": "component of Lewy bodies are fibrils composed primarily of alpha-synuclein",
            "probability": 8.045963563181665e-05,
            "start_logit": -2.1952757835388184,
            "end_logit": 6.564753532409668
        },
        {
            "text": "composed primarily of alpha-synuclein",
            "probability": 7.492562096080611e-05,
            "start_logit": -2.266535520553589,
            "end_logit": 6.564753532409668
        },
        {
            "text": "alpha-synuclein, a highly conserved 140 amino acid protein",
            "probability": 7.267153102409249e-05,
            "start_logit": 7.209346771240234,
            "end_logit": -2.9416749477386475
        },
        {
            "text": "alpha-synuclein, a highly conserved 140 amino acid protein that is predominantly expressed in neurons",
            "probability": 6.300424291427039e-05,
            "start_logit": 7.209346771240234,
            "end_logit": -3.0844225883483887
        },
        {
            "text": "primarily of alpha-synuclein",
            "probability": 6.039320359184647e-05,
            "start_logit": -2.4821548461914062,
            "end_logit": 6.564753532409668
        },
        {
            "text": "structural component of Lewy bodies are fibrils composed primarily of alpha-synuclein",
            "probability": 5.413811845055939e-05,
            "start_logit": -2.5914928913116455,
            "end_logit": 6.564753532409668
        },
        {
            "text": "alpha-s",
            "probability": 4.8519898269642914e-05,
            "start_logit": 7.209346771240234,
            "end_logit": -3.3456506729125977
        },
        {
            "text": "alpha-syn",
            "probability": 4.110843090056305e-05,
            "start_logit": 7.209346771240234,
            "end_logit": -3.511411428451538
        }
    ],
    "58a2e5f760087bc10a000007_002": [
        {
            "text": "alpha-synuclein",
            "probability": 0.9862655047913444,
            "start_logit": 7.518147945404053,
            "end_logit": 7.0577006340026855
        },
        {
            "text": "alpha-synuclein,",
            "probability": 0.009102774234680104,
            "start_logit": 7.518147945404053,
            "end_logit": 2.37235426902771
        },
        {
            "text": "synuclein",
            "probability": 0.0013695945429545802,
            "start_logit": 0.9387370944023132,
            "end_logit": 7.0577006340026855
        },
        {
            "text": "alpha-synuclein, the major protein component of Lewy bodies associated with Parkinson's disease,",
            "probability": 0.0006967433736802517,
            "start_logit": 7.518147945404053,
            "end_logit": -0.1975630819797516
        },
        {
            "text": "alpha-synuclein, the major protein component of Lewy bodies",
            "probability": 0.0006216915719225153,
            "start_logit": 7.518147945404053,
            "end_logit": -0.31153613328933716
        },
        {
            "text": "-synuclein",
            "probability": 0.00040702158961881095,
            "start_logit": -0.2746666967868805,
            "end_logit": 7.0577006340026855
        },
        {
            "text": "amyloidogenic protein sequences that may be targeted to inhibit the aggregation of the host protein. For alpha-synuclein",
            "probability": 0.00037870452822120706,
            "start_logit": -0.3467766344547272,
            "end_logit": 7.0577006340026855
        },
        {
            "text": "For alpha-synuclein",
            "probability": 0.0002394719094045506,
            "start_logit": -0.8050968050956726,
            "end_logit": 7.0577006340026855
        },
        {
            "text": "alpha",
            "probability": 0.00021440033847556082,
            "start_logit": 7.518147945404053,
            "end_logit": -1.376135230064392
        },
        {
            "text": "alpha-synuclein, the major protein component of Lewy bodies associated with Parkinson's disease",
            "probability": 0.00019199047505145782,
            "start_logit": 7.518147945404053,
            "end_logit": -1.4865344762802124
        },
        {
            "text": "lein",
            "probability": 0.0001147586718826157,
            "start_logit": -1.5407015085220337,
            "end_logit": 7.0577006340026855
        },
        {
            "text": ". For alpha-synuclein",
            "probability": 9.743650474867778e-05,
            "start_logit": -1.7043319940567017,
            "end_logit": 7.0577006340026855
        },
        {
            "text": "alpha-synuclein, the major protein component",
            "probability": 9.555481681553146e-05,
            "start_logit": 7.518147945404053,
            "end_logit": -2.1842801570892334
        },
        {
            "text": "alpha-synuclein, the major protein component of Lewy bodies associated",
            "probability": 4.366234187626351e-05,
            "start_logit": 7.518147945404053,
            "end_logit": -2.967494249343872
        },
        {
            "text": "alpha-s",
            "probability": 3.206484166768269e-05,
            "start_logit": 7.518147945404053,
            "end_logit": -3.2762200832366943
        },
        {
            "text": "alpha-synuclein, the major protein",
            "probability": 2.9412667514296312e-05,
            "start_logit": 7.518147945404053,
            "end_logit": -3.3625547885894775
        },
        {
            "text": "alpha-syn",
            "probability": 2.7092866383116204e-05,
            "start_logit": 7.518147945404053,
            "end_logit": -3.4447097778320312
        },
        {
            "text": "alpha-synuc",
            "probability": 2.662875877927332e-05,
            "start_logit": 7.518147945404053,
            "end_logit": -3.4619884490966797
        },
        {
            "text": "alpha-synuclein, the major protein component of Lewy",
            "probability": 2.421726164538511e-05,
            "start_logit": 7.518147945404053,
            "end_logit": -3.5569145679473877
        },
        {
            "text": "alpha-synuclein, the major protein component of",
            "probability": 2.1273913333584856e-05,
            "start_logit": 7.518147945404053,
            "end_logit": -3.6864986419677734
        }
    ],
    "58a2e5f760087bc10a000007_003": [
        {
            "text": "\u03b1-synuclein",
            "probability": 0.8536285016600591,
            "start_logit": 7.274868488311768,
            "end_logit": 6.912582874298096
        },
        {
            "text": "\u03b1-synuclein amyloid fibrils by solid-state NMR. Fibrillar \u03b1-synuclein",
            "probability": 0.0707232846886528,
            "start_logit": 4.784147262573242,
            "end_logit": 6.912582874298096
        },
        {
            "text": "\u03b1-synuclein (AS)",
            "probability": 0.04243729901779289,
            "start_logit": 7.274868488311768,
            "end_logit": 3.911114454269409
        },
        {
            "text": "Fibrillar \u03b1-synuclein",
            "probability": 0.019206599534862485,
            "start_logit": 3.480626344680786,
            "end_logit": 6.912582874298096
        },
        {
            "text": "\u03b1-synuclein (AS",
            "probability": 0.004282563603374593,
            "start_logit": 7.274868488311768,
            "end_logit": 1.6176385879516602
        },
        {
            "text": "synuclein",
            "probability": 0.003899432420377756,
            "start_logit": 1.886203408241272,
            "end_logit": 6.912582874298096
        },
        {
            "text": "Fibrillar \u03b1-synuclein (AS)",
            "probability": 0.000954837152216538,
            "start_logit": 3.480626344680786,
            "end_logit": 3.911114454269409
        },
        {
            "text": "synuclein amyloid fibrils by solid-state NMR. Fibrillar \u03b1-synuclein",
            "probability": 0.0007727308164717455,
            "start_logit": 0.2675478756427765,
            "end_logit": 6.912582874298096
        },
        {
            "text": "-synuclein",
            "probability": 0.0007056535471834901,
            "start_logit": 0.17674151062965393,
            "end_logit": 6.912582874298096
        },
        {
            "text": "\u03b1-synuclein (AS) is the major component of Lewy bodies",
            "probability": 0.0006782062934690425,
            "start_logit": 7.274868488311768,
            "end_logit": -0.22521698474884033
        },
        {
            "text": "\u03b1-synuclein (AS) is the major component of Lewy bodies,",
            "probability": 0.0005242977554360379,
            "start_logit": 7.274868488311768,
            "end_logit": -0.48260873556137085
        },
        {
            "text": "amyloid fibrils by solid-state NMR. Fibrillar \u03b1-synuclein",
            "probability": 0.0004969386164760585,
            "start_logit": -0.17391636967658997,
            "end_logit": 6.912582874298096
        },
        {
            "text": "\u03b1-synuclein amyloid fibrils by solid-state NMR. Fibrillar \u03b1-synuclein (AS",
            "probability": 0.0003548112139293809,
            "start_logit": 4.784147262573242,
            "end_logit": 1.6176385879516602
        },
        {
            "text": ". Fibrillar \u03b1-synuclein",
            "probability": 0.0003262730016320121,
            "start_logit": -0.5946484208106995,
            "end_logit": 6.912582874298096
        },
        {
            "text": "human \u03b1-synuclein amyloid fibrils by solid-state NMR. Fibrillar \u03b1-synuclein",
            "probability": 0.00025489041863453136,
            "start_logit": -0.8415491580963135,
            "end_logit": 6.912582874298096
        },
        {
            "text": "synuclein (AS)",
            "probability": 0.0001938564367303031,
            "start_logit": 1.886203408241272,
            "end_logit": 3.911114454269409
        },
        {
            "text": "\u03b1-synuclein (AS) is the major component",
            "probability": 0.0001583664441191177,
            "start_logit": 7.274868488311768,
            "end_logit": -1.6797568798065186
        },
        {
            "text": "\u03b1",
            "probability": 0.0001553764872425903,
            "start_logit": 7.274868488311768,
            "end_logit": -1.6988173723220825
        },
        {
            "text": "AS)",
            "probability": 0.00012643411372797227,
            "start_logit": 1.4588068723678589,
            "end_logit": 3.911114454269409
        },
        {
            "text": "(AS)",
            "probability": 0.00011964677761209312,
            "start_logit": 1.4036294221878052,
            "end_logit": 3.911114454269409
        }
    ],
    "58a2e5f760087bc10a000007_004": [
        {
            "text": "\u03b1-synuclein",
            "probability": 0.6153755977985489,
            "start_logit": 7.095768928527832,
            "end_logit": 6.513624668121338
        },
        {
            "text": "\u03b1-synuclein (\u03b1Syn",
            "probability": 0.15764307105785008,
            "start_logit": 7.095768928527832,
            "end_logit": 5.1517252922058105
        },
        {
            "text": "\u03b1-synuclein (\u03b1Syn)",
            "probability": 0.08140717046458298,
            "start_logit": 7.095768928527832,
            "end_logit": 4.4908552169799805
        },
        {
            "text": "\u03b1Syn",
            "probability": 0.0691361650934687,
            "start_logit": 6.27151346206665,
            "end_logit": 5.1517252922058105
        },
        {
            "text": "\u03b1Syn)",
            "probability": 0.03570204221006449,
            "start_logit": 6.27151346206665,
            "end_logit": 4.4908552169799805
        },
        {
            "text": "\u03b1-synuclein and fibril formation rates by NMR and fluorescence. Aggregation of \u03b1-synuclein",
            "probability": 0.028204284696998646,
            "start_logit": 4.013010025024414,
            "end_logit": 6.513624668121338
        },
        {
            "text": "(\u03b1Syn",
            "probability": 0.0025147992860137637,
            "start_logit": 2.9576284885406494,
            "end_logit": 5.1517252922058105
        },
        {
            "text": "\u03b1-synuclein (\u03b1Syn),",
            "probability": 0.0022877575686555494,
            "start_logit": 7.095768928527832,
            "end_logit": 0.9189639687538147
        },
        {
            "text": "synuclein",
            "probability": 0.0019642872876502104,
            "start_logit": 1.3486655950546265,
            "end_logit": 6.513624668121338
        },
        {
            "text": "(\u03b1Syn)",
            "probability": 0.001298646954712061,
            "start_logit": 2.9576284885406494,
            "end_logit": 4.4908552169799805
        },
        {
            "text": "\u03b1Syn),",
            "probability": 0.0010033221498353098,
            "start_logit": 6.27151346206665,
            "end_logit": 0.9189639687538147
        },
        {
            "text": "\u03b1-synuclein (\u03b1Syn), the primary protein component in Lewy body",
            "probability": 0.0007398608862179795,
            "start_logit": 7.095768928527832,
            "end_logit": -0.20990124344825745
        },
        {
            "text": "synuclein (\u03b1Syn",
            "probability": 0.0005031988294187182,
            "start_logit": 1.3486655950546265,
            "end_logit": 5.1517252922058105
        },
        {
            "text": "synuclein and fibril formation rates by NMR and fluorescence. Aggregation of \u03b1-synuclein",
            "probability": 0.0004792148217476055,
            "start_logit": -0.06207018345594406,
            "end_logit": 6.513624668121338
        },
        {
            "text": "\u03b1-synuclein (\u03b1Syn), the primary protein component in Lewy body inclusions of patients with Parkinson's disease,",
            "probability": 0.00043757982992296537,
            "start_logit": 7.095768928527832,
            "end_logit": -0.7351042628288269
        },
        {
            "text": "-synuclein",
            "probability": 0.0003367780636909395,
            "start_logit": -0.41479501128196716,
            "end_logit": 6.513624668121338
        },
        {
            "text": "\u03b1Syn), the primary protein component in Lewy body",
            "probability": 0.0003244744220759023,
            "start_logit": 6.27151346206665,
            "end_logit": -0.20990124344825745
        },
        {
            "text": "synuclein (\u03b1Syn)",
            "probability": 0.00025985279663218245,
            "start_logit": 1.3486655950546265,
            "end_logit": 4.4908552169799805
        },
        {
            "text": "\u03b1Syn), the primary protein component in Lewy body inclusions of patients with Parkinson's disease,",
            "probability": 0.00019190562046348577,
            "start_logit": 6.27151346206665,
            "end_logit": -0.7351042628288269
        },
        {
            "text": "\u03b1",
            "probability": 0.00018999016144958118,
            "start_logit": 7.095768928527832,
            "end_logit": -1.569391131401062
        }
    ],
    "58a2e5f760087bc10a000007_005": [
        {
            "text": "Alpha-synuclein",
            "probability": 0.8359635439612,
            "start_logit": 7.5633015632629395,
            "end_logit": 6.937318801879883
        },
        {
            "text": "Alpha-synuclein (alphaS)",
            "probability": 0.06167024824589249,
            "start_logit": 7.5633015632629395,
            "end_logit": 4.330535411834717
        },
        {
            "text": "Alpha-synuclein (alphaS",
            "probability": 0.044638623463571066,
            "start_logit": 7.5633015632629395,
            "end_logit": 4.007333278656006
        },
        {
            "text": "alpha-synuclein at low pH. Alpha-synuclein",
            "probability": 0.033718531110362375,
            "start_logit": 4.352764129638672,
            "end_logit": 6.937318801879883
        },
        {
            "text": "alphaS)",
            "probability": 0.006541446579542385,
            "start_logit": 5.319658279418945,
            "end_logit": 4.330535411834717
        },
        {
            "text": "alphaS",
            "probability": 0.00473487912043075,
            "start_logit": 5.319658279418945,
            "end_logit": 4.007333278656006
        },
        {
            "text": "alpha-synuclein at low pH. Alpha-synuclein (alphaS)",
            "probability": 0.0024874651521399485,
            "start_logit": 4.352764129638672,
            "end_logit": 4.330535411834717
        },
        {
            "text": "synuclein",
            "probability": 0.002193206498276569,
            "start_logit": 1.6200811862945557,
            "end_logit": 6.937318801879883
        },
        {
            "text": "alpha-synuclein at low pH. Alpha-synuclein (alphaS",
            "probability": 0.0018004957570853502,
            "start_logit": 4.352764129638672,
            "end_logit": 4.007333278656006
        },
        {
            "text": "Alpha-synuclein (alphaS) is the primary component of Lewy bodies,",
            "probability": 0.0012710283805012434,
            "start_logit": 7.5633015632629395,
            "end_logit": 0.44856011867523193
        },
        {
            "text": "Alpha-synuclein (alphaS) is the primary component of Lewy bodies",
            "probability": 0.001199086312265893,
            "start_logit": 7.5633015632629395,
            "end_logit": 0.3902936577796936
        },
        {
            "text": "alpha-synuclein",
            "probability": 0.0010808119189332818,
            "start_logit": 4.352764129638672,
            "end_logit": 3.496983766555786
        },
        {
            "text": "alphaS) is the primary component of Lewy bodies, the pathological hallmark of Parkinson's Disease. Aggregation of alphaS",
            "probability": 0.0008312069795051357,
            "start_logit": 5.319658279418945,
            "end_logit": 2.267500638961792
        },
        {
            "text": ". Alpha-synuclein",
            "probability": 0.0003352235234645832,
            "start_logit": -0.2582411766052246,
            "end_logit": 6.937318801879883
        },
        {
            "text": "-synuclein",
            "probability": 0.0003050718193472707,
            "start_logit": -0.35249149799346924,
            "end_logit": 6.937318801879883
        },
        {
            "text": "Alpha",
            "probability": 0.0002758499273992897,
            "start_logit": 7.5633015632629395,
            "end_logit": -1.0791645050048828
        },
        {
            "text": "Alpha-synuclein (alpha",
            "probability": 0.00026614747143938845,
            "start_logit": 7.5633015632629395,
            "end_logit": -1.1149709224700928
        },
        {
            "text": "(alphaS)",
            "probability": 0.0002634594983301143,
            "start_logit": 2.1076443195343018,
            "end_logit": 4.330535411834717
        },
        {
            "text": "synuclein at low pH. Alpha-synuclein",
            "probability": 0.00023297504237591336,
            "start_logit": -0.6221073865890503,
            "end_logit": 6.937318801879883
        },
        {
            "text": "(alphaS",
            "probability": 0.00019069923793670803,
            "start_logit": 2.1076443195343018,
            "end_logit": 4.007333278656006
        }
    ],
    "589a246078275d0c4a00002a_000": [
        {
            "text": "teriflunomide",
            "probability": 0.9699123576904449,
            "start_logit": 6.70173454284668,
            "end_logit": 5.574192047119141
        },
        {
            "text": "fingolimod, and teriflunomide",
            "probability": 0.009982845187353588,
            "start_logit": 4.444967746734619,
            "end_logit": 3.2546212673187256
        },
        {
            "text": "fingolimod",
            "probability": 0.007661832403861175,
            "start_logit": 4.444967746734619,
            "end_logit": 2.990004301071167
        },
        {
            "text": "fingolimod,",
            "probability": 0.0028098309255554493,
            "start_logit": 4.444967746734619,
            "end_logit": 1.98687744140625
        },
        {
            "text": "Dimethyl fumarate (DMF), fingolimod, and teriflunomide",
            "probability": 0.0020900105871212308,
            "start_logit": 2.8812687397003174,
            "end_logit": 3.2546212673187256
        },
        {
            "text": "Dimethyl fumarate (DMF), fingolimod",
            "probability": 0.0016040828581719623,
            "start_logit": 2.8812687397003174,
            "end_logit": 2.990004301071167
        },
        {
            "text": "teriflunomide (TEMSO,",
            "probability": 0.001158050281258364,
            "start_logit": 6.70173454284668,
            "end_logit": -1.1562758684158325
        },
        {
            "text": "teriflunomide (TEMSO",
            "probability": 0.0008898538514245282,
            "start_logit": 6.70173454284668,
            "end_logit": -1.419711709022522
        },
        {
            "text": "Dimethyl fumarate (DMF), fingolimod,",
            "probability": 0.0005882667989153032,
            "start_logit": 2.8812687397003174,
            "end_logit": 1.98687744140625
        },
        {
            "text": "Dimethyl fumarate",
            "probability": 0.0005562829294163972,
            "start_logit": 2.8812687397003174,
            "end_logit": 1.9309738874435425
        },
        {
            "text": "te",
            "probability": 0.000493361875447797,
            "start_logit": 6.70173454284668,
            "end_logit": -2.009526014328003
        },
        {
            "text": "teriflunomide (TEMSO, NCT00134563",
            "probability": 0.0004622681450316941,
            "start_logit": 6.70173454284668,
            "end_logit": -2.0746238231658936
        },
        {
            "text": "teriflunomide (TEMSO, NCT00134563;",
            "probability": 0.00042299271002616077,
            "start_logit": 6.70173454284668,
            "end_logit": -2.1634140014648438
        },
        {
            "text": "Dimethyl fumarate (DMF),",
            "probability": 0.00032298180978251455,
            "start_logit": 2.8812687397003174,
            "end_logit": 1.3872928619384766
        },
        {
            "text": "and teriflunomide",
            "probability": 0.0002540365961748135,
            "start_logit": -1.5457481145858765,
            "end_logit": 5.574192047119141
        },
        {
            "text": "teriflunomide (TEMSO, NCT00134563; TOWER,",
            "probability": 0.00019042152516523224,
            "start_logit": 6.70173454284668,
            "end_logit": -2.961528778076172
        },
        {
            "text": "Dimethyl fumarate (DMF)",
            "probability": 0.0001616561934241882,
            "start_logit": 2.8812687397003174,
            "end_logit": 0.695168673992157
        },
        {
            "text": "teriflunomi",
            "probability": 0.00015887449127146295,
            "start_logit": 6.70173454284668,
            "end_logit": -3.1426544189453125
        },
        {
            "text": "(DMF), fingolimod, and teriflunomide",
            "probability": 0.00014056416660251556,
            "start_logit": 0.18200841546058655,
            "end_logit": 3.2546212673187256
        },
        {
            "text": "dimethyl fumarate, fingolimod, and teriflunomide",
            "probability": 0.00013942897355089803,
            "start_logit": 1.5577154159545898,
            "end_logit": 1.8708055019378662
        }
    ],
    "589a246078275d0c4a00002a_001": [
        {
            "text": "Teriflunomide",
            "probability": 0.6891454630456982,
            "start_logit": 6.120622634887695,
            "end_logit": 4.235558032989502
        },
        {
            "text": "teriflunomide",
            "probability": 0.1785832330060678,
            "start_logit": 4.964880466461182,
            "end_logit": 4.040902614593506
        },
        {
            "text": "Teriflunomide Multiple Sclerosis",
            "probability": 0.07580614547829569,
            "start_logit": 6.120622634887695,
            "end_logit": 2.028285026550293
        },
        {
            "text": "Teriflunomide Multiple Sclerosis Oral",
            "probability": 0.04051364466270431,
            "start_logit": 6.120622634887695,
            "end_logit": 1.4017444849014282
        },
        {
            "text": "teriflunomide is well-tolerated and efficacy of teriflunomide",
            "probability": 0.00363440904685452,
            "start_logit": 2.967757225036621,
            "end_logit": 2.1434175968170166
        },
        {
            "text": "teriflunomide: Nine-year follow-up of the randomized TEMSO study.",
            "probability": 0.0018949861698797123,
            "start_logit": 4.964880466461182,
            "end_logit": -0.5049406290054321
        },
        {
            "text": "teriflunomide:",
            "probability": 0.0016128752688751653,
            "start_logit": 4.964880466461182,
            "end_logit": -0.6661337018013
        },
        {
            "text": "Teriflunomide Multiple Sclerosis Oral (TEMSO",
            "probability": 0.0015826970907785744,
            "start_logit": 6.120622634887695,
            "end_logit": -1.8407639265060425
        },
        {
            "text": "Te",
            "probability": 0.0015596442871942502,
            "start_logit": 6.120622634887695,
            "end_logit": -1.8554365634918213
        },
        {
            "text": "Teriflunomide Multiple",
            "probability": 0.0011242522241759621,
            "start_logit": 6.120622634887695,
            "end_logit": -2.1827762126922607
        },
        {
            "text": "Teriflunomide Multiple Sclerosis Oral (TEMSO) trial (NCT00134563).",
            "probability": 0.0011125475804446335,
            "start_logit": 6.120622634887695,
            "end_logit": -2.193241834640503
        },
        {
            "text": "teriflunomide.",
            "probability": 0.00082875358618769,
            "start_logit": 2.9482767581939697,
            "end_logit": 0.684619128704071
        },
        {
            "text": "Teriflunomide Multiple Sclerosis Oral (TEMSO)",
            "probability": 0.0004487409166944876,
            "start_logit": 6.120622634887695,
            "end_logit": -3.1012039184570312
        },
        {
            "text": "Teriflunomi",
            "probability": 0.0004220707013195664,
            "start_logit": 6.120622634887695,
            "end_logit": -3.1624767780303955
        },
        {
            "text": "(NCT00803049) of the pivotal phase 3 Teriflunomide",
            "probability": 0.00041807193042098684,
            "start_logit": -1.2869315147399902,
            "end_logit": 4.235558032989502
        },
        {
            "text": "teriflunomide in an extension (NCT00803049) of the pivotal phase 3 Te",
            "probability": 0.0004052079534453973,
            "start_logit": 4.772809982299805,
            "end_logit": -1.8554365634918213
        },
        {
            "text": "with teriflunomide",
            "probability": 0.00034731682289279293,
            "start_logit": -1.3398126363754272,
            "end_logit": 4.103023052215576
        },
        {
            "text": "te",
            "probability": 0.00032434037460651497,
            "start_logit": 4.964880466461182,
            "end_logit": -2.270113945007324
        },
        {
            "text": "teriflunomide: Nine-year follow-up of the randomized TEMSO",
            "probability": 0.0001209575465488977,
            "start_logit": 4.964880466461182,
            "end_logit": -3.256467819213867
        },
        {
            "text": "teriflunomi",
            "probability": 0.00011464230691467941,
            "start_logit": 4.964880466461182,
            "end_logit": -3.3100905418395996
        }
    ],
    "589a246078275d0c4a00002a_002": [
        {
            "text": "teriflunomide",
            "probability": 0.5075172915401404,
            "start_logit": 5.092928409576416,
            "end_logit": 4.271821975708008
        },
        {
            "text": "Teriflunomide",
            "probability": 0.43538999928440203,
            "start_logit": 5.648025989532471,
            "end_logit": 3.5634357929229736
        },
        {
            "text": "Teriflunomide Multiple Sclerosis",
            "probability": 0.02020772972099094,
            "start_logit": 5.648025989532471,
            "end_logit": 0.4932588040828705
        },
        {
            "text": "Teriflunomide Multiple Sclerosis Oral",
            "probability": 0.011419496332400013,
            "start_logit": 5.648025989532471,
            "end_logit": -0.07748428732156754
        },
        {
            "text": "teriflunomide. IMPLICATIONS: Clinical evidence suggests that teriflunomide",
            "probability": 0.004381906741782531,
            "start_logit": 2.5591681003570557,
            "end_logit": 2.0535354614257812
        },
        {
            "text": "Teriflunomide: a once-daily oral medication for the treatment of relapsing forms of multiple sclerosis.",
            "probability": 0.004131542059761557,
            "start_logit": 4.373658657073975,
            "end_logit": 0.18021166324615479
        },
        {
            "text": "Teriflunomide Oral",
            "probability": 0.0026143300354820867,
            "start_logit": 4.60477876663208,
            "end_logit": -0.508551299571991
        },
        {
            "text": "Teriflunomide,",
            "probability": 0.0022719618152214787,
            "start_logit": 4.268874645233154,
            "end_logit": -0.3130113482475281
        },
        {
            "text": "Te",
            "probability": 0.0016806898752477009,
            "start_logit": 5.648025989532471,
            "end_logit": -1.9936020374298096
        },
        {
            "text": "Teriflunomide:",
            "probability": 0.0015728823033920078,
            "start_logit": 4.373658657073975,
            "end_logit": -0.7855292558670044
        },
        {
            "text": "(Teriflunomide",
            "probability": 0.0013407951189573562,
            "start_logit": -0.13495337963104248,
            "end_logit": 3.5634357929229736
        },
        {
            "text": "Teriflunomide Multiple",
            "probability": 0.0010993293449734914,
            "start_logit": 5.648025989532471,
            "end_logit": -2.4181060791015625
        },
        {
            "text": "Teriflunomide Multiple Sclerosis Oral) trial.",
            "probability": 0.0010796444300205023,
            "start_logit": 5.648025989532471,
            "end_logit": -2.4361746311187744
        },
        {
            "text": "Teriflunomide Multiple Sclerosis Oral)",
            "probability": 0.001023333116667507,
            "start_logit": 5.648025989532471,
            "end_logit": -2.489741325378418
        },
        {
            "text": "In the TEMSO and TOWER studies, the 14-mg dose of teriflunomide",
            "probability": 0.0009615220641048253,
            "start_logit": -1.175840139389038,
            "end_logit": 4.271821975708008
        },
        {
            "text": "Teriflunomide Oral in People With Relapsing Multiple Sclerosis",
            "probability": 0.0007670931792026149,
            "start_logit": 4.60477876663208,
            "end_logit": -1.734706163406372
        },
        {
            "text": "Teriflunomide Oral in People With Relapsing Multiple Sclerosis)",
            "probability": 0.0007610703543113242,
            "start_logit": 4.60477876663208,
            "end_logit": -1.7425886392593384
        },
        {
            "text": "TEMSO (Teriflunomide",
            "probability": 0.0006798694721076504,
            "start_logit": -0.8140706419944763,
            "end_logit": 3.5634357929229736
        },
        {
            "text": "te",
            "probability": 0.0005718617876628136,
            "start_logit": 5.092928409576416,
            "end_logit": -2.516566753387451
        },
        {
            "text": "teriflunomide.",
            "probability": 0.0005276514231711779,
            "start_logit": 2.5591681003570557,
            "end_logit": -0.06326789408922195
        }
    ],
    "589a246078275d0c4a00002a_003": [
        {
            "text": "Teriflunomide",
            "probability": 0.9120064296987883,
            "start_logit": 6.400733947753906,
            "end_logit": 5.56830358505249
        },
        {
            "text": "fingolimod",
            "probability": 0.02135397628892371,
            "start_logit": 4.782617092132568,
            "end_logit": 3.432011365890503
        },
        {
            "text": "fingolimod, teriflunomide, and dimethyl fumarate (DMF)",
            "probability": 0.013422130948823111,
            "start_logit": 4.782617092132568,
            "end_logit": 2.9676783084869385
        },
        {
            "text": "Teriflunomide,",
            "probability": 0.013200600717723925,
            "start_logit": 6.400733947753906,
            "end_logit": 1.3329188823699951
        },
        {
            "text": "fingolimod, teriflunomide, and dimethyl fumarate",
            "probability": 0.008513299696110583,
            "start_logit": 4.782617092132568,
            "end_logit": 2.5124030113220215
        },
        {
            "text": "fingolimod, teriflunomide",
            "probability": 0.00821517401443381,
            "start_logit": 4.782617092132568,
            "end_logit": 2.4767563343048096
        },
        {
            "text": "fingolimod,",
            "probability": 0.0045088189374633296,
            "start_logit": 4.782617092132568,
            "end_logit": 1.8768086433410645
        },
        {
            "text": "teriflunomide, and dimethyl fumarate (DMF)",
            "probability": 0.0036239131309348392,
            "start_logit": 3.4732666015625,
            "end_logit": 2.9676783084869385
        },
        {
            "text": "fingolimod, teriflunomide,",
            "probability": 0.002968523894046591,
            "start_logit": 4.782617092132568,
            "end_logit": 1.4588382244110107
        },
        {
            "text": "teriflunomide, and dimethyl fumarate",
            "probability": 0.002298551450134962,
            "start_logit": 3.4732666015625,
            "end_logit": 2.5124030113220215
        },
        {
            "text": "teriflunomide",
            "probability": 0.0022180588981984095,
            "start_logit": 3.4732666015625,
            "end_logit": 2.4767563343048096
        },
        {
            "text": "dimethyl fumarate (DMF)",
            "probability": 0.0019347351366732033,
            "start_logit": 2.8456826210021973,
            "end_logit": 2.9676783084869385
        },
        {
            "text": "dimethyl fumarate",
            "probability": 0.0012271508983108725,
            "start_logit": 2.8456826210021973,
            "end_logit": 2.5124030113220215
        },
        {
            "text": "fingolimod, teriflunomide, and dimethyl fumarate (DMF",
            "probability": 0.001186026252217826,
            "start_logit": 4.782617092132568,
            "end_logit": 0.5413818359375
        },
        {
            "text": "teriflunomide,",
            "probability": 0.0008014876892608862,
            "start_logit": 3.4732666015625,
            "end_logit": 1.4588382244110107
        },
        {
            "text": "fingolimod, teriflunomide, and dimethyl fumarate (DMF)-",
            "probability": 0.0006813098109888582,
            "start_logit": 4.782617092132568,
            "end_logit": -0.01296474039554596
        },
        {
            "text": "DMF)",
            "probability": 0.000538669138306997,
            "start_logit": 1.5670584440231323,
            "end_logit": 2.9676783084869385
        },
        {
            "text": "Te",
            "probability": 0.0005109168349496047,
            "start_logit": 6.400733947753906,
            "end_logit": -1.9188919067382812
        },
        {
            "text": ". Teriflunomide",
            "probability": 0.00047000497405094135,
            "start_logit": -1.1699250936508179,
            "end_logit": 5.56830358505249
        },
        {
            "text": "teriflunomide, and dimethyl fumarate (DMF",
            "probability": 0.0003202215896591651,
            "start_logit": 3.4732666015625,
            "end_logit": 0.5413818359375
        }
    ],
    "58a1c0f178275d0c4a000056_000": [
        {
            "text": "1962",
            "probability": 0.9284783694765728,
            "start_logit": 6.600815296173096,
            "end_logit": 6.034300804138184
        },
        {
            "text": "in 1962",
            "probability": 0.0335764093139868,
            "start_logit": 3.2810919284820557,
            "end_logit": 6.034300804138184
        },
        {
            "text": "1962,",
            "probability": 0.020981244089434498,
            "start_logit": 6.600815296173096,
            "end_logit": 2.244382619857788
        },
        {
            "text": "1955 IPV was used extensively in the US and polio incidence declined by more than 95 per cent. However, in 1962",
            "probability": 0.009011870773736172,
            "start_logit": 1.9658108949661255,
            "end_logit": 6.034300804138184
        },
        {
            "text": "1962, when oral poliovirus vaccine (OPV) became available,",
            "probability": 0.0038735521734992156,
            "start_logit": 6.600815296173096,
            "end_logit": 0.5549256801605225
        },
        {
            "text": "However, in 1962",
            "probability": 0.000905260217158354,
            "start_logit": -0.33226463198661804,
            "end_logit": 6.034300804138184
        },
        {
            "text": "in 1962,",
            "probability": 0.0007587412508712129,
            "start_logit": 3.2810919284820557,
            "end_logit": 2.244382619857788
        },
        {
            "text": "1962, when oral poliovirus vaccine (OPV) became available",
            "probability": 0.0006447055765303739,
            "start_logit": 6.600815296173096,
            "end_logit": -1.2382078170776367
        },
        {
            "text": ", in 1962",
            "probability": 0.0005579445426209645,
            "start_logit": -0.8162274956703186,
            "end_logit": 6.034300804138184
        },
        {
            "text": "From 1955 IPV was used extensively in the US and polio incidence declined by more than 95 per cent. However, in 1962",
            "probability": 0.0003047802828853294,
            "start_logit": -1.4208959341049194,
            "end_logit": 6.034300804138184
        },
        {
            "text": "1955 IPV was used extensively in the US and polio incidence declined by more than 95 per cent. However, in 1962,",
            "probability": 0.0002036453046426844,
            "start_logit": 1.9658108949661255,
            "end_logit": 2.244382619857788
        },
        {
            "text": "1962, when oral poliovirus vaccine",
            "probability": 0.000203024267576098,
            "start_logit": 6.600815296173096,
            "end_logit": -2.3936760425567627
        },
        {
            "text": "in 1962, when oral poliovirus vaccine (OPV) became available,",
            "probability": 0.00014007862493319457,
            "start_logit": 3.2810919284820557,
            "end_logit": 0.5549256801605225
        },
        {
            "text": "1962, when oral poliovirus",
            "probability": 0.00010326366610453857,
            "start_logit": 6.600815296173096,
            "end_logit": -3.069715976715088
        },
        {
            "text": "1962, when oral poliovirus vaccine (OPV",
            "probability": 9.721865165319972e-05,
            "start_logit": 6.600815296173096,
            "end_logit": -3.1300389766693115
        },
        {
            "text": "1955",
            "probability": 4.228552292257577e-05,
            "start_logit": 1.9658108949661255,
            "end_logit": 0.6724476218223572
        },
        {
            "text": "2004 marks the golden jubilee of this breakthrough. From 1955",
            "probability": 3.4340183815617715e-05,
            "start_logit": 1.7576823234558105,
            "end_logit": 0.6724476218223572
        },
        {
            "text": "2004",
            "probability": 3.331283685281327e-05,
            "start_logit": 1.7576823234558105,
            "end_logit": 0.6420742273330688
        },
        {
            "text": "1954, and found to be safe and effective. The year 2004 marks the golden jubilee of this breakthrough. From 1955",
            "probability": 2.5355905341530822e-05,
            "start_logit": 1.4543777704238892,
            "end_logit": 0.6724476218223572
        },
        {
            "text": "1954, and found to be safe and effective. The year 2004",
            "probability": 2.45973388620488e-05,
            "start_logit": 1.4543777704238892,
            "end_logit": 0.6420742273330688
        }
    ],
    "58a1c0f178275d0c4a000056_001": [
        {
            "text": "1958 and 1959",
            "probability": 0.3540654266690897,
            "start_logit": 2.506373643875122,
            "end_logit": 1.927769660949707
        },
        {
            "text": "1959",
            "probability": 0.2895438468505655,
            "start_logit": 2.3051986694335938,
            "end_logit": 1.927769660949707
        },
        {
            "text": "1958",
            "probability": 0.1839889557054887,
            "start_logit": 2.506373643875122,
            "end_logit": 1.2731636762619019
        },
        {
            "text": "1958 and 1959.",
            "probability": 0.060189950021871164,
            "start_logit": 2.506373643875122,
            "end_logit": 0.15579333901405334
        },
        {
            "text": "1959.",
            "probability": 0.04922149512034609,
            "start_logit": 2.3051986694335938,
            "end_logit": 0.15579333901405334
        },
        {
            "text": "in 1958 and 1959",
            "probability": 0.018652368249722613,
            "start_logit": -0.4371349513530731,
            "end_logit": 1.927769660949707
        },
        {
            "text": "in 1958",
            "probability": 0.009692642933217178,
            "start_logit": -0.4371349513530731,
            "end_logit": 1.2731636762619019
        },
        {
            "text": "during a vaccination campaign launched by the Wistar Institute, Philadelphia, PA, USA, in the Belgian Congo in 1958 and 1959",
            "probability": 0.007973724063226939,
            "start_logit": -1.2869564294815063,
            "end_logit": 1.927769660949707
        },
        {
            "text": "in the Belgian Congo in 1958 and 1959",
            "probability": 0.006769002055650824,
            "start_logit": -1.4507544040679932,
            "end_logit": 1.927769660949707
        },
        {
            "text": "during a vaccination campaign launched by the Wistar Institute, Philadelphia, PA, USA, in the Belgian Congo in 1958",
            "probability": 0.004143519962619744,
            "start_logit": -1.2869564294815063,
            "end_logit": 1.2731636762619019
        },
        {
            "text": "in the Belgian Congo in 1958",
            "probability": 0.0035174900613820035,
            "start_logit": -1.4507544040679932,
            "end_logit": 1.2731636762619019
        },
        {
            "text": "in 1958 and 1959.",
            "probability": 0.0031708408338597953,
            "start_logit": -0.4371349513530731,
            "end_logit": 0.15579333901405334
        },
        {
            "text": "Belgian Congo in 1958 and 1959",
            "probability": 0.0016233439103058172,
            "start_logit": -2.878619909286499,
            "end_logit": 1.927769660949707
        },
        {
            "text": "during a vaccination campaign launched by the Wistar Institute, Philadelphia, PA, USA, in the Belgian Congo in 1958 and 1959.",
            "probability": 0.0013555066852160408,
            "start_logit": -1.2869564294815063,
            "end_logit": 0.15579333901405334
        },
        {
            "text": "Congo in 1958 and 1959",
            "probability": 0.0012053357935507302,
            "start_logit": -3.1763498783111572,
            "end_logit": 1.927769660949707
        },
        {
            "text": "in the Belgian Congo in 1958 and 1959.",
            "probability": 0.0011507079334474174,
            "start_logit": -1.4507544040679932,
            "end_logit": 0.15579333901405334
        },
        {
            "text": "launched by the Wistar Institute, Philadelphia, PA, USA, in the Belgian Congo in 1958 and 1959",
            "probability": 0.0010313667829463169,
            "start_logit": -3.3322231769561768,
            "end_logit": 1.927769660949707
        },
        {
            "text": "campaign launched by the Wistar Institute, Philadelphia, PA, USA, in the Belgian Congo in 1958 and 1959",
            "probability": 0.0009350228657408027,
            "start_logit": -3.4302923679351807,
            "end_logit": 1.927769660949707
        },
        {
            "text": "vaccination campaign launched by the Wistar Institute, Philadelphia, PA, USA, in the Belgian Congo in 1958 and 1959",
            "probability": 0.0009103437970335872,
            "start_logit": -3.457041025161743,
            "end_logit": 1.927769660949707
        },
        {
            "text": "the Belgian Congo in 1958 and 1959",
            "probability": 0.0008591097047194479,
            "start_logit": -3.5149667263031006,
            "end_logit": 1.927769660949707
        }
    ],
    "58aa0c6f396a458e50000008_000": [
        {
            "text": "oxytocin",
            "probability": 0.9247291464199842,
            "start_logit": 5.2913055419921875,
            "end_logit": 4.317145824432373
        },
        {
            "text": "oxytocine",
            "probability": 0.027627189530068173,
            "start_logit": 3.5169737339019775,
            "end_logit": 2.580777168273926
        },
        {
            "text": "oxytocin,",
            "probability": 0.02385444355546239,
            "start_logit": 5.2913055419921875,
            "end_logit": 0.6596154570579529
        },
        {
            "text": "oxytocin, a hormone involved in parent-offspring bonding,",
            "probability": 0.006460352863711435,
            "start_logit": 5.2913055419921875,
            "end_logit": -0.6466711163520813
        },
        {
            "text": "urinary oxytocin",
            "probability": 0.004386654968791065,
            "start_logit": 0.9877117872238159,
            "end_logit": 3.269805669784546
        },
        {
            "text": "oxytocin.",
            "probability": 0.002612896289428527,
            "start_logit": 3.7833917140960693,
            "end_logit": -0.04398193210363388
        },
        {
            "text": "oxytocin levels following a rare cooperative event--food sharing. Subjects showed higher urinary oxytocin",
            "probability": 0.0024481065724554336,
            "start_logit": 2.3629791736602783,
            "end_logit": 1.311286211013794
        },
        {
            "text": "oxytocin, a hormone involved in parent-offspring bonding",
            "probability": 0.0021314246465821258,
            "start_logit": 5.2913055419921875,
            "end_logit": -1.7555644512176514
        },
        {
            "text": "o",
            "probability": 0.0012183419742181423,
            "start_logit": 5.2913055419921875,
            "end_logit": -2.314864158630371
        },
        {
            "text": "oxytocin, a hormone involved in parent-offspring bonding, is likely to facilitate non-kin as well as kin bonds.",
            "probability": 0.0011736516734100943,
            "start_logit": 5.2913055419921875,
            "end_logit": -2.3522350788116455
        },
        {
            "text": "oxytocin, a hormone",
            "probability": 0.0007719604213668033,
            "start_logit": 5.2913055419921875,
            "end_logit": -2.771177053451538
        },
        {
            "text": "recent evidence shows that oxytocin",
            "probability": 0.000500557118956701,
            "start_logit": -2.230228900909424,
            "end_logit": 4.317145824432373
        },
        {
            "text": "that oxytocin",
            "probability": 0.00032605414907786983,
            "start_logit": -2.6588871479034424,
            "end_logit": 4.317145824432373
        },
        {
            "text": "and recent evidence shows that oxytocin",
            "probability": 0.00027298603684080397,
            "start_logit": -2.8365299701690674,
            "end_logit": 4.317145824432373
        },
        {
            "text": "oxytocin, a hormone involved in parent-offspring bonding, is likely to facilitate non-kin as well as kin bonds",
            "probability": 0.0002701576852534831,
            "start_logit": 5.2913055419921875,
            "end_logit": -3.8211045265197754
        },
        {
            "text": "cooperative relationships between non-kin, and recent evidence shows that oxytocin",
            "probability": 0.0002671290692561796,
            "start_logit": -2.8582186698913574,
            "end_logit": 4.317145824432373
        },
        {
            "text": "evidence shows that oxytocin",
            "probability": 0.0002513997759859849,
            "start_logit": -2.9189062118530273,
            "end_logit": 4.317145824432373
        },
        {
            "text": "oxytocin, a hormone involved",
            "probability": 0.0002508994294716896,
            "start_logit": 5.2913055419921875,
            "end_logit": -3.8950581550598145
        },
        {
            "text": "oxytocin, a hormone involved in parent-offspring",
            "probability": 0.00022775580517766592,
            "start_logit": 5.2913055419921875,
            "end_logit": -3.9918363094329834
        },
        {
            "text": "cin",
            "probability": 0.00021889201450142604,
            "start_logit": -3.0573720932006836,
            "end_logit": 4.317145824432373
        }
    ],
    "58aa0c6f396a458e50000008_001": [
        {
            "text": "oxytocin",
            "probability": 0.7452321672679412,
            "start_logit": 5.676962852478027,
            "end_logit": 4.978531837463379
        },
        {
            "text": "Oxytocin Receptor Specific Manner. The neurohypophysial hormone oxytocin",
            "probability": 0.08336687897370482,
            "start_logit": 3.486518144607544,
            "end_logit": 4.978531837463379
        },
        {
            "text": "oxytocin (OXT)",
            "probability": 0.07781393046394863,
            "start_logit": 5.676962852478027,
            "end_logit": 2.719156503677368
        },
        {
            "text": "neurohypophysial hormone oxytocin",
            "probability": 0.04137037801881551,
            "start_logit": 2.785832166671753,
            "end_logit": 4.978531837463379
        },
        {
            "text": "The neurohypophysial hormone oxytocin",
            "probability": 0.009279385308647602,
            "start_logit": 1.291062355041504,
            "end_logit": 4.978531837463379
        },
        {
            "text": "Oxytocin",
            "probability": 0.009206593055002864,
            "start_logit": 3.486518144607544,
            "end_logit": 2.775200605392456
        },
        {
            "text": "Oxytocin Receptor Specific Manner. The neurohypophysial hormone oxytocin (OXT)",
            "probability": 0.008704810136200027,
            "start_logit": 3.486518144607544,
            "end_logit": 2.719156503677368
        },
        {
            "text": "oxytocin (OXT",
            "probability": 0.008167593005236678,
            "start_logit": 5.676962852478027,
            "end_logit": 0.46501028537750244
        },
        {
            "text": "neurohypophysial hormone oxytocin (OXT)",
            "probability": 0.004319716539109012,
            "start_logit": 2.785832166671753,
            "end_logit": 2.719156503677368
        },
        {
            "text": "OXT)",
            "probability": 0.0037288267020541897,
            "start_logit": 2.6387360095977783,
            "end_logit": 2.719156503677368
        },
        {
            "text": "oxytocin (OXT) and its receptor (OXTR)",
            "probability": 0.0016388048702616644,
            "start_logit": 5.676962852478027,
            "end_logit": -1.1411967277526855
        },
        {
            "text": "hormone oxytocin",
            "probability": 0.0016138448376362842,
            "start_logit": -0.45811352133750916,
            "end_logit": 4.978531837463379
        },
        {
            "text": "The neurohypophysial hormone oxytocin (OXT)",
            "probability": 0.000968913413657947,
            "start_logit": 1.291062355041504,
            "end_logit": 2.719156503677368
        },
        {
            "text": "oxytocin (OXT) and its receptor (OXTR",
            "probability": 0.0009664185220193165,
            "start_logit": 5.676962852478027,
            "end_logit": -1.6693222522735596
        },
        {
            "text": "Oxytocin Receptor Specific Manner. The neurohypophysial hormone oxytocin (OXT",
            "probability": 0.0009136840403310591,
            "start_logit": 3.486518144607544,
            "end_logit": 0.46501028537750244
        },
        {
            "text": "oxytocin (OXT) and its receptor (OXT",
            "probability": 0.0007573231424384571,
            "start_logit": 5.676962852478027,
            "end_logit": -1.913129210472107
        },
        {
            "text": "o",
            "probability": 0.0006733594973422363,
            "start_logit": 5.676962852478027,
            "end_logit": -2.030639886856079
        },
        {
            "text": "neurohypophysial hormone oxytocin (OXT",
            "probability": 0.0004534109301390198,
            "start_logit": 2.785832166671753,
            "end_logit": 0.46501028537750244
        },
        {
            "text": "(OXT)",
            "probability": 0.0004325719868884564,
            "start_logit": 0.4846358597278595,
            "end_logit": 2.719156503677368
        },
        {
            "text": "OXT",
            "probability": 0.00039138928862548166,
            "start_logit": 2.6387360095977783,
            "end_logit": 0.46501028537750244
        }
    ],
    "58aa0c6f396a458e50000008_002": [
        {
            "text": "oxytocin",
            "probability": 0.9240472311859526,
            "start_logit": 5.238123416900635,
            "end_logit": 4.46882963180542
        },
        {
            "text": "Oxytocin",
            "probability": 0.04383561906712311,
            "start_logit": 3.775888681411743,
            "end_logit": 2.8827478885650635
        },
        {
            "text": "oxytocin (OT)",
            "probability": 0.015532319637102728,
            "start_logit": 5.238123416900635,
            "end_logit": 0.38298943638801575
        },
        {
            "text": "oxytocin (OT",
            "probability": 0.008461121118926584,
            "start_logit": 5.238123416900635,
            "end_logit": -0.22445186972618103
        },
        {
            "text": "oxytocin (OT) hormone",
            "probability": 0.001480959047701111,
            "start_logit": 5.238123416900635,
            "end_logit": -1.9672436714172363
        },
        {
            "text": "The oxytocin",
            "probability": 0.001124617686556033,
            "start_logit": -1.4731966257095337,
            "end_logit": 4.46882963180542
        },
        {
            "text": "o",
            "probability": 0.0009931572421604147,
            "start_logit": 5.238123416900635,
            "end_logit": -2.366799831390381
        },
        {
            "text": "oxytocin (OT) hormone pathway is involved in numerous physiological processes, and one of its receptor genes (OXTR",
            "probability": 0.0008340062994522035,
            "start_logit": 5.238123416900635,
            "end_logit": -2.541447877883911
        },
        {
            "text": "oxytocin (OT) hormone pathway is involved in numerous physiological processes, and one of its receptor genes (OXTR)",
            "probability": 0.0008213973391426628,
            "start_logit": 5.238123416900635,
            "end_logit": -2.5566818714141846
        },
        {
            "text": "oxytocin (OT) hormone pathway",
            "probability": 0.0005526053978706744,
            "start_logit": 5.238123416900635,
            "end_logit": -2.9530446529388428
        },
        {
            "text": "oxytocin (OT) hormone pathway is involved in numerous physiological processes,",
            "probability": 0.00036967454517185114,
            "start_logit": 5.238123416900635,
            "end_logit": -3.3550658226013184
        },
        {
            "text": "oxytocin (O",
            "probability": 0.0003230931248820345,
            "start_logit": 5.238123416900635,
            "end_logit": -3.489748239517212
        },
        {
            "text": "cin",
            "probability": 0.0003041030966703748,
            "start_logit": -2.7810282707214355,
            "end_logit": 4.46882963180542
        },
        {
            "text": "oxytocin (",
            "probability": 0.0002817440856010588,
            "start_logit": 5.238123416900635,
            "end_logit": -3.6266896724700928
        },
        {
            "text": "Oxytocin receptor gene sequences in owl monkeys and other primates show remarkable interspecific regulatory and protein coding variation. The o",
            "probability": 0.00023013227829725327,
            "start_logit": 3.775888681411743,
            "end_logit": -2.366799831390381
        },
        {
            "text": ". The oxytocin",
            "probability": 0.00022137146025088817,
            "start_logit": -3.098552942276001,
            "end_logit": 4.46882963180542
        },
        {
            "text": "oxytocin (OT) hormone pathway is involved in numerous physiological processes, and one of its receptor genes (O",
            "probability": 0.00018690624267785088,
            "start_logit": 5.238123416900635,
            "end_logit": -4.037081718444824
        },
        {
            "text": "OT)",
            "probability": 0.0001545375663090451,
            "start_logit": 0.6278823614120483,
            "end_logit": 0.38298943638801575
        },
        {
            "text": "O",
            "probability": 0.00012710826600822954,
            "start_logit": 3.775888681411743,
            "end_logit": -2.9604148864746094
        },
        {
            "text": "cin receptor gene sequences in owl monkeys and other primates show remarkable interspecific regulatory and protein coding variation. The oxytocin",
            "probability": 0.00011829531214301463,
            "start_logit": -3.7252109050750732,
            "end_logit": 4.46882963180542
        }
    ],
    "58aa0c6f396a458e50000008_003": [
        {
            "text": "oxytocin",
            "probability": 0.8304216361405051,
            "start_logit": 5.6745381355285645,
            "end_logit": 4.932807922363281
        },
        {
            "text": "oxytocin. Neuropeptide hormone oxytocin",
            "probability": 0.1113238005894874,
            "start_logit": 3.6650476455688477,
            "end_logit": 4.932807922363281
        },
        {
            "text": "Neuropeptide hormone oxytocin",
            "probability": 0.04153863574135531,
            "start_logit": 2.6792285442352295,
            "end_logit": 4.932807922363281
        },
        {
            "text": "corticosterone",
            "probability": 0.00497786901234715,
            "start_logit": 3.2071166038513184,
            "end_logit": 2.2832977771759033
        },
        {
            "text": "oxytocin has roles in social bonding,",
            "probability": 0.004477801457351317,
            "start_logit": 5.6745381355285645,
            "end_logit": -0.2899934649467468
        },
        {
            "text": "oxytocin has roles in social bonding, energy metabolism,",
            "probability": 0.0011409261126378509,
            "start_logit": 5.6745381355285645,
            "end_logit": -1.6572853326797485
        },
        {
            "text": "hormone oxytocin",
            "probability": 0.0010213470767472047,
            "start_logit": -1.0262730121612549,
            "end_logit": 4.932807922363281
        },
        {
            "text": "o",
            "probability": 0.0009122726801117153,
            "start_logit": 5.6745381355285645,
            "end_logit": -1.8809419870376587
        },
        {
            "text": ". Neuropeptide hormone oxytocin",
            "probability": 0.0006961312180028834,
            "start_logit": -1.4096125364303589,
            "end_logit": 4.932807922363281
        },
        {
            "text": "oxytocin. Neuropeptide hormone oxytocin has roles in social bonding,",
            "probability": 0.0006002804537153843,
            "start_logit": 3.6650476455688477,
            "end_logit": -0.2899934649467468
        },
        {
            "text": "oxytocin. Neuropeptide",
            "probability": 0.0005762019998859569,
            "start_logit": 3.6650476455688477,
            "end_logit": -0.3309321403503418
        },
        {
            "text": "host oxytocin. Neuropeptide hormone oxytocin",
            "probability": 0.00043126026482715607,
            "start_logit": -1.8884389400482178,
            "end_logit": 4.932807922363281
        },
        {
            "text": "oxytocin has",
            "probability": 0.00034470941262566395,
            "start_logit": 5.6745381355285645,
            "end_logit": -2.8541791439056396
        },
        {
            "text": "oxytocin. Neuropeptide hormone",
            "probability": 0.00028482847744616967,
            "start_logit": 3.6650476455688477,
            "end_logit": -1.0355032682418823
        },
        {
            "text": "oxyto",
            "probability": 0.0002497887212720203,
            "start_logit": 5.6745381355285645,
            "end_logit": -3.1762654781341553
        },
        {
            "text": "oxytocin has roles in social bonding",
            "probability": 0.00024114183464608635,
            "start_logit": 5.6745381355285645,
            "end_logit": -3.2114956378936768
        },
        {
            "text": "Neuropeptide hormone oxytocin has roles in social bonding,",
            "probability": 0.00022398472723265524,
            "start_logit": 2.6792285442352295,
            "end_logit": -0.2899934649467468
        },
        {
            "text": "Neuropeptide",
            "probability": 0.00021500025026062063,
            "start_logit": 2.6792285442352295,
            "end_logit": -0.3309321403503418
        },
        {
            "text": "oxytocin has roles in social bonding, energy metabolism, and wound healing contributing to good physical, mental and social health.",
            "probability": 0.00016943474256876688,
            "start_logit": 5.6745381355285645,
            "end_logit": -3.564413070678711
        },
        {
            "text": "oxytocin. Neuropeptide hormone oxytocin has roles in social bonding, energy metabolism,",
            "probability": 0.00015294908697338546,
            "start_logit": 3.6650476455688477,
            "end_logit": -1.6572853326797485
        }
    ],
    "58aa0c6f396a458e50000008_004": [
        {
            "text": "Oxytocin",
            "probability": 0.8846194247102429,
            "start_logit": 5.657045841217041,
            "end_logit": 4.512713432312012
        },
        {
            "text": "oxytocin: implications for psychiatry. Oxytocin",
            "probability": 0.06338419803325941,
            "start_logit": 3.0211029052734375,
            "end_logit": 4.512713432312012
        },
        {
            "text": "Oxytocin is known as the 'love hormone",
            "probability": 0.014797723456796997,
            "start_logit": 5.657045841217041,
            "end_logit": 0.4220292568206787
        },
        {
            "text": "Oxytocin is known as the 'love hormone'",
            "probability": 0.012709098922766551,
            "start_logit": 5.657045841217041,
            "end_logit": 0.26987409591674805
        },
        {
            "text": "oxytocin",
            "probability": 0.0058675051538612105,
            "start_logit": 3.0211029052734375,
            "end_logit": 2.1329283714294434
        },
        {
            "text": "Oxytocin is known as the 'love hormone' due its role in promoting mother-child and pair bonding.",
            "probability": 0.0033764225965140027,
            "start_logit": 5.657045841217041,
            "end_logit": -1.0556273460388184
        },
        {
            "text": "oxytocin may have broader pro-social effects on behavior and cognition, which points towards oxytocin",
            "probability": 0.0031457053362671837,
            "start_logit": 2.8324644565582275,
            "end_logit": 1.6981754302978516
        },
        {
            "text": ". Oxytocin",
            "probability": 0.0020920369762080578,
            "start_logit": -0.3899734616279602,
            "end_logit": 4.512713432312012
        },
        {
            "text": "oxytocin has also uncovered a 'darker side', including oxytocin",
            "probability": 0.001967007117153631,
            "start_logit": 2.2970197200775146,
            "end_logit": 1.7640951871871948
        },
        {
            "text": "O",
            "probability": 0.001646894765779148,
            "start_logit": 5.657045841217041,
            "end_logit": -1.7735525369644165
        },
        {
            "text": "oxytocin: implications for psychiatry. Oxytocin is known as the 'love hormone",
            "probability": 0.0010602772308942366,
            "start_logit": 3.0211029052734375,
            "end_logit": 0.4220292568206787
        },
        {
            "text": "Oxytocin is known as the 'love hormone' due its role in promoting mother-child and pair bonding",
            "probability": 0.0009272930607589478,
            "start_logit": 5.657045841217041,
            "end_logit": -2.3479297161102295
        },
        {
            "text": "oxytocin: implications for psychiatry. Oxytocin is known as the 'love hormone'",
            "probability": 0.0009106244114058188,
            "start_logit": 3.0211029052734375,
            "end_logit": 0.26987409591674805
        },
        {
            "text": "Oxytocin is known as the 'love",
            "probability": 0.000815130048217979,
            "start_logit": 5.657045841217041,
            "end_logit": -2.47685170173645
        },
        {
            "text": "Oxytocin is known as the 'love hormone' due its role in promoting mother-child",
            "probability": 0.0007370428992006435,
            "start_logit": 5.657045841217041,
            "end_logit": -2.5775532722473145
        },
        {
            "text": "Oxytocin is",
            "probability": 0.0006692874579882695,
            "start_logit": 5.657045841217041,
            "end_logit": -2.673985719680786
        },
        {
            "text": "Oxytocin is known as the 'love hormone' due its role in promoting mother-child and",
            "probability": 0.00041363358889900254,
            "start_logit": 5.657045841217041,
            "end_logit": -3.1552188396453857
        },
        {
            "text": "Oxyto",
            "probability": 0.0003870666617317671,
            "start_logit": 5.657045841217041,
            "end_logit": -3.221602439880371
        },
        {
            "text": "love hormone' due its role in promoting mother-child and pair bonding. More recent research indicates that oxytocin",
            "probability": 0.00032110726912659135,
            "start_logit": -0.057580940425395966,
            "end_logit": 2.3062026500701904
        },
        {
            "text": "cin",
            "probability": 0.00015252030292771477,
            "start_logit": -3.0085692405700684,
            "end_logit": 4.512713432312012
        }
    ],
    "58a9c532396a458e50000002_000": [
        {
            "text": "six",
            "probability": 0.647500588488078,
            "start_logit": 2.409170627593994,
            "end_logit": 1.5238581895828247
        },
        {
            "text": "17",
            "probability": 0.08179346590982924,
            "start_logit": 1.2757991552352905,
            "end_logit": 0.5883073210716248
        },
        {
            "text": "six cysteines",
            "probability": 0.08031659653770572,
            "start_logit": 2.409170627593994,
            "end_logit": -0.563285231590271
        },
        {
            "text": "six cysteines in the sequence of mature CFBD peptide, which possibly form three",
            "probability": 0.057449563120586945,
            "start_logit": 2.409170627593994,
            "end_logit": -0.8983541131019592
        },
        {
            "text": "41 residues and intervening propeptide of 3 residues. There are six",
            "probability": 0.03516221310003785,
            "start_logit": -0.5039770603179932,
            "end_logit": 1.5238581895828247
        },
        {
            "text": "3 residues. There are six",
            "probability": 0.03318578013014746,
            "start_logit": -0.5618276000022888,
            "end_logit": 1.5238581895828247
        },
        {
            "text": "six cysteines in the sequence of mature CFBD peptide,",
            "probability": 0.018457436436975238,
            "start_logit": 2.409170627593994,
            "end_logit": -2.0337941646575928
        },
        {
            "text": "17 residues,",
            "probability": 0.009579213400086557,
            "start_logit": 1.2757991552352905,
            "end_logit": -1.556294560432434
        },
        {
            "text": "There are six",
            "probability": 0.007365759096068598,
            "start_logit": -2.0671069622039795,
            "end_logit": 1.5238581895828247
        },
        {
            "text": "41 residues and intervening propeptide of 3 residues. There are six cysteines",
            "probability": 0.0043615547740626795,
            "start_logit": -0.5039770603179932,
            "end_logit": -0.563285231590271
        },
        {
            "text": "3 residues. There are six cysteines",
            "probability": 0.004116396125176866,
            "start_logit": -0.5618276000022888,
            "end_logit": -0.563285231590271
        },
        {
            "text": "3 residues. There are six cysteines in the sequence of mature CFBD peptide, which possibly form three",
            "probability": 0.0029444121043110524,
            "start_logit": -0.5618276000022888,
            "end_logit": -0.8983541131019592
        },
        {
            "text": "17 residues",
            "probability": 0.0029234930324401067,
            "start_logit": 1.2757991552352905,
            "end_logit": -2.7431108951568604
        },
        {
            "text": "three domains: signal peptide of 17",
            "probability": 0.0024190622438779344,
            "start_logit": -2.245018243789673,
            "end_logit": 0.5883073210716248
        },
        {
            "text": "41",
            "probability": 0.0022851204222386957,
            "start_logit": -0.5039770603179932,
            "end_logit": -1.2096951007843018
        },
        {
            "text": "three",
            "probability": 0.0022737820302813423,
            "start_logit": -0.8202922344207764,
            "end_logit": -0.8983541131019592
        },
        {
            "text": ". There are six",
            "probability": 0.002008840907688308,
            "start_logit": -3.366391181945801,
            "end_logit": 1.5238581895828247
        },
        {
            "text": "six cysteines in the sequence of mature CFBD peptide, which possibly form three disulfide-bridges.",
            "probability": 0.0020008686847264607,
            "start_logit": 2.409170627593994,
            "end_logit": -4.255680084228516
        },
        {
            "text": "41 residues and intervening propeptide of 3",
            "probability": 0.0019564653364732955,
            "start_logit": -0.5039770603179932,
            "end_logit": -1.3649743795394897
        },
        {
            "text": "six cysteines in the sequence",
            "probability": 0.001899388119207155,
            "start_logit": 2.409170627593994,
            "end_logit": -4.307729721069336
        }
    ],
    "58a9c532396a458e50000002_001": [
        {
            "text": "six",
            "probability": 0.8299660570728103,
            "start_logit": 6.286904811859131,
            "end_logit": 5.290030002593994
        },
        {
            "text": "six cysteines",
            "probability": 0.1103886355721561,
            "start_logit": 6.286904811859131,
            "end_logit": 3.2726523876190186
        },
        {
            "text": "six cysteines,",
            "probability": 0.02980811870545635,
            "start_logit": 6.286904811859131,
            "end_logit": 1.9634259939193726
        },
        {
            "text": "six cysteines, which form three",
            "probability": 0.0125349634697145,
            "start_logit": 6.286904811859131,
            "end_logit": 1.0971670150756836
        },
        {
            "text": "Alpha defensins contain six",
            "probability": 0.010855775472873875,
            "start_logit": 1.9502172470092773,
            "end_logit": 5.290030002593994
        },
        {
            "text": "six cysteines, which form three well defined disulfide bridges under oxidizing conditions. Residues C3",
            "probability": 0.0017444801570464083,
            "start_logit": 6.286904811859131,
            "end_logit": -0.8748981952667236
        },
        {
            "text": "Alpha defensins contain six cysteines",
            "probability": 0.0014438593389646257,
            "start_logit": 1.9502172470092773,
            "end_logit": 3.2726523876190186
        },
        {
            "text": "six cysteines, which form three well defined disulfide bridges under oxidizing conditions.",
            "probability": 0.0006923479165012537,
            "start_logit": 6.286904811859131,
            "end_logit": -1.7990214824676514
        },
        {
            "text": "six cystein",
            "probability": 0.00055690427254218,
            "start_logit": 6.286904811859131,
            "end_logit": -2.016716718673706
        },
        {
            "text": "defensins contain six",
            "probability": 0.0004992349242914037,
            "start_logit": -1.1291584968566895,
            "end_logit": 5.290030002593994
        },
        {
            "text": ". Alpha defensins contain six",
            "probability": 0.00043043749212830673,
            "start_logit": -1.277433156967163,
            "end_logit": 5.290030002593994
        },
        {
            "text": "Alpha defensins contain six cysteines,",
            "probability": 0.00038988370810785875,
            "start_logit": 1.9502172470092773,
            "end_logit": 1.9634259939193726
        },
        {
            "text": "contain six",
            "probability": 0.00017157666711809948,
            "start_logit": -2.197205066680908,
            "end_logit": 5.290030002593994
        },
        {
            "text": "Alpha defensins contain six cysteines, which form three",
            "probability": 0.00016395459528528538,
            "start_logit": 1.9502172470092773,
            "end_logit": 1.0971670150756836
        },
        {
            "text": "three",
            "probability": 0.00011651795486799706,
            "start_logit": 1.608673095703125,
            "end_logit": 1.0971670150756836
        },
        {
            "text": "defensins contain six cysteines",
            "probability": 6.640013968385949e-05,
            "start_logit": -1.1291584968566895,
            "end_logit": 3.2726523876190186
        },
        {
            "text": "Alpha defensins",
            "probability": 5.789981631282806e-05,
            "start_logit": 1.9502172470092773,
            "end_logit": 0.056291695684194565
        },
        {
            "text": ". Alpha defensins contain six cysteines",
            "probability": 5.724982009833696e-05,
            "start_logit": -1.277433156967163,
            "end_logit": 3.2726523876190186
        },
        {
            "text": "three well defined disulfide bridges under oxidizing conditions. Residues C3-C31,",
            "probability": 3.28825561265432e-05,
            "start_logit": 1.608673095703125,
            "end_logit": -0.1679360568523407
        },
        {
            "text": "contain six cysteines",
            "probability": 2.2820347913967118e-05,
            "start_logit": -2.197205066680908,
            "end_logit": 3.2726523876190186
        }
    ],
    "58a9c532396a458e50000002_002": [
        {
            "text": "six",
            "probability": 0.9114796703358796,
            "start_logit": 6.170665740966797,
            "end_logit": 5.297745704650879
        },
        {
            "text": "six conserved cysteines",
            "probability": 0.04373999694297733,
            "start_logit": 6.170665740966797,
            "end_logit": 2.260939359664917
        },
        {
            "text": "six conserved cysteines whose three",
            "probability": 0.014180216824884097,
            "start_logit": 6.170665740966797,
            "end_logit": 1.1345242261886597
        },
        {
            "text": "six conserved",
            "probability": 0.006158326411160373,
            "start_logit": 6.170665740966797,
            "end_logit": 0.3004814684391022
        },
        {
            "text": "typically contain six",
            "probability": 0.004904551056246827,
            "start_logit": 0.9457600116729736,
            "end_logit": 5.297745704650879
        },
        {
            "text": "four myeloid \u03b1-defensins (HNP1-4",
            "probability": 0.0045728948999193475,
            "start_logit": 3.416076898574829,
            "end_logit": 2.7574117183685303
        },
        {
            "text": "four",
            "probability": 0.004100496683553224,
            "start_logit": 3.416076898574829,
            "end_logit": 2.6483733654022217
        },
        {
            "text": "4",
            "probability": 0.002795696499570474,
            "start_logit": 2.924011707305908,
            "end_logit": 2.7574117183685303
        },
        {
            "text": "They typically contain six",
            "probability": 0.0021715010821044605,
            "start_logit": 0.1310151219367981,
            "end_logit": 5.297745704650879
        },
        {
            "text": "Defensins are small, multifunctional cationic peptides. They typically contain six",
            "probability": 0.0015217435189715525,
            "start_logit": -0.22454681992530823,
            "end_logit": 5.297745704650879
        },
        {
            "text": "six conserved cysteines whose three intramolecular disulfides stabilize a largely \u03b2-sheet structure.",
            "probability": 0.0009316506704661016,
            "start_logit": 6.170665740966797,
            "end_logit": -1.588120937347412
        },
        {
            "text": "four myeloid \u03b1-defensins (HNP1-4)",
            "probability": 0.0007391297747922524,
            "start_logit": 3.416076898574829,
            "end_logit": 0.934983491897583
        },
        {
            "text": "4)",
            "probability": 0.00045187623361985803,
            "start_logit": 2.924011707305908,
            "end_logit": 0.934983491897583
        },
        {
            "text": ". They typically contain six",
            "probability": 0.0004388758061295234,
            "start_logit": -1.4679423570632935,
            "end_logit": 5.297745704650879
        },
        {
            "text": "six conserved cystein",
            "probability": 0.00042648025407919374,
            "start_logit": 6.170665740966797,
            "end_logit": -2.3695127964019775
        },
        {
            "text": ". Defensins are small, multifunctional cationic peptides. They typically contain six",
            "probability": 0.00035131017974741863,
            "start_logit": -1.6904892921447754,
            "end_logit": 5.297745704650879
        },
        {
            "text": "contain six",
            "probability": 0.00031176827810023753,
            "start_logit": -1.8098986148834229,
            "end_logit": 5.297745704650879
        },
        {
            "text": "(HNP1-4",
            "probability": 0.0002803809693012762,
            "start_logit": 0.6243244409561157,
            "end_logit": 2.7574117183685303
        },
        {
            "text": "typically contain six conserved cysteines",
            "probability": 0.0002353591146227761,
            "start_logit": 0.9457600116729736,
            "end_logit": 2.260939359664917
        },
        {
            "text": "HNP1-4",
            "probability": 0.0002080744638740812,
            "start_logit": 0.326071172952652,
            "end_logit": 2.7574117183685303
        }
    ],
    "58a9c532396a458e50000002_003": [
        {
            "text": "six",
            "probability": 0.4370121637384618,
            "start_logit": 4.084946155548096,
            "end_logit": 3.296698808670044
        },
        {
            "text": "three",
            "probability": 0.2094995357946018,
            "start_logit": 3.520094394683838,
            "end_logit": 3.1263110637664795
        },
        {
            "text": "six conserved cysteines",
            "probability": 0.11514306241792603,
            "start_logit": 4.084946155548096,
            "end_logit": 1.962913155555725
        },
        {
            "text": "six conserved cysteines,",
            "probability": 0.05346262936520439,
            "start_logit": 4.084946155548096,
            "end_logit": 1.1957206726074219
        },
        {
            "text": "three subfamilies of defensins in primates: \u03b1,",
            "probability": 0.03688199318501761,
            "start_logit": 3.520094394683838,
            "end_logit": 1.389312982559204
        },
        {
            "text": "three kinds of defensins have six",
            "probability": 0.03220797812849676,
            "start_logit": 1.4771993160247803,
            "end_logit": 3.296698808670044
        },
        {
            "text": "All three kinds of defensins have six",
            "probability": 0.02182453858868694,
            "start_logit": 1.0880200862884521,
            "end_logit": 3.296698808670044
        },
        {
            "text": "six conserved cysteines, three intramolecular disulfide bonds,",
            "probability": 0.013769356929577047,
            "start_logit": 4.084946155548096,
            "end_logit": -0.16081660985946655
        },
        {
            "text": "six conserved cysteines, three",
            "probability": 0.00967945224296531,
            "start_logit": 4.084946155548096,
            "end_logit": -0.5132569074630737
        },
        {
            "text": "three kinds of defensins have six conserved cysteines",
            "probability": 0.008486091563858931,
            "start_logit": 1.4771993160247803,
            "end_logit": 1.962913155555725
        },
        {
            "text": "three subfamilies of defensins in primates: \u03b1, \u03b2 and \u03b8-defensins",
            "probability": 0.007989083143207946,
            "start_logit": 3.520094394683838,
            "end_logit": -0.14033445715904236
        },
        {
            "text": "three subfamilies",
            "probability": 0.007718243314718449,
            "start_logit": 3.520094394683838,
            "end_logit": -0.17482367157936096
        },
        {
            "text": "three subfamilies of defensins in primates: \u03b1, \u03b2",
            "probability": 0.007370452769456525,
            "start_logit": 3.520094394683838,
            "end_logit": -0.22093132138252258
        },
        {
            "text": "three subfamilies of defensins in primates: \u03b1",
            "probability": 0.007244310998799746,
            "start_logit": 3.520094394683838,
            "end_logit": -0.23819398880004883
        },
        {
            "text": "\u03b1,",
            "probability": 0.005893000516007779,
            "start_logit": 1.686136245727539,
            "end_logit": 1.389312982559204
        },
        {
            "text": "All three kinds of defensins have six conserved cysteines",
            "probability": 0.0057502843569899684,
            "start_logit": 1.0880200862884521,
            "end_logit": 1.962913155555725
        },
        {
            "text": "There are three",
            "probability": 0.005640888051368546,
            "start_logit": -0.09458561986684799,
            "end_logit": 3.1263110637664795
        },
        {
            "text": "12",
            "probability": 0.005218748016556865,
            "start_logit": 1.8165607452392578,
            "end_logit": 1.1373807191848755
        },
        {
            "text": "three subfamilies of defensins in primates: \u03b1, \u03b2 and \u03b8-defensins.",
            "probability": 0.004827473589296438,
            "start_logit": 3.520094394683838,
            "end_logit": -0.6440871953964233
        },
        {
            "text": "three subfamilies of defensins in primates: \u03b1, \u03b2 and \u03b8",
            "probability": 0.004380713288800997,
            "start_logit": 3.520094394683838,
            "end_logit": -0.7411988973617554
        }
    ],
    "58a3428d60087bc10a00001b_000": [
        {
            "text": "HTT",
            "probability": 0.577400820332008,
            "start_logit": 6.276800155639648,
            "end_logit": 5.012774467468262
        },
        {
            "text": "HTT gene",
            "probability": 0.4073087592063491,
            "start_logit": 6.276800155639648,
            "end_logit": 4.663809299468994
        },
        {
            "text": "the HTT",
            "probability": 0.006283817107308353,
            "start_logit": 1.7562410831451416,
            "end_logit": 5.012774467468262
        },
        {
            "text": "the HTT gene",
            "probability": 0.00443271581703971,
            "start_logit": 1.7562410831451416,
            "end_logit": 4.663809299468994
        },
        {
            "text": "HTT gene.",
            "probability": 0.0025556070511354146,
            "start_logit": 6.276800155639648,
            "end_logit": -0.4074724316596985
        },
        {
            "text": "H",
            "probability": 0.0006646617721303027,
            "start_logit": 6.276800155639648,
            "end_logit": -1.7542392015457153
        },
        {
            "text": "TT",
            "probability": 0.00023756512803950185,
            "start_logit": -1.5190500020980835,
            "end_logit": 5.012774467468262
        },
        {
            "text": "in the HTT",
            "probability": 0.00021779563988414855,
            "start_logit": -1.6059346199035645,
            "end_logit": 5.012774467468262
        },
        {
            "text": "TT gene",
            "probability": 0.00016758264644797037,
            "start_logit": -1.5190500020980835,
            "end_logit": 4.663809299468994
        },
        {
            "text": "in the HTT gene",
            "probability": 0.00015363689956442514,
            "start_logit": -1.6059346199035645,
            "end_logit": 4.663809299468994
        },
        {
            "text": "CAG (polyQ) motif in the HTT",
            "probability": 9.869318075596408e-05,
            "start_logit": -2.3974759578704834,
            "end_logit": 5.012774467468262
        },
        {
            "text": "(polyQ) motif in the HTT",
            "probability": 9.12700909076048e-05,
            "start_logit": -2.4756686687469482,
            "end_logit": 5.012774467468262
        },
        {
            "text": "gene",
            "probability": 7.543582931490703e-05,
            "start_logit": -2.317244291305542,
            "end_logit": 4.663809299468994
        },
        {
            "text": "CAG (polyQ) motif in the HTT gene",
            "probability": 6.961991666850298e-05,
            "start_logit": -2.3974759578704834,
            "end_logit": 4.663809299468994
        },
        {
            "text": "(polyQ) motif in the HTT gene",
            "probability": 6.438353769371396e-05,
            "start_logit": -2.4756686687469482,
            "end_logit": 4.663809299468994
        },
        {
            "text": "HTT gene. Cardiovascular symptoms, often present in early stage HD",
            "probability": 5.9525436089353095e-05,
            "start_logit": 6.276800155639648,
            "end_logit": -4.167113780975342
        },
        {
            "text": "caused by an expanded trinucleotide CAG (polyQ) motif in the HTT",
            "probability": 4.870620488179473e-05,
            "start_logit": -3.1036853790283203,
            "end_logit": 5.012774467468262
        },
        {
            "text": "caused by an expanded trinucleotide CAG (polyQ) motif in the HTT gene",
            "probability": 3.4358219069808096e-05,
            "start_logit": -3.1036853790283203,
            "end_logit": 4.663809299468994
        },
        {
            "text": "the HTT gene.",
            "probability": 2.781251210943655e-05,
            "start_logit": 1.7562410831451416,
            "end_logit": -0.4074724316596985
        },
        {
            "text": "the H",
            "probability": 7.233472602073394e-06,
            "start_logit": 1.7562410831451416,
            "end_logit": -1.7542392015457153
        }
    ],
    "58a3428d60087bc10a00001b_001": [
        {
            "text": "huntingtin",
            "probability": 0.5244802878835136,
            "start_logit": 6.5487565994262695,
            "end_logit": 5.086094856262207
        },
        {
            "text": "huntingtin protein",
            "probability": 0.1593490693087495,
            "start_logit": 6.5487565994262695,
            "end_logit": 3.8947842121124268
        },
        {
            "text": "huntingtin protein (HTT) gene",
            "probability": 0.11951023674609151,
            "start_logit": 6.5487565994262695,
            "end_logit": 3.607089042663574
        },
        {
            "text": "huntingtin protein (HTT)",
            "probability": 0.07535887008858734,
            "start_logit": 6.5487565994262695,
            "end_logit": 3.145948648452759
        },
        {
            "text": "huntingtin protein (HTT",
            "probability": 0.07004430214125358,
            "start_logit": 6.5487565994262695,
            "end_logit": 3.07281494140625
        },
        {
            "text": "HTT) gene",
            "probability": 0.013228248890185925,
            "start_logit": 4.3477091789245605,
            "end_logit": 3.607089042663574
        },
        {
            "text": "HTT)",
            "probability": 0.008341259433139082,
            "start_logit": 4.3477091789245605,
            "end_logit": 3.145948648452759
        },
        {
            "text": "HTT",
            "probability": 0.007753004991801992,
            "start_logit": 4.3477091789245605,
            "end_logit": 3.07281494140625
        },
        {
            "text": "Huntingtin",
            "probability": 0.005606875455467197,
            "start_logit": 4.0001068115234375,
            "end_logit": 3.096330404281616
        },
        {
            "text": "the huntingtin",
            "probability": 0.00397896716622192,
            "start_logit": 1.6673710346221924,
            "end_logit": 5.086094856262207
        },
        {
            "text": "huntingtin protein (HTT) gene underlie both adult-onset and juvenile forms of Huntington's disease (HD). HTT",
            "probability": 0.003576400817991577,
            "start_logit": 6.5487565994262695,
            "end_logit": 0.09804394841194153
        },
        {
            "text": "(HTT) gene",
            "probability": 0.00185874934727106,
            "start_logit": 2.385258436203003,
            "end_logit": 3.607089042663574
        },
        {
            "text": "the huntingtin protein",
            "probability": 0.0012089009432673966,
            "start_logit": 1.6673710346221924,
            "end_logit": 3.8947842121124268
        },
        {
            "text": "(HTT)",
            "probability": 0.001172060690381214,
            "start_logit": 2.385258436203003,
            "end_logit": 3.145948648452759
        },
        {
            "text": "(HTT",
            "probability": 0.0010894029200337093,
            "start_logit": 2.385258436203003,
            "end_logit": 3.07281494140625
        },
        {
            "text": "the huntingtin protein (HTT) gene",
            "probability": 0.0009066638327992233,
            "start_logit": 1.6673710346221924,
            "end_logit": 3.607089042663574
        },
        {
            "text": "hunting",
            "probability": 0.0008505724049904375,
            "start_logit": 6.5487565994262695,
            "end_logit": -1.3381587266921997
        },
        {
            "text": "Mutations of the huntingtin",
            "probability": 0.0005819535041293532,
            "start_logit": -0.2550159692764282,
            "end_logit": 5.086094856262207
        },
        {
            "text": "the huntingtin protein (HTT)",
            "probability": 0.0005717097032875877,
            "start_logit": 1.6673710346221924,
            "end_logit": 3.145948648452759
        },
        {
            "text": "huntingtin protein (H",
            "probability": 0.0005324637308366981,
            "start_logit": 6.5487565994262695,
            "end_logit": -1.8065534830093384
        }
    ],
    "58a3428d60087bc10a00001b_002": [
        {
            "text": "huntingtin",
            "probability": 0.7967448939535987,
            "start_logit": 4.454747676849365,
            "end_logit": 3.230485200881958
        },
        {
            "text": "huntingtin. As a result, this polyQ expansion leads to the misfolding and aggregation of mutant huntingtin",
            "probability": 0.1807941817717048,
            "start_logit": 4.454747676849365,
            "end_logit": 1.747309923171997
        },
        {
            "text": "huntingtin.",
            "probability": 0.01529025884441142,
            "start_logit": 4.454747676849365,
            "end_logit": -0.7228333950042725
        },
        {
            "text": "hunting",
            "probability": 0.0025906295158410818,
            "start_logit": 4.454747676849365,
            "end_logit": -2.4981484413146973
        },
        {
            "text": "(HD) is caused by a genetic mutation that results in polyglutamine expansion in the N-terminal regions of huntingtin",
            "probability": 0.0009242961297847346,
            "start_logit": -2.3045096397399902,
            "end_logit": 3.230485200881958
        },
        {
            "text": "mutant huntingtin",
            "probability": 0.000655190212646367,
            "start_logit": -1.1654412746429443,
            "end_logit": 1.747309923171997
        },
        {
            "text": "huntingtin. As a result, this polyQ expansion leads to the misfolding and aggregation of mutant hunting",
            "probability": 0.0005370886569506526,
            "start_logit": 4.454747676849365,
            "end_logit": -4.071641445159912
        },
        {
            "text": "HD) is caused by a genetic mutation that results in polyglutamine expansion in the N-terminal regions of huntingtin",
            "probability": 0.0005000157066568137,
            "start_logit": -2.918902635574341,
            "end_logit": 3.230485200881958
        },
        {
            "text": "tin",
            "probability": 0.0003355443911764989,
            "start_logit": -3.3177878856658936,
            "end_logit": 3.230485200881958
        },
        {
            "text": "mutation that results in polyglutamine expansion in the N-terminal regions of huntingtin",
            "probability": 0.0002868106907521868,
            "start_logit": -3.474719762802124,
            "end_logit": 3.230485200881958
        },
        {
            "text": "caused by a genetic mutation that results in polyglutamine expansion in the N-terminal regions of huntingtin",
            "probability": 0.00027854413773285944,
            "start_logit": -3.5039656162261963,
            "end_logit": 3.230485200881958
        },
        {
            "text": "huntingtin. As a result, this polyQ expansion leads to the misfolding and aggregation of mutant huntingtin as",
            "probability": 0.000221573591565326,
            "start_logit": 4.454747676849365,
            "end_logit": -4.95704984664917
        },
        {
            "text": "of huntingtin",
            "probability": 0.00021396350721797754,
            "start_logit": -3.7677366733551025,
            "end_logit": 3.230485200881958
        },
        {
            "text": "regions of huntingtin",
            "probability": 0.000195539313612336,
            "start_logit": -3.857780694961548,
            "end_logit": 3.230485200881958
        },
        {
            "text": "huntingtin ubiquitously or selectively in different cell types, and knock-in mice that express full-length mutant Htt",
            "probability": 0.0001304871942622824,
            "start_logit": 0.5277944207191467,
            "end_logit": -1.5595762729644775
        },
        {
            "text": "tin. As a result, this polyQ expansion leads to the misfolding and aggregation of mutant huntingtin",
            "probability": 7.614039840256948e-05,
            "start_logit": -3.3177878856658936,
            "end_logit": 1.747309923171997
        },
        {
            "text": "huntingtin as well as age-dependent neurodegeneration. The genetic mutation in HD",
            "probability": 7.410117965393405e-05,
            "start_logit": 2.5791075229644775,
            "end_logit": -4.176733016967773
        },
        {
            "text": "Htt",
            "probability": 5.467394306031287e-05,
            "start_logit": -0.34209343791007996,
            "end_logit": -1.5595762729644775
        },
        {
            "text": "of huntingtin. As a result, this polyQ expansion leads to the misfolding and aggregation of mutant huntingtin",
            "probability": 4.855174788071044e-05,
            "start_logit": -3.7677366733551025,
            "end_logit": 1.747309923171997
        },
        {
            "text": "huntingtin as well as age-dependent neurodegeneration.",
            "probability": 4.7515113088325286e-05,
            "start_logit": 2.5791075229644775,
            "end_logit": -4.621116638183594
        }
    ],
    "58a872bd38c171fb5b000002_000": [
        {
            "text": "SMIM1",
            "probability": 0.9508918685970695,
            "start_logit": 5.005557060241699,
            "end_logit": 4.259594917297363
        },
        {
            "text": "Disruption of SMIM1",
            "probability": 0.03034524376119079,
            "start_logit": 1.5607964992523193,
            "end_logit": 4.259594917297363
        },
        {
            "text": "SMIM",
            "probability": 0.006751105640421566,
            "start_logit": 5.005557060241699,
            "end_logit": -0.6880991458892822
        },
        {
            "text": "SMIM1 cDNA in Vel- cultured cells generated anti-Vel cell surface reactivity, confirming that SMIM1",
            "probability": 0.0044854290870560524,
            "start_logit": 2.3506648540496826,
            "end_logit": 1.5579209327697754
        },
        {
            "text": "SMIM1 causes the Vel- blood type.",
            "probability": 0.0025816151115520395,
            "start_logit": 5.005557060241699,
            "end_logit": -1.6493902206420898
        },
        {
            "text": "SMIM1 causes the Vel- blood type",
            "probability": 0.0010070602365386476,
            "start_logit": 5.005557060241699,
            "end_logit": -2.5907700061798096
        },
        {
            "text": "SM",
            "probability": 0.0009436959269393644,
            "start_logit": 5.005557060241699,
            "end_logit": -2.655756711959839
        },
        {
            "text": "17 nucleotide deletion in the coding sequence of SMIM1",
            "probability": 0.00041031730612278467,
            "start_logit": -1.2316733598709106,
            "end_logit": 2.748600482940674
        },
        {
            "text": "a 17 nucleotide deletion in the coding sequence of SMIM1",
            "probability": 0.00040875412565628914,
            "start_logit": -1.235490322113037,
            "end_logit": 2.748600482940674
        },
        {
            "text": "1",
            "probability": 0.0003417559845624808,
            "start_logit": -2.925501585006714,
            "end_logit": 4.259594917297363
        },
        {
            "text": "deletion in the coding sequence of SMIM1",
            "probability": 0.0002992018497593301,
            "start_logit": -1.5474857091903687,
            "end_logit": 2.748600482940674
        },
        {
            "text": "SMIM1 causes",
            "probability": 0.00027928006664931776,
            "start_logit": 5.005557060241699,
            "end_logit": -3.8733456134796143
        },
        {
            "text": "Disruption of SMIM",
            "probability": 0.00021544399850468324,
            "start_logit": 1.5607964992523193,
            "end_logit": -0.6880991458892822
        },
        {
            "text": "SMIM1 causes the Vel- blood type. Here, we report the biochemical and genetic basis of the Vel blood group antigen,",
            "probability": 0.0002087765548944504,
            "start_logit": 5.005557060241699,
            "end_logit": -4.1642961502075195
        },
        {
            "text": "SMIM1 causes the Vel- blood type. Here, we report the biochemical and genetic basis of the Vel blood group antigen",
            "probability": 0.00018087069007361657,
            "start_logit": 5.005557060241699,
            "end_logit": -4.307778358459473
        },
        {
            "text": "tion of SMIM1",
            "probability": 0.00017505248984904086,
            "start_logit": -3.594512701034546,
            "end_logit": 4.259594917297363
        },
        {
            "text": "(SMIM1",
            "probability": 0.00013382624372566812,
            "start_logit": -0.5223668217658997,
            "end_logit": 0.9189054369926453
        },
        {
            "text": "ruption of SMIM1",
            "probability": 0.00012171712643661641,
            "start_logit": -3.9578988552093506,
            "end_logit": 4.259594917297363
        },
        {
            "text": "SMIM1. The genetic homogeneity of the Vel- blood type,",
            "probability": 0.00011675456292161762,
            "start_logit": 3.449286699295044,
            "end_logit": -3.189216375350952
        },
        {
            "text": "SMIM1 causes the Vel- blood type. Here, we report the biochemical and genetic basis of the Vel blood group",
            "probability": 0.00010223064007587314,
            "start_logit": 5.005557060241699,
            "end_logit": -4.878329277038574
        }
    ],
    "58a872bd38c171fb5b000002_001": [
        {
            "text": "SMIM1",
            "probability": 0.8202739302409074,
            "start_logit": 4.782634258270264,
            "end_logit": 3.984992027282715
        },
        {
            "text": "SMIM1 gene",
            "probability": 0.15414963730293138,
            "start_logit": 4.782634258270264,
            "end_logit": 2.31327748298645
        },
        {
            "text": "SMIM1 17 bp (64-80del) gene",
            "probability": 0.005134704309150865,
            "start_logit": 4.271272659301758,
            "end_logit": -0.5772624611854553
        },
        {
            "text": "the SMIM1",
            "probability": 0.005065477627934536,
            "start_logit": -0.30455565452575684,
            "end_logit": 3.984992027282715
        },
        {
            "text": "SMIM",
            "probability": 0.004164598018194038,
            "start_logit": 4.782634258270264,
            "end_logit": -1.2980265617370605
        },
        {
            "text": "SM",
            "probability": 0.0012827671896603967,
            "start_logit": 4.782634258270264,
            "end_logit": -2.4756267070770264
        },
        {
            "text": "SMIM1 protein carries the Vel blood group antigen,",
            "probability": 0.0010998774220280587,
            "start_logit": 3.7493507862091064,
            "end_logit": -1.5961641073226929
        },
        {
            "text": "SMIM1 17 bp",
            "probability": 0.0010858904162134803,
            "start_logit": 4.271272659301758,
            "end_logit": -2.1308844089508057
        },
        {
            "text": "Vel blood group antigen, and homozygosity for a 17 bp deletion in the coding region of the SMIM1",
            "probability": 0.0010756640506368012,
            "start_logit": -1.8540658950805664,
            "end_logit": 3.984992027282715
        },
        {
            "text": "SMIM1 gene represents the molecular basis of the Vel- blood group phenotype. We developed PCR-based methods for typing the SM",
            "probability": 0.001001837497772098,
            "start_logit": 4.782634258270264,
            "end_logit": -2.7228105068206787
        },
        {
            "text": "the SMIM1 gene",
            "probability": 0.0009519277772035195,
            "start_logit": -0.30455565452575684,
            "end_logit": 2.31327748298645
        },
        {
            "text": "SMIM1 protein",
            "probability": 0.0007122983362035567,
            "start_logit": 3.7493507862091064,
            "end_logit": -2.030621290206909
        },
        {
            "text": "SMIM1 17 bp (64-80del)",
            "probability": 0.0006555572811474206,
            "start_logit": 4.271272659301758,
            "end_logit": -2.635554313659668
        },
        {
            "text": "homozygosity for a 17 bp deletion in the coding region of the SMIM1",
            "probability": 0.0006038788575899872,
            "start_logit": -2.4313857555389404,
            "end_logit": 3.984992027282715
        },
        {
            "text": "SMIM1 17 bp (64-80del) gene deletion",
            "probability": 0.0006024360732888853,
            "start_logit": 4.271272659301758,
            "end_logit": -2.7200584411621094
        },
        {
            "text": "SMIM1 gene represents the molecular basis of the Vel- blood group phenotype. We developed PCR",
            "probability": 0.0005358858298725567,
            "start_logit": 4.782634258270264,
            "end_logit": -3.348480463027954
        },
        {
            "text": "SMIM1 17",
            "probability": 0.000419906488900855,
            "start_logit": 4.271272659301758,
            "end_logit": -3.081007957458496
        },
        {
            "text": "The SMIM1",
            "probability": 0.0004054685370606537,
            "start_logit": -1.7284878492355347,
            "end_logit": 2.8837637901306152
        },
        {
            "text": "1",
            "probability": 0.00040104915965542473,
            "start_logit": -2.8406753540039062,
            "end_logit": 3.984992027282715
        },
        {
            "text": "deletion in the coding region of the SMIM1",
            "probability": 0.00037720758364802754,
            "start_logit": -2.901963710784912,
            "end_logit": 3.984992027282715
        }
    ],
    "5895bc397d9090f35300000b_000": [
        {
            "text": "SLC9A6",
            "probability": 0.7511415679395756,
            "start_logit": 6.6186203956604,
            "end_logit": 5.615396022796631
        },
        {
            "text": "SLC9A6 gene",
            "probability": 0.22718642758356775,
            "start_logit": 6.6186203956604,
            "end_logit": 4.419572830200195
        },
        {
            "text": "SLC9A6 gene,",
            "probability": 0.012317028072939773,
            "start_logit": 6.6186203956604,
            "end_logit": 1.5047845840454102
        },
        {
            "text": "the SLC9A6",
            "probability": 0.002934783019395738,
            "start_logit": 1.0736597776412964,
            "end_logit": 5.615396022796631
        },
        {
            "text": "Slc9a6",
            "probability": 0.0027154704397359154,
            "start_logit": 3.959104299545288,
            "end_logit": 2.652283191680908
        },
        {
            "text": "SLC9A",
            "probability": 0.000988063570352726,
            "start_logit": 6.6186203956604,
            "end_logit": -1.0182063579559326
        },
        {
            "text": "the SLC9A6 gene",
            "probability": 0.0008876394255990225,
            "start_logit": 1.0736597776412964,
            "end_logit": 4.419572830200195
        },
        {
            "text": "SL",
            "probability": 0.0003189683839066252,
            "start_logit": 6.6186203956604,
            "end_logit": -2.1488614082336426
        },
        {
            "text": "SLC9",
            "probability": 0.00030458679435226146,
            "start_logit": 6.6186203956604,
            "end_logit": -2.1949973106384277
        },
        {
            "text": "6",
            "probability": 0.0002668754500663066,
            "start_logit": -1.3239469528198242,
            "end_logit": 5.615396022796631
        },
        {
            "text": "mutations in the SLC9A6",
            "probability": 0.0002382925289756819,
            "start_logit": -1.4372299909591675,
            "end_logit": 5.615396022796631
        },
        {
            "text": "CS is caused by mutations in the SLC9A6",
            "probability": 0.00015443189208561478,
            "start_logit": -1.8709758520126343,
            "end_logit": 5.615396022796631
        },
        {
            "text": "in the SLC9A6",
            "probability": 0.00010399112504674027,
            "start_logit": -2.266423463821411,
            "end_logit": 5.615396022796631
        },
        {
            "text": "6 gene",
            "probability": 8.07177803734573e-05,
            "start_logit": -1.3239469528198242,
            "end_logit": 4.419572830200195
        },
        {
            "text": "9A6",
            "probability": 7.584492984719871e-05,
            "start_logit": -2.582038164138794,
            "end_logit": 5.615396022796631
        },
        {
            "text": "SLC",
            "probability": 7.233387333551949e-05,
            "start_logit": 6.6186203956604,
            "end_logit": -3.6326608657836914
        },
        {
            "text": "mutations in the SLC9A6 gene",
            "probability": 7.207273660322034e-05,
            "start_logit": -1.4372299909591675,
            "end_logit": 4.419572830200195
        },
        {
            "text": "the SLC9A6 gene,",
            "probability": 4.812382429724899e-05,
            "start_logit": 1.0736597776412964,
            "end_logit": 1.5047845840454102
        },
        {
            "text": "CS is caused by mutations in the SLC9A6 gene",
            "probability": 4.670867831764599e-05,
            "start_logit": -1.8709758520126343,
            "end_logit": 4.419572830200195
        },
        {
            "text": ". CS is caused by mutations in the SLC9A6",
            "probability": 4.607195162577937e-05,
            "start_logit": -3.0805246829986572,
            "end_logit": 5.615396022796631
        }
    ],
    "5895bc397d9090f35300000b_001": [
        {
            "text": "SLC9A6",
            "probability": 0.9855005249356863,
            "start_logit": 5.344005107879639,
            "end_logit": 4.790295124053955
        },
        {
            "text": "SLC9",
            "probability": 0.0027371191393097227,
            "start_logit": 5.344005107879639,
            "end_logit": -1.095948576927185
        },
        {
            "text": "SLC9A",
            "probability": 0.0026018468146828022,
            "start_logit": 5.344005107879639,
            "end_logit": -1.1466330289840698
        },
        {
            "text": "Christianson syndrome (CS) is caused by mutations in SLC9A6",
            "probability": 0.002161115585877846,
            "start_logit": -0.7785199880599976,
            "end_logit": 4.790295124053955
        },
        {
            "text": "Christianson syndrome: spectrum of neuroimaging findings. Christianson syndrome (CS) is caused by mutations in SLC9A6",
            "probability": 0.0016098486790393563,
            "start_logit": -1.0730043649673462,
            "end_logit": 4.790295124053955
        },
        {
            "text": "mutations in SLC9A6",
            "probability": 0.001277914291496837,
            "start_logit": -1.30391526222229,
            "end_logit": 4.790295124053955
        },
        {
            "text": "6",
            "probability": 0.000999395598125613,
            "start_logit": -1.5497491359710693,
            "end_logit": 4.790295124053955
        },
        {
            "text": "SL",
            "probability": 0.0005539538612891361,
            "start_logit": 5.344005107879639,
            "end_logit": -2.693528413772583
        },
        {
            "text": "in SLC9A6",
            "probability": 0.0005049651411394255,
            "start_logit": -2.232410430908203,
            "end_logit": 4.790295124053955
        },
        {
            "text": "(CS) is caused by mutations in SLC9A6",
            "probability": 0.00034656869775554335,
            "start_logit": -2.608818769454956,
            "end_logit": 4.790295124053955
        },
        {
            "text": ". Christianson syndrome (CS) is caused by mutations in SLC9A6",
            "probability": 0.00030376030637030866,
            "start_logit": -2.7406609058380127,
            "end_logit": 4.790295124053955
        },
        {
            "text": "9A6",
            "probability": 0.00026927164882063434,
            "start_logit": -2.8611791133880615,
            "end_logit": 4.790295124053955
        },
        {
            "text": "SLC",
            "probability": 0.0002590046078293175,
            "start_logit": 5.344005107879639,
            "end_logit": -3.453763961791992
        },
        {
            "text": "caused by mutations in SLC9A6",
            "probability": 0.00022136947792495857,
            "start_logit": -3.0570666790008545,
            "end_logit": 4.790295124053955
        },
        {
            "text": "CS) is caused by mutations in SLC9A6",
            "probability": 0.00021683196160161614,
            "start_logit": -3.077777147293091,
            "end_logit": 4.790295124053955
        },
        {
            "text": "SLC9A6 and",
            "probability": 0.00021625677216066013,
            "start_logit": 5.344005107879639,
            "end_logit": -3.634143352508545
        },
        {
            "text": "SLC9A6 and is characterized by severe intellectual disability, absent speech, microcephaly, ataxia, seizures,",
            "probability": 0.0001096305509859687,
            "start_logit": 5.344005107879639,
            "end_logit": -4.313493728637695
        },
        {
            "text": "is caused by mutations in SLC9A6",
            "probability": 8.309329594680005e-05,
            "start_logit": -4.036935806274414,
            "end_logit": 4.790295124053955
        },
        {
            "text": "confirmed mutations in SLC9A6",
            "probability": 1.854631923968931e-05,
            "start_logit": -3.2375428676605225,
            "end_logit": 2.4912095069885254
        },
        {
            "text": "CS and confirmed mutations in SLC9A6",
            "probability": 8.982314717303059e-06,
            "start_logit": -3.9625566005706787,
            "end_logit": 2.4912095069885254
        }
    ],
    "5895bc397d9090f35300000b_002": [
        {
            "text": "SLC9A6",
            "probability": 0.7744802533136287,
            "start_logit": 5.465137004852295,
            "end_logit": 4.449709415435791
        },
        {
            "text": "SLC9A6 Mutation. BACKGROUND: Mutations of SLC9A6",
            "probability": 0.2098231193275016,
            "start_logit": 4.159209728240967,
            "end_logit": 4.449709415435791
        },
        {
            "text": "SLC9A6 may cause an X",
            "probability": 0.0027433446514616676,
            "start_logit": 5.465137004852295,
            "end_logit": -1.1933048963546753
        },
        {
            "text": "Mutations of SLC9A6",
            "probability": 0.0022518866385457543,
            "start_logit": -0.3752867877483368,
            "end_logit": 4.449709415435791
        },
        {
            "text": "SLC9A",
            "probability": 0.002133976858267093,
            "start_logit": 5.465137004852295,
            "end_logit": -1.444495439529419
        },
        {
            "text": "SLC9",
            "probability": 0.0014733002950095542,
            "start_logit": 5.465137004852295,
            "end_logit": -1.814977765083313
        },
        {
            "text": "SLC9A6 may cause an X-linked clinical syndrome first described by Christianson",
            "probability": 0.0010042426209544472,
            "start_logit": 5.465137004852295,
            "end_logit": -2.198249101638794
        },
        {
            "text": "SLC9A6 may cause an X-linked",
            "probability": 0.0009547451297739443,
            "start_logit": 5.465137004852295,
            "end_logit": -2.248793601989746
        },
        {
            "text": "SLC9A6 Mutation. BACKGROUND: Mutations of SLC9A6 may cause an X",
            "probability": 0.0007432302240080568,
            "start_logit": 4.159209728240967,
            "end_logit": -1.1933048963546753
        },
        {
            "text": "SL",
            "probability": 0.0006544516702630995,
            "start_logit": 5.465137004852295,
            "end_logit": -2.6264402866363525
        },
        {
            "text": "SLC9A6 Mutation. BACKGROUND: Mutations of SLC9A",
            "probability": 0.0005781395704520077,
            "start_logit": 4.159209728240967,
            "end_logit": -1.444495439529419
        },
        {
            "text": "SLC9A6 may",
            "probability": 0.0004994074273134312,
            "start_logit": 5.465137004852295,
            "end_logit": -2.896815776824951
        },
        {
            "text": "6",
            "probability": 0.00045872201050752937,
            "start_logit": -1.9663660526275635,
            "end_logit": 4.449709415435791
        },
        {
            "text": "SLC9A6 Mutation. BACKGROUND: Mutations of SLC9",
            "probability": 0.00039914828335829586,
            "start_logit": 4.159209728240967,
            "end_logit": -1.814977765083313
        },
        {
            "text": "SLC9A6 may cause an X-linked clinical",
            "probability": 0.00038155893357986293,
            "start_logit": 5.465137004852295,
            "end_logit": -3.1659727096557617
        },
        {
            "text": "6 Mutation. BACKGROUND: Mutations of SLC9A6",
            "probability": 0.0003690159936264596,
            "start_logit": -2.1839704513549805,
            "end_logit": 4.449709415435791
        },
        {
            "text": "BACKGROUND: Mutations of SLC9A6",
            "probability": 0.00033460326823790036,
            "start_logit": -2.281864881515503,
            "end_logit": 4.449709415435791
        },
        {
            "text": "SLC9A6 Mutation. BACKGROUND: Mutations of SLC9A6 may cause an X-linked",
            "probability": 0.0002586606959116179,
            "start_logit": 4.159209728240967,
            "end_logit": -2.248793601989746
        },
        {
            "text": "SLC9A6 may cause an X-linked clinical syndrome",
            "probability": 0.0002323979011992788,
            "start_logit": 5.465137004852295,
            "end_logit": -3.6617870330810547
        },
        {
            "text": ". BACKGROUND: Mutations of SLC9A6",
            "probability": 0.00022579518639973418,
            "start_logit": -2.6751821041107178,
            "end_logit": 4.449709415435791
        }
    ],
    "5895bc397d9090f35300000b_003": [
        {
            "text": "SLC9A6",
            "probability": 0.8345376370321796,
            "start_logit": 6.0270562171936035,
            "end_logit": 5.424318313598633
        },
        {
            "text": "SLC9A6 encoding the recycling endosomal alkali cation/proton exchanger NHE6",
            "probability": 0.12276200659405472,
            "start_logit": 6.0270562171936035,
            "end_logit": 3.507688045501709
        },
        {
            "text": "NHE6",
            "probability": 0.0168296338478074,
            "start_logit": 4.039949893951416,
            "end_logit": 3.507688045501709
        },
        {
            "text": "SLC9A6 encoding the recycling endosomal alkali cation/proton exchanger NHE6.",
            "probability": 0.012543745384198581,
            "start_logit": 6.0270562171936035,
            "end_logit": 1.2266626358032227
        },
        {
            "text": "gene SLC9A6",
            "probability": 0.0032834801235832787,
            "start_logit": 0.4890822470188141,
            "end_logit": 5.424318313598633
        },
        {
            "text": "NHE6.",
            "probability": 0.0017196415059772252,
            "start_logit": 4.039949893951416,
            "end_logit": 1.2266626358032227
        },
        {
            "text": "X-linked neurodevelopmental disorder, is caused by mutations in the human gene SLC9A6",
            "probability": 0.0013726679890222067,
            "start_logit": -0.3830653429031372,
            "end_logit": 5.424318313598633
        },
        {
            "text": "human gene SLC9A6",
            "probability": 0.0013135480422463647,
            "start_logit": -0.42708972096443176,
            "end_logit": 5.424318313598633
        },
        {
            "text": "SLC9A",
            "probability": 0.0011541298715602199,
            "start_logit": 6.0270562171936035,
            "end_logit": -1.1592128276824951
        },
        {
            "text": "SLC9",
            "probability": 0.0006123193922826431,
            "start_logit": 6.0270562171936035,
            "end_logit": -1.7930607795715332
        },
        {
            "text": "SLC9A6 encoding the recycling endosomal alkali cation/proton exchanger",
            "probability": 0.0005434531007919083,
            "start_logit": 6.0270562171936035,
            "end_logit": -1.9123713970184326
        },
        {
            "text": "the human gene SLC9A6",
            "probability": 0.0005300344503409992,
            "start_logit": -1.3346349000930786,
            "end_logit": 5.424318313598633
        },
        {
            "text": "gene SLC9A6 encoding the recycling endosomal alkali cation/proton exchanger NHE6",
            "probability": 0.00048300590733840694,
            "start_logit": 0.4890822470188141,
            "end_logit": 3.507688045501709
        },
        {
            "text": "mutations in the human gene SLC9A6",
            "probability": 0.00046556438662185564,
            "start_logit": -1.4643265008926392,
            "end_logit": 5.424318313598633
        },
        {
            "text": "SLC9A6 encoding the recycling endosomal alkali cation/proton exchanger NHE",
            "probability": 0.00042177461494855766,
            "start_logit": 6.0270562171936035,
            "end_logit": -2.1658437252044678
        },
        {
            "text": "SL",
            "probability": 0.0003962431609463271,
            "start_logit": 6.0270562171936035,
            "end_logit": -2.2282867431640625
        },
        {
            "text": "6",
            "probability": 0.0003574049144584444,
            "start_logit": -1.7287075519561768,
            "end_logit": 5.424318313598633
        },
        {
            "text": "SLC9A6 disrupts recycling endosomal function and elicits neurodegeneration and cell death. BACK",
            "probability": 0.0002969479065116944,
            "start_logit": 4.82535982131958,
            "end_logit": -1.3150616884231567
        },
        {
            "text": "human gene SLC9A6 encoding the recycling endosomal alkali cation/proton exchanger NHE6",
            "probability": 0.0001932253097623181,
            "start_logit": -0.42708972096443176,
            "end_logit": 3.507688045501709
        },
        {
            "text": "in the human gene SLC9A6",
            "probability": 0.00018353646536703862,
            "start_logit": -2.3951635360717773,
            "end_logit": 5.424318313598633
        }
    ],
    "5895bc397d9090f35300000b_004": [
        {
            "text": "NHE6",
            "probability": 0.5530746518165289,
            "start_logit": 4.961421012878418,
            "end_logit": 4.091892719268799
        },
        {
            "text": "NHE6)",
            "probability": 0.15882020005631078,
            "start_logit": 4.961421012878418,
            "end_logit": 2.844172477722168
        },
        {
            "text": "Na(+) /H(+) exchanger 6",
            "probability": 0.059158447022314285,
            "start_logit": 2.5599563121795654,
            "end_logit": 4.258083820343018
        },
        {
            "text": "(NHE6",
            "probability": 0.05152258710447074,
            "start_logit": 2.5879483222961426,
            "end_logit": 4.091892719268799
        },
        {
            "text": "Na(+) /H(+) exchanger 6 (NHE6",
            "probability": 0.050100364622364904,
            "start_logit": 2.5599563121795654,
            "end_logit": 4.091892719268799
        },
        {
            "text": "X-linked Na(+) /H(+) exchanger 6",
            "probability": 0.026146532399838343,
            "start_logit": 1.7434535026550293,
            "end_logit": 4.258083820343018
        },
        {
            "text": "X-linked Na(+) /H(+) exchanger 6 (NHE6",
            "probability": 0.022143089833786062,
            "start_logit": 1.7434535026550293,
            "end_logit": 4.091892719268799
        },
        {
            "text": "NHE6).",
            "probability": 0.01607852507243634,
            "start_logit": 4.961421012878418,
            "end_logit": 0.5538842678070068
        },
        {
            "text": "(NHE6)",
            "probability": 0.014795159323384113,
            "start_logit": 2.5879483222961426,
            "end_logit": 2.844172477722168
        },
        {
            "text": "Na(+) /H(+) exchanger 6 (NHE6)",
            "probability": 0.014386755759071855,
            "start_logit": 2.5599563121795654,
            "end_logit": 2.844172477722168
        },
        {
            "text": "X-linked Na(+) /H(+) exchanger 6 (NHE6)",
            "probability": 0.006358580972236238,
            "start_logit": 1.7434535026550293,
            "end_logit": 2.844172477722168
        },
        {
            "text": "6",
            "probability": 0.006313154369786327,
            "start_logit": 0.3223723769187927,
            "end_logit": 4.258083820343018
        },
        {
            "text": "6 (NHE6",
            "probability": 0.005346511813000563,
            "start_logit": 0.3223723769187927,
            "end_logit": 4.091892719268799
        },
        {
            "text": "NHE6 mutations in Christianson syndrome.",
            "probability": 0.004842675903529263,
            "start_logit": 4.722563743591309,
            "end_logit": -0.40727555751800537
        },
        {
            "text": "NHE",
            "probability": 0.0031458063266054225,
            "start_logit": 4.961421012878418,
            "end_logit": -1.077530026435852
        },
        {
            "text": "H(+) exchanger 6",
            "probability": 0.0017155009829569968,
            "start_logit": -0.980557918548584,
            "end_logit": 4.258083820343018
        },
        {
            "text": "the X-linked Na(+) /H(+) exchanger 6",
            "probability": 0.001561861510007014,
            "start_logit": -1.0743846893310547,
            "end_logit": 4.258083820343018
        },
        {
            "text": "6 (NHE6)",
            "probability": 0.0015352974014543354,
            "start_logit": 0.3223723769187927,
            "end_logit": 2.844172477722168
        },
        {
            "text": "(NHE6).",
            "probability": 0.0014978216879677666,
            "start_logit": 2.5879483222961426,
            "end_logit": 0.5538842678070068
        },
        {
            "text": "Na(+) /H(+) exchanger 6 (NHE6).",
            "probability": 0.0014564760219495975,
            "start_logit": 2.5599563121795654,
            "end_logit": 0.5538842678070068
        }
    ],
    "5895bc397d9090f35300000b_005": [
        {
            "text": "solute carrier family 9, subfamily A member 6",
            "probability": 0.2736409647926143,
            "start_logit": 5.815048694610596,
            "end_logit": 5.684372901916504
        },
        {
            "text": "SLC9A6)",
            "probability": 0.10631948916631134,
            "start_logit": 5.872090816497803,
            "end_logit": 4.681962490081787
        },
        {
            "text": "SLC9A6",
            "probability": 0.10089837520942578,
            "start_logit": 5.872090816497803,
            "end_logit": 4.629627704620361
        },
        {
            "text": "solute carrier family 9, subfamily A member 6 (SLC9A6)",
            "probability": 0.10042452876481205,
            "start_logit": 5.815048694610596,
            "end_logit": 4.681962490081787
        },
        {
            "text": "solute carrier family 9, subfamily A member 6 (SLC9A6",
            "probability": 0.09530399236297724,
            "start_logit": 5.815048694610596,
            "end_logit": 4.629627704620361
        },
        {
            "text": "SLC9A6) gene, encoding the endosomal Na+/H+ exchanger 6",
            "probability": 0.0576328330653871,
            "start_logit": 5.872090816497803,
            "end_logit": 4.069606304168701
        },
        {
            "text": "SLC9A6) gene",
            "probability": 0.04588721028023159,
            "start_logit": 5.872090816497803,
            "end_logit": 3.841700315475464
        },
        {
            "text": "solute carrier family 9, subfamily A member 6 (SLC9A6) gene",
            "probability": 0.04334296096471712,
            "start_logit": 5.815048694610596,
            "end_logit": 3.841700315475464
        },
        {
            "text": "SLC9A6) gene, encoding the endosomal Na+/H+ exchanger 6 (NHE6",
            "probability": 0.03782727605469325,
            "start_logit": 5.872090816497803,
            "end_logit": 3.6485443115234375
        },
        {
            "text": "(SLC9A6)",
            "probability": 0.023078264334457678,
            "start_logit": 4.344533443450928,
            "end_logit": 4.681962490081787
        },
        {
            "text": "(SLC9A6",
            "probability": 0.021901528988330136,
            "start_logit": 4.344533443450928,
            "end_logit": 4.629627704620361
        },
        {
            "text": "SLC9A6) gene, encoding the endosomal Na+/H+ exchanger 6 (NHE6)",
            "probability": 0.01761809995459175,
            "start_logit": 5.872090816497803,
            "end_logit": 2.8844406604766846
        },
        {
            "text": "endosomal Na+/H+ exchanger 6",
            "probability": 0.014174687494576623,
            "start_logit": 4.469456195831299,
            "end_logit": 4.069606304168701
        },
        {
            "text": "(SLC9A6) gene, encoding the endosomal Na+/H+ exchanger 6",
            "probability": 0.012510084145966008,
            "start_logit": 4.344533443450928,
            "end_logit": 4.069606304168701
        },
        {
            "text": "NHE6",
            "probability": 0.012028994729493378,
            "start_logit": 4.726380348205566,
            "end_logit": 3.6485443115234375
        },
        {
            "text": "(SLC9A6) gene",
            "probability": 0.009960517838469685,
            "start_logit": 4.344533443450928,
            "end_logit": 3.841700315475464
        },
        {
            "text": "endosomal Na+/H+ exchanger 6 (NHE6",
            "probability": 0.009303547792592914,
            "start_logit": 4.469456195831299,
            "end_logit": 3.6485443115234375
        },
        {
            "text": "(SLC9A6) gene, encoding the endosomal Na+/H+ exchanger 6 (NHE6",
            "probability": 0.008210986364664826,
            "start_logit": 4.344533443450928,
            "end_logit": 3.6485443115234375
        },
        {
            "text": "NHE6)",
            "probability": 0.005602518965178772,
            "start_logit": 4.726380348205566,
            "end_logit": 2.8844406604766846
        },
        {
            "text": "endosomal Na+/H+ exchanger 6 (NHE6)",
            "probability": 0.004333138730508377,
            "start_logit": 4.469456195831299,
            "end_logit": 2.8844406604766846
        }
    ],
    "58a8045860087bc10a000035_000": [
        {
            "text": "hair pulling disorder",
            "probability": 0.9350299190634004,
            "start_logit": 7.342386722564697,
            "end_logit": 6.305356979370117
        },
        {
            "text": "hair pulling disorder; HPD",
            "probability": 0.033106191084509004,
            "start_logit": 7.342386722564697,
            "end_logit": 2.96449875831604
        },
        {
            "text": "(hair pulling disorder",
            "probability": 0.01583856904357977,
            "start_logit": 3.264256238937378,
            "end_logit": 6.305356979370117
        },
        {
            "text": "hair pulling disorder;",
            "probability": 0.005355213202918266,
            "start_logit": 7.342386722564697,
            "end_logit": 1.1428489685058594
        },
        {
            "text": "hair pulling disorder; HPD)",
            "probability": 0.0035128950286215134,
            "start_logit": 7.342386722564697,
            "end_logit": 0.7212189435958862
        },
        {
            "text": "trichotillomania (hair pulling disorder",
            "probability": 0.0030132233547278757,
            "start_logit": 1.60481858253479,
            "end_logit": 6.305356979370117
        },
        {
            "text": "hair pulling",
            "probability": 0.001226912615202629,
            "start_logit": 7.342386722564697,
            "end_logit": -0.33072060346603394
        },
        {
            "text": "HPD",
            "probability": 0.0006750925394702353,
            "start_logit": 3.449760913848877,
            "end_logit": 2.96449875831604
        },
        {
            "text": "(hair pulling disorder; HPD",
            "probability": 0.0005607892138758254,
            "start_logit": 3.264256238937378,
            "end_logit": 2.96449875831604
        },
        {
            "text": "pediatric trichotillomania (hair pulling disorder",
            "probability": 0.0004839261128788412,
            "start_logit": -0.22401484847068787,
            "end_logit": 6.305356979370117
        },
        {
            "text": "hair",
            "probability": 0.00037770532645597157,
            "start_logit": 7.342386722564697,
            "end_logit": -1.5088624954223633
        },
        {
            "text": "hair pulling disorder; HPD) have taken place.",
            "probability": 0.00012176992894109656,
            "start_logit": 7.342386722564697,
            "end_logit": -2.640843391418457
        },
        {
            "text": "pulling disorder",
            "probability": 0.00011437562643812486,
            "start_logit": -1.666459083557129,
            "end_logit": 6.305356979370117
        },
        {
            "text": "hair pulling disorder; HP",
            "probability": 0.00010911267013886066,
            "start_logit": 7.342386722564697,
            "end_logit": -2.750595808029175
        },
        {
            "text": "trichotillomania (hair pulling disorder; HPD",
            "probability": 0.00010668786755171443,
            "start_logit": 1.60481858253479,
            "end_logit": 2.96449875831604
        },
        {
            "text": "(hair pulling disorder;",
            "probability": 9.071251339472881e-05,
            "start_logit": 3.264256238937378,
            "end_logit": 1.1428489685058594
        },
        {
            "text": "disorder",
            "probability": 8.739083671005796e-05,
            "start_logit": -1.9355566501617432,
            "end_logit": 6.305356979370117
        },
        {
            "text": "HPD)",
            "probability": 7.163401007717087e-05,
            "start_logit": 3.449760913848877,
            "end_logit": 0.7212189435958862
        },
        {
            "text": "(hair pulling disorder; HPD)",
            "probability": 5.9505294236362624e-05,
            "start_logit": 3.264256238937378,
            "end_logit": 0.7212189435958862
        },
        {
            "text": "neurocognitive examinations of pediatric trichotillomania (hair pulling disorder",
            "probability": 5.837466687133068e-05,
            "start_logit": -2.3390650749206543,
            "end_logit": 6.305356979370117
        }
    ],
    "58a8045860087bc10a000035_001": [
        {
            "text": "Hair pulling disorder",
            "probability": 0.9450218184903777,
            "start_logit": 7.10615873336792,
            "end_logit": 6.2074875831604
        },
        {
            "text": "Hair pulling disorder (HPD",
            "probability": 0.02749060329599555,
            "start_logit": 7.10615873336792,
            "end_logit": 2.670123815536499
        },
        {
            "text": "hair pulling disorder. Hair pulling disorder",
            "probability": 0.017229162418692583,
            "start_logit": 3.1015541553497314,
            "end_logit": 6.2074875831604
        },
        {
            "text": "Hair pulling",
            "probability": 0.0035325870104850545,
            "start_logit": 7.10615873336792,
            "end_logit": 0.6183100342750549
        },
        {
            "text": "Hair pulling disorder (HPD;",
            "probability": 0.0016915602998863744,
            "start_logit": 7.10615873336792,
            "end_logit": -0.11806907504796982
        },
        {
            "text": "Hair pulling disorder (HPD; trichotillomania)",
            "probability": 0.0011615188719460714,
            "start_logit": 7.10615873336792,
            "end_logit": -0.4939919114112854
        },
        {
            "text": "HPD",
            "probability": 0.0011524112379562416,
            "start_logit": 3.934170961380005,
            "end_logit": 2.670123815536499
        },
        {
            "text": "Hair pulling disorder (HPD; trichotillomania",
            "probability": 0.0007102819714537561,
            "start_logit": 7.10615873336792,
            "end_logit": -0.9858136773109436
        },
        {
            "text": "hair pulling disorder. Hair pulling disorder (HPD",
            "probability": 0.000501194850645002,
            "start_logit": 3.1015541553497314,
            "end_logit": 2.670123815536499
        },
        {
            "text": "Hair",
            "probability": 0.0003416567513440678,
            "start_logit": 7.10615873336792,
            "end_logit": -1.717669129371643
        },
        {
            "text": "pulling disorder",
            "probability": 0.00022002757526826128,
            "start_logit": -1.2590516805648804,
            "end_logit": 6.2074875831604
        },
        {
            "text": ". Hair pulling disorder",
            "probability": 0.00020529844424790964,
            "start_logit": -1.3283398151397705,
            "end_logit": 6.2074875831604
        },
        {
            "text": "hair pulling disorder",
            "probability": 0.00018907816609420853,
            "start_logit": 3.1015541553497314,
            "end_logit": 1.6952893733978271
        },
        {
            "text": "Hair pulling disorder (HP",
            "probability": 0.00012554178967682405,
            "start_logit": 7.10615873336792,
            "end_logit": -2.718837022781372
        },
        {
            "text": "adults with hair pulling disorder. Hair pulling disorder",
            "probability": 8.933769206911721e-05,
            "start_logit": -2.1603810787200928,
            "end_logit": 6.2074875831604
        },
        {
            "text": "disorder",
            "probability": 8.269222280221585e-05,
            "start_logit": -2.2376790046691895,
            "end_logit": 6.2074875831604
        },
        {
            "text": "HPD;",
            "probability": 7.091052452652597e-05,
            "start_logit": 3.934170961380005,
            "end_logit": -0.11806907504796982
        },
        {
            "text": "hair pulling disorder. Hair pulling",
            "probability": 6.440434937156998e-05,
            "start_logit": 3.1015541553497314,
            "end_logit": 0.6183100342750549
        },
        {
            "text": "Hair pulling disorder (HPD; trichotillomania) is thought to be associated with significant psychiatric",
            "probability": 6.122813495572092e-05,
            "start_logit": 7.10615873336792,
            "end_logit": -3.436868906021118
        },
        {
            "text": "Hair pulling disorder (HPD; trichotillomania) is thought to be associated with significant psychiatric comorbidity",
            "probability": 5.868590220542643e-05,
            "start_logit": 7.10615873336792,
            "end_logit": -3.479276180267334
        }
    ],
    "58a8045860087bc10a000035_002": [
        {
            "text": "hair pulling disorder",
            "probability": 0.766186597886388,
            "start_logit": 6.798793315887451,
            "end_logit": 6.1127471923828125
        },
        {
            "text": "hair pulling disorder, HPD",
            "probability": 0.09839691144713493,
            "start_logit": 6.798793315887451,
            "end_logit": 4.060330867767334
        },
        {
            "text": "Hair Pulling Disorder",
            "probability": 0.06102722948837078,
            "start_logit": 6.038161277770996,
            "end_logit": 4.343273639678955
        },
        {
            "text": "(hair pulling disorder",
            "probability": 0.014420526822522392,
            "start_logit": 2.8260202407836914,
            "end_logit": 6.1127471923828125
        },
        {
            "text": "hair pulling disorder, HPD)",
            "probability": 0.013269563486619045,
            "start_logit": 6.798793315887451,
            "end_logit": 2.0567944049835205
        },
        {
            "text": "hair pulling disorder,",
            "probability": 0.013044992302986157,
            "start_logit": 6.798793315887451,
            "end_logit": 2.0397257804870605
        },
        {
            "text": "Trichotillomania (hair pulling disorder",
            "probability": 0.008952194656340725,
            "start_logit": 2.349266290664673,
            "end_logit": 6.1127471923828125
        },
        {
            "text": "Hair Pulling",
            "probability": 0.00439405039574961,
            "start_logit": 6.038161277770996,
            "end_logit": 1.712204933166504
        },
        {
            "text": "HPD",
            "probability": 0.003955481792682416,
            "start_logit": 3.584886312484741,
            "end_logit": 4.060330867767334
        },
        {
            "text": "hair pulling",
            "probability": 0.0036751855711272246,
            "start_logit": 6.798793315887451,
            "end_logit": 0.772925078868866
        },
        {
            "text": "Hair Pulling Disorder)",
            "probability": 0.0030657677874811368,
            "start_logit": 6.038161277770996,
            "end_logit": 1.3522515296936035
        },
        {
            "text": "(Hair Pulling Disorder",
            "probability": 0.002844018798317227,
            "start_logit": 2.9720592498779297,
            "end_logit": 4.343273639678955
        },
        {
            "text": "(hair pulling disorder, HPD",
            "probability": 0.0018519448195662295,
            "start_logit": 2.8260202407836914,
            "end_logit": 4.060330867767334
        },
        {
            "text": "Trichotillomania (Hair Pulling Disorder",
            "probability": 0.0015698211892449234,
            "start_logit": 2.377802848815918,
            "end_logit": 4.343273639678955
        },
        {
            "text": "Trichotillomania (hair pulling disorder, HPD",
            "probability": 0.0011496785604021883,
            "start_logit": 2.349266290664673,
            "end_logit": 4.060330867767334
        },
        {
            "text": "hair pulling disorder, HPD) is characterized by significant psychological distress, childhood-onset, and, in adults, certain cognitive deficits",
            "probability": 0.0006228249681293158,
            "start_logit": 6.798793315887451,
            "end_logit": -1.0021682977676392
        },
        {
            "text": "HPD)",
            "probability": 0.0005334264663008723,
            "start_logit": 3.584886312484741,
            "end_logit": 2.0567944049835205
        },
        {
            "text": "Inattention and Hyperactivity. Trichotillomania (hair pulling disorder",
            "probability": 0.00041706924958443716,
            "start_logit": -0.7171354293823242,
            "end_logit": 6.1127471923828125
        },
        {
            "text": "Hair Pulling Disorder):",
            "probability": 0.00031869499541432346,
            "start_logit": 6.038161277770996,
            "end_logit": -0.9115672707557678
        },
        {
            "text": "pulling disorder",
            "probability": 0.0003040193156377066,
            "start_logit": -1.0332964658737183,
            "end_logit": 6.1127471923828125
        }
    ],
    "58a9c152396a458e50000001_000": [
        {
            "text": "breast",
            "probability": 0.4009964495600544,
            "start_logit": -2.0037307739257812,
            "end_logit": -2.2365705966949463
        },
        {
            "text": "breast milk",
            "probability": 0.17684764842635203,
            "start_logit": -1.5833102464675903,
            "end_logit": -3.4756550788879395
        },
        {
            "text": "LOS. CONCLUSIONS: The concentrations of lactoferrin and defensins in preterm breast",
            "probability": 0.08844500333174583,
            "start_logit": -3.5153024196624756,
            "end_logit": -2.2365705966949463
        },
        {
            "text": "breast milk consumed by preterm infants",
            "probability": 0.03944941449854422,
            "start_logit": -1.5833102464675903,
            "end_logit": -4.975924491882324
        },
        {
            "text": "breast milk consumed by preterm infants at risk of late-onset neonatal sepsis.",
            "probability": 0.03853878558865071,
            "start_logit": -1.5833102464675903,
            "end_logit": -4.999278545379639
        },
        {
            "text": "preterm breast",
            "probability": 0.03701699240357717,
            "start_logit": -4.386306285858154,
            "end_logit": -2.2365705966949463
        },
        {
            "text": "lactoferrin and defensins in preterm breast",
            "probability": 0.03202108920603624,
            "start_logit": -4.5312886238098145,
            "end_logit": -2.2365705966949463
        },
        {
            "text": "human breast",
            "probability": 0.030959981443626494,
            "start_logit": -3.5828516483306885,
            "end_logit": -3.2187068462371826
        },
        {
            "text": "breast milk consumed by preterm infants,",
            "probability": 0.025145112824733078,
            "start_logit": -2.189833402633667,
            "end_logit": -4.819756984710693
        },
        {
            "text": "human breast milk",
            "probability": 0.023944705069095053,
            "start_logit": -3.5828516483306885,
            "end_logit": -3.4756550788879395
        },
        {
            "text": "preterm infants",
            "probability": 0.01794001195620841,
            "start_logit": -2.8241872787475586,
            "end_logit": -4.523033142089844
        },
        {
            "text": "alpha-defensin 5 were measured by enzyme-linked immunosorbent assay. The antimicrobial activity of breast",
            "probability": 0.0171989889604489,
            "start_logit": -4.345316410064697,
            "end_logit": -3.0440869331359863
        },
        {
            "text": "defensins in preterm breast",
            "probability": 0.012670016226746504,
            "start_logit": -5.458445072174072,
            "end_logit": -2.2365705966949463
        },
        {
            "text": "breast milk consumed by preterm",
            "probability": 0.011347229487649694,
            "start_logit": -1.5833102464675903,
            "end_logit": -6.221970081329346
        },
        {
            "text": "mothers of preterm infants",
            "probability": 0.008778327113937997,
            "start_logit": -3.5389349460601807,
            "end_logit": -4.523033142089844
        },
        {
            "text": "breast milk consumed by preterm infants at risk of late-onset neonatal sepsis",
            "probability": 0.008495615020110876,
            "start_logit": -1.5833102464675903,
            "end_logit": -6.5113935470581055
        },
        {
            "text": "5 were measured by enzyme-linked immunosorbent assay. The antimicrobial activity of breast",
            "probability": 0.008352341886683842,
            "start_logit": -5.067625045776367,
            "end_logit": -3.0440869331359863
        },
        {
            "text": "Staphylococcus",
            "probability": 0.007410015071755727,
            "start_logit": -1.9374618530273438,
            "end_logit": -6.293959617614746
        },
        {
            "text": "milk from mothers of preterm infants",
            "probability": 0.0073435483947634946,
            "start_logit": -3.7173986434936523,
            "end_logit": -4.523033142089844
        },
        {
            "text": "breast milk. Levels of AMPs were similar in the breast milk fed to infants with and without LOS",
            "probability": 0.007098723529279549,
            "start_logit": -3.439114809036255,
            "end_logit": -4.835224151611328
        }
    ],
    "58a9c152396a458e50000001_001": [
        {
            "text": "Human",
            "probability": 0.5313363432636677,
            "start_logit": 0.22186464071273804,
            "end_logit": 0.6661515235900879
        },
        {
            "text": "human alpha defensin. Human",
            "probability": 0.31929796184745857,
            "start_logit": -0.2874058783054352,
            "end_logit": 0.6661515235900879
        },
        {
            "text": "human",
            "probability": 0.09384704353117139,
            "start_logit": -0.2874058783054352,
            "end_logit": -0.5583069324493408
        },
        {
            "text": "small intestine",
            "probability": 0.015917535859719254,
            "start_logit": -1.141365647315979,
            "end_logit": -1.478592038154602
        },
        {
            "text": "mammalian",
            "probability": 0.009828856186519058,
            "start_logit": -1.677619457244873,
            "end_logit": -1.4244370460510254
        },
        {
            "text": "the small intestine",
            "probability": 0.0036076454385222723,
            "start_logit": -2.6257317066192627,
            "end_logit": -1.478592038154602
        },
        {
            "text": ". Human",
            "probability": 0.003431168926799395,
            "start_logit": -4.820629596710205,
            "end_logit": 0.6661515235900879
        },
        {
            "text": "alpha defensin. Human",
            "probability": 0.0033064924482240064,
            "start_logit": -4.857642650604248,
            "end_logit": 0.6661515235900879
        },
        {
            "text": "human alpha defensin.",
            "probability": 0.0030571639123306497,
            "start_logit": -0.2874058783054352,
            "end_logit": -3.98248553276062
        },
        {
            "text": "reduction of human alpha defensin. Human",
            "probability": 0.0029698710111998525,
            "start_logit": -4.965012073516846,
            "end_logit": 0.6661515235900879
        },
        {
            "text": "small intestine,",
            "probability": 0.002611080872868306,
            "start_logit": -1.141365647315979,
            "end_logit": -3.2862491607666016
        },
        {
            "text": "Human alpha defensins",
            "probability": 0.0022276793266831118,
            "start_logit": 0.22186464071273804,
            "end_logit": -4.80828332901001
        },
        {
            "text": "Human alpha",
            "probability": 0.0014719701875128826,
            "start_logit": 0.22186464071273804,
            "end_logit": -5.222641944885254
        },
        {
            "text": "human alpha defensin. Human alpha defensins",
            "probability": 0.0013386877778595087,
            "start_logit": -0.2874058783054352,
            "end_logit": -4.80828332901001
        },
        {
            "text": "crypt of the small intestine",
            "probability": 0.0012794794380507366,
            "start_logit": -3.6623337268829346,
            "end_logit": -1.478592038154602
        },
        {
            "text": "Human alpha defensins are a class of antimicrobial peptides with additional antiviral activity.",
            "probability": 0.0010048926775571593,
            "start_logit": 0.22186464071273804,
            "end_logit": -5.604362964630127
        },
        {
            "text": "human alpha defensin. Human alpha",
            "probability": 0.000884556621679944,
            "start_logit": -0.2874058783054352,
            "end_logit": -5.222641944885254
        },
        {
            "text": "Human alpha defensins are",
            "probability": 0.0008735368620780237,
            "start_logit": 0.22186464071273804,
            "end_logit": -5.744448661804199
        },
        {
            "text": "reduction of human",
            "probability": 0.0008728950615826017,
            "start_logit": -4.965012073516846,
            "end_logit": -0.5583069324493408
        },
        {
            "text": "the crypt of the small intestine",
            "probability": 0.0008351387485155312,
            "start_logit": -4.088944435119629,
            "end_logit": -1.478592038154602
        }
    ],
    "58a9c152396a458e50000001_002": [
        {
            "text": "epithelial cells",
            "probability": 0.669099149058209,
            "start_logit": 6.642659664154053,
            "end_logit": 4.923739433288574
        },
        {
            "text": "epithelial cells in the genitourinary tract",
            "probability": 0.17981847322447464,
            "start_logit": 6.642659664154053,
            "end_logit": 3.609755039215088
        },
        {
            "text": "epithelial",
            "probability": 0.1385457596513346,
            "start_logit": 6.642659664154053,
            "end_logit": 3.3490078449249268
        },
        {
            "text": "epithelial cells in the genitourinary tract.",
            "probability": 0.005816094109343322,
            "start_logit": 6.642659664154053,
            "end_logit": 0.17843610048294067
        },
        {
            "text": "epithelial cells in the genitourinary",
            "probability": 0.002835001528567644,
            "start_logit": 6.642659664154053,
            "end_logit": -0.5401503443717957
        },
        {
            "text": "e",
            "probability": 0.0007922720962846166,
            "start_logit": 6.642659664154053,
            "end_logit": -1.8150432109832764
        },
        {
            "text": "cells",
            "probability": 0.0007150091528029484,
            "start_logit": -0.19873252511024475,
            "end_logit": 4.923739433288574
        },
        {
            "text": "\u03b1-defensin 5 (HD5) is an innate immune effector peptide secreted by epithelial cells",
            "probability": 0.0004306578319839469,
            "start_logit": -0.7057139873504639,
            "end_logit": 4.923739433288574
        },
        {
            "text": "Human \u03b1-defensin 5 (HD5) is an innate immune effector peptide secreted by epithelial cells",
            "probability": 0.00033036229574447487,
            "start_logit": -0.9708379507064819,
            "end_logit": 4.923739433288574
        },
        {
            "text": "genitourinary tract",
            "probability": 0.0002709699748247643,
            "start_logit": 0.1449645459651947,
            "end_logit": 3.609755039215088
        },
        {
            "text": "epithelial cells in",
            "probability": 0.00024302437421905667,
            "start_logit": 6.642659664154053,
            "end_logit": -2.99678635597229
        },
        {
            "text": "cells in the genitourinary tract",
            "probability": 0.00019215665477907527,
            "start_logit": -0.19873252511024475,
            "end_logit": 3.609755039215088
        },
        {
            "text": "by epithelial cells",
            "probability": 0.00017174655657075912,
            "start_logit": -1.6250079870224,
            "end_logit": 4.923739433288574
        },
        {
            "text": "secreted by epithelial cells",
            "probability": 0.0001666124783877998,
            "start_logit": -1.6553572416305542,
            "end_logit": 4.923739433288574
        },
        {
            "text": "epithelial cells in the g",
            "probability": 0.00011361605980557472,
            "start_logit": 6.642659664154053,
            "end_logit": -3.7571232318878174
        },
        {
            "text": "defensin 5 (HD5) is an innate immune effector peptide secreted by epithelial cells",
            "probability": 9.864488048081284e-05,
            "start_logit": -2.179501533508301,
            "end_logit": 4.923739433288574
        },
        {
            "text": "in the genitourinary tract",
            "probability": 9.335310934509762e-05,
            "start_logit": -0.920654296875,
            "end_logit": 3.609755039215088
        },
        {
            "text": "epithel",
            "probability": 9.0101521425757e-05,
            "start_logit": 6.642659664154053,
            "end_logit": -3.98901104927063
        },
        {
            "text": "\u03b1-defensin 5 (HD5) is an innate immune effector peptide secreted by epithelial",
            "probability": 8.917335579636502e-05,
            "start_logit": -0.7057139873504639,
            "end_logit": 3.3490078449249268
        },
        {
            "text": "epithelial cells in the",
            "probability": 8.782208561958602e-05,
            "start_logit": 6.642659664154053,
            "end_logit": -4.01463508605957
        }
    ],
    "58a9c152396a458e50000001_003": [
        {
            "text": "Human",
            "probability": 0.6140353814303617,
            "start_logit": 2.179555654525757,
            "end_logit": 2.4512646198272705
        },
        {
            "text": "human defensin 5. Human",
            "probability": 0.18616694470293968,
            "start_logit": 0.9861469268798828,
            "end_logit": 2.4512646198272705
        },
        {
            "text": "Escherichia coli by the antimicrobial peptide human defensin 5. Human",
            "probability": 0.1491579304114892,
            "start_logit": 0.7645087838172913,
            "end_logit": 2.4512646198272705
        },
        {
            "text": "human",
            "probability": 0.01825684701998765,
            "start_logit": 0.9861469268798828,
            "end_logit": 0.12916098535060883
        },
        {
            "text": "Escherichia coli by the antimicrobial peptide human",
            "probability": 0.014627481380681012,
            "start_logit": 0.7645087838172913,
            "end_logit": 0.12916098535060883
        },
        {
            "text": "Escherichia coli",
            "probability": 0.005756427860935826,
            "start_logit": 0.7645087838172913,
            "end_logit": -0.8034239411354065
        },
        {
            "text": "Human \u03b1-defensin 5",
            "probability": 0.0017223551222868055,
            "start_logit": 2.179555654525757,
            "end_logit": -3.425095319747925
        },
        {
            "text": ". Human",
            "probability": 0.0015018139723862896,
            "start_logit": -3.8338232040405273,
            "end_logit": 2.4512646198272705
        },
        {
            "text": "defensin 5. Human",
            "probability": 0.0013875643680810801,
            "start_logit": -3.912946939468384,
            "end_logit": 2.4512646198272705
        },
        {
            "text": "5. Human",
            "probability": 0.0013176493648744483,
            "start_logit": -3.9646475315093994,
            "end_logit": 2.4512646198272705
        },
        {
            "text": "Human \u03b1-defensin 5 (HD5) is a 32-residue cysteine-rich host",
            "probability": 0.0013059681843548296,
            "start_logit": 2.179555654525757,
            "end_logit": -3.70184326171875
        },
        {
            "text": "Human \u03b1",
            "probability": 0.000996934852147429,
            "start_logit": 2.179555654525757,
            "end_logit": -3.971857786178589
        },
        {
            "text": "attack of Escherichia coli by the antimicrobial peptide human defensin 5. Human",
            "probability": 0.0005879856093661464,
            "start_logit": -4.771549701690674,
            "end_logit": 2.4512646198272705
        },
        {
            "text": "human gut",
            "probability": 0.0005349180237684068,
            "start_logit": -0.4074201285839081,
            "end_logit": -2.0074539184570312
        },
        {
            "text": "human defensin 5. Human \u03b1-defensin 5",
            "probability": 0.000522193998109142,
            "start_logit": 0.9861469268798828,
            "end_logit": -3.425095319747925
        },
        {
            "text": "Human \u03b1-defensin 5 (HD5",
            "probability": 0.0004794115557881485,
            "start_logit": 2.179555654525757,
            "end_logit": -4.703983783721924
        },
        {
            "text": "E. coli",
            "probability": 0.00046578154599477133,
            "start_logit": -1.4086227416992188,
            "end_logit": -1.1446480751037598
        },
        {
            "text": "Escherichia coli by the antimicrobial peptide human defensin 5. Human \u03b1-defensin 5",
            "probability": 0.0004183845642175961,
            "start_logit": 0.7645087838172913,
            "end_logit": -3.425095319747925
        },
        {
            "text": "human defensin 5. Human \u03b1-defensin 5 (HD5) is a 32-residue cysteine-rich host",
            "probability": 0.0003959512987577858,
            "start_logit": 0.9861469268798828,
            "end_logit": -3.70184326171875
        },
        {
            "text": "human defensin 5.",
            "probability": 0.0003620747334719531,
            "start_logit": 0.9861469268798828,
            "end_logit": -3.7912838459014893
        }
    ],
    "58a9c152396a458e50000001_004": [
        {
            "text": "C. difficile",
            "probability": 0.3164856805519631,
            "start_logit": -0.5223727822303772,
            "end_logit": -0.7311223745346069
        },
        {
            "text": "Human",
            "probability": 0.2151463237440424,
            "start_logit": -0.7478674650192261,
            "end_logit": -0.8915873169898987
        },
        {
            "text": "human",
            "probability": 0.18157157637249707,
            "start_logit": -0.8307691812515259,
            "end_logit": -0.9783540368080139
        },
        {
            "text": "C. difficile bacilli",
            "probability": 0.09129856723915009,
            "start_logit": -0.7599300146102905,
            "end_logit": -1.7367080450057983
        },
        {
            "text": "Human \u03b1-defensin 5 (HD5), the most abundant enteric",
            "probability": 0.0255928251850918,
            "start_logit": -0.7478674650192261,
            "end_logit": -3.0205936431884766
        },
        {
            "text": "intestinal physiological range produced massive C. difficile",
            "probability": 0.018438433554728715,
            "start_logit": -3.2077701091766357,
            "end_logit": -0.8885657787322998
        },
        {
            "text": "C. difficile bacilli, compared to commensals like Escherichia coli",
            "probability": 0.016735827219667977,
            "start_logit": -0.5223727822303772,
            "end_logit": -3.6708486080169678
        },
        {
            "text": "bacilli",
            "probability": 0.016418720695940286,
            "start_logit": -2.4756429195404053,
            "end_logit": -1.7367080450057983
        },
        {
            "text": "Human \u03b1-defensin 5 (HD5),",
            "probability": 0.013933393966315906,
            "start_logit": -0.7478674650192261,
            "end_logit": -3.628617286682129
        },
        {
            "text": "human \u03b1-defensin 5 in the fight against hypervirulent Clostridium difficile",
            "probability": 0.013280045311078587,
            "start_logit": -0.8307691812515259,
            "end_logit": -3.5937414169311523
        },
        {
            "text": "C. difficile bacilli,",
            "probability": 0.012023281908638854,
            "start_logit": -0.5223727822303772,
            "end_logit": -4.001555442810059
        },
        {
            "text": "Human \u03b1-defensin 5",
            "probability": 0.011621968733182836,
            "start_logit": -0.7478674650192261,
            "end_logit": -3.8100085258483887
        },
        {
            "text": "CDI is precipitated by antibiotic treatment that destroys the equilibrium of the gut microbiota. Human",
            "probability": 0.010967171851488766,
            "start_logit": -3.7242794036865234,
            "end_logit": -0.8915873169898987
        },
        {
            "text": "Clostridium difficile",
            "probability": 0.0106360731132455,
            "start_logit": -1.0527803897857666,
            "end_logit": -3.5937414169311523
        },
        {
            "text": "1 and 5 against a panel of C. difficile",
            "probability": 0.009922930541474919,
            "start_logit": -3.670599937438965,
            "end_logit": -1.0453249216079712
        },
        {
            "text": "enteric",
            "probability": 0.007999770945464323,
            "start_logit": -1.9107666015625,
            "end_logit": -3.0205936431884766
        },
        {
            "text": "mucosa of the small intestine, could indeed control the very early steps of CDI by killing C. difficile",
            "probability": 0.007309496099041148,
            "start_logit": -4.291252613067627,
            "end_logit": -0.7303462028503418
        },
        {
            "text": "Clostridium difficile strains. Clostridium difficile",
            "probability": 0.007117970301756971,
            "start_logit": -1.0527803897857666,
            "end_logit": -3.9953701496124268
        },
        {
            "text": "small intestine, could indeed control the very early steps of CDI by killing C. difficile",
            "probability": 0.0069335521137528725,
            "start_logit": -4.344054698944092,
            "end_logit": -0.7303462028503418
        },
        {
            "text": "faecalis",
            "probability": 0.006566390551478002,
            "start_logit": -3.8614180088043213,
            "end_logit": -1.2673908472061157
        }
    ],
    "58a9c152396a458e50000001_005": [
        {
            "text": "Human",
            "probability": 0.6371751705911219,
            "start_logit": 1.4608691930770874,
            "end_logit": 2.0803654193878174
        },
        {
            "text": "human",
            "probability": 0.3059346494159125,
            "start_logit": 1.286124587059021,
            "end_logit": 1.5214369297027588
        },
        {
            "text": "Escherichia coli",
            "probability": 0.03989122576419078,
            "start_logit": 0.8246816992759705,
            "end_logit": -0.054335303604602814
        },
        {
            "text": "Human \u03b1-defensin 5",
            "probability": 0.002767406195254893,
            "start_logit": 1.4608691930770874,
            "end_logit": -3.3587687015533447
        },
        {
            "text": ". Human",
            "probability": 0.002303992511401686,
            "start_logit": -4.161531925201416,
            "end_logit": 2.0803654193878174
        },
        {
            "text": "5 and its linear analogs: N-terminal fatty acylation results in enhanced antimicrobial activity of the linear analogs. Human",
            "probability": 0.0014218866684430715,
            "start_logit": -4.644190788269043,
            "end_logit": 2.0803654193878174
        },
        {
            "text": "Human \u03b1-defensin 5 (HD5) exhibits broad spectrum antimicrobial activity and plays an important role in mucosal",
            "probability": 0.0012225128234931752,
            "start_logit": 1.4608691930770874,
            "end_logit": -4.1757707595825195
        },
        {
            "text": "Human \u03b1",
            "probability": 0.0010944178811567514,
            "start_logit": 1.4608691930770874,
            "end_logit": -4.28645658493042
        },
        {
            "text": "Human \u03b1-defensin 5 (HD5)",
            "probability": 0.0010343115123706513,
            "start_logit": 1.4608691930770874,
            "end_logit": -4.34294319152832
        },
        {
            "text": "Escherichia",
            "probability": 0.0009284456116122514,
            "start_logit": 0.8246816992759705,
            "end_logit": -3.814735174179077
        },
        {
            "text": "Antimicrobial activity of human",
            "probability": 0.0009051081866942912,
            "start_logit": -4.536947727203369,
            "end_logit": 1.5214369297027588
        },
        {
            "text": "Human \u03b1-defensin 5 (HD5",
            "probability": 0.0007853423421762411,
            "start_logit": 1.4608691930770874,
            "end_logit": -4.618314743041992
        },
        {
            "text": "human \u03b1-defensin 5",
            "probability": 0.0007143950354240837,
            "start_logit": 1.286124587059021,
            "end_logit": -4.5382537841796875
        },
        {
            "text": "activity of human",
            "probability": 0.0007082303866855514,
            "start_logit": -4.782232761383057,
            "end_logit": 1.5214369297027588
        },
        {
            "text": "Human \u03b1-defensin",
            "probability": 0.0005885033987429782,
            "start_logit": 1.4608691930770874,
            "end_logit": -4.906851768493652
        },
        {
            "text": "Human \u03b1-defensin 5 (HD5) exhibits broad spectrum antimicrobial activity and plays an important role in mucosal immunity",
            "probability": 0.0005652262344177636,
            "start_logit": 1.4608691930770874,
            "end_logit": -4.947208404541016
        },
        {
            "text": "Human \u03b1-defensin 5 (HD5) exhibits broad spectrum antimicrobial activity and plays an important role in mucosa",
            "probability": 0.000555399942897237,
            "start_logit": 1.4608691930770874,
            "end_logit": -4.964745998382568
        },
        {
            "text": "Human \u03b1-defensin 5 (HD5) exhibits",
            "probability": 0.0004896986054071995,
            "start_logit": 1.4608691930770874,
            "end_logit": -5.090644359588623
        },
        {
            "text": "bacteria",
            "probability": 0.00047282244144938656,
            "start_logit": -1.4776638746261597,
            "end_logit": -2.1871814727783203
        },
        {
            "text": "Human \u03b1-defensin 5 (HD5) exhibits broad spectrum antimicrobial activity",
            "probability": 0.0004412544511476184,
            "start_logit": 1.4608691930770874,
            "end_logit": -5.194812774658203
        }
    ],
    "58a9c152396a458e50000001_006": [
        {
            "text": "Paneth cells",
            "probability": 0.951374742796053,
            "start_logit": 6.778486251831055,
            "end_logit": 6.030389308929443
        },
        {
            "text": "Paneth",
            "probability": 0.019994732835801537,
            "start_logit": 6.778486251831055,
            "end_logit": 2.16795015335083
        },
        {
            "text": "Paneth cells in the intestine",
            "probability": 0.012913962675588945,
            "start_logit": 6.778486251831055,
            "end_logit": 1.730790376663208
        },
        {
            "text": "Paneth cells in the intestine,",
            "probability": 0.006094543936273968,
            "start_logit": 6.778486251831055,
            "end_logit": 0.9798752069473267
        },
        {
            "text": "Paneth cell",
            "probability": 0.00410870403710658,
            "start_logit": 4.306854724884033,
            "end_logit": 3.057220458984375
        },
        {
            "text": "enteric \u03b1-defensins (HD5 and HD6), major antimicrobial peptides produced by Paneth cells",
            "probability": 0.0011638702233201413,
            "start_logit": 0.0723290666937828,
            "end_logit": 6.030389308929443
        },
        {
            "text": "Human enteric \u03b1-defensins (HD5 and HD6), major antimicrobial peptides produced by Paneth cells",
            "probability": 0.0011247010992554958,
            "start_logit": 0.03809552639722824,
            "end_logit": 6.030389308929443
        },
        {
            "text": "\u03b1-defensins (HD5 and HD6), major antimicrobial peptides produced by Paneth cells",
            "probability": 0.0006207429910686385,
            "start_logit": -0.5562599301338196,
            "end_logit": 6.030389308929443
        },
        {
            "text": "Paneth cells in",
            "probability": 0.0006136849490304455,
            "start_logit": 6.778486251831055,
            "end_logit": -1.3157923221588135
        },
        {
            "text": "(HD5 and HD6), major antimicrobial peptides produced by Paneth cells",
            "probability": 0.0005433121427382557,
            "start_logit": -0.6894930601119995,
            "end_logit": 6.030389308929443
        },
        {
            "text": "Pan",
            "probability": 0.00024484726306680675,
            "start_logit": 6.778486251831055,
            "end_logit": -2.2346394062042236
        },
        {
            "text": "by Paneth cells",
            "probability": 0.00021767451567384234,
            "start_logit": -1.6041761636734009,
            "end_logit": 6.030389308929443
        },
        {
            "text": "HD5 and HD6), major antimicrobial peptides produced by Paneth cells",
            "probability": 0.00018506709459729345,
            "start_logit": -1.7664586305618286,
            "end_logit": 6.030389308929443
        },
        {
            "text": "produced by Paneth cells",
            "probability": 0.0001632318560417449,
            "start_logit": -1.892005443572998,
            "end_logit": 6.030389308929443
        },
        {
            "text": "cells",
            "probability": 0.00015074445732484663,
            "start_logit": -1.9715909957885742,
            "end_logit": 6.030389308929443
        },
        {
            "text": "Paneth cells in the",
            "probability": 0.00013557116617105542,
            "start_logit": 6.778486251831055,
            "end_logit": -2.825777292251587
        },
        {
            "text": "Paneth cells in the intestine, play important roles in intestinal",
            "probability": 0.00012256182718047102,
            "start_logit": 6.778486251831055,
            "end_logit": -2.9266583919525146
        },
        {
            "text": ". Human enteric \u03b1-defensins (HD5 and HD6), major antimicrobial peptides produced by Paneth cells",
            "probability": 8.595033364460236e-05,
            "start_logit": -2.53340744972229,
            "end_logit": 6.030389308929443
        },
        {
            "text": "major antimicrobial peptides produced by Paneth cells",
            "probability": 7.198631810356364e-05,
            "start_logit": -2.7107009887695312,
            "end_logit": 6.030389308929443
        },
        {
            "text": "Paneth cell lineage. Human enteric",
            "probability": 6.936748195876888e-05,
            "start_logit": 4.306854724884033,
            "end_logit": -1.0242242813110352
        }
    ],
    "5891c90949702f2e01000001_000": [
        {
            "text": "INCA",
            "probability": 0.6113840396130528,
            "start_logit": 5.3273024559021,
            "end_logit": 4.464134693145752
        },
        {
            "text": "INteractive Codon usage Analysis (INCA",
            "probability": 0.1604001835197795,
            "start_logit": 4.585039138793945,
            "end_logit": 3.86834454536438
        },
        {
            "text": "INteractive Codon usage Analysis (INCA)",
            "probability": 0.0679679759557512,
            "start_logit": 4.585039138793945,
            "end_logit": 3.009709358215332
        },
        {
            "text": "INteractive Codon usage Analysis",
            "probability": 0.0651536048635058,
            "start_logit": 4.585039138793945,
            "end_logit": 2.9674203395843506
        },
        {
            "text": "INCA)",
            "probability": 0.06109579508305853,
            "start_logit": 4.478445529937744,
            "end_logit": 3.009709358215332
        },
        {
            "text": "(INCA",
            "probability": 0.0064799341790179035,
            "start_logit": 1.376077651977539,
            "end_logit": 3.86834454536438
        },
        {
            "text": "UNLABELLED: INteractive Codon usage Analysis (INCA",
            "probability": 0.004924872746523219,
            "start_logit": 1.101665735244751,
            "end_logit": 3.86834454536438
        },
        {
            "text": "(INCA)",
            "probability": 0.002745807397533486,
            "start_logit": 1.376077651977539,
            "end_logit": 3.009709358215332
        },
        {
            "text": "INCA: synonymous codon usage analysis and clustering by means of self-organizing map.",
            "probability": 0.0025767689178242464,
            "start_logit": 5.3273024559021,
            "end_logit": -1.0050543546676636
        },
        {
            "text": "INCA: synonymous codon usage analysis and clustering by means of self-organizing map. UNLABELLED",
            "probability": 0.002360723951703561,
            "start_logit": 5.3273024559021,
            "end_logit": -1.0926222801208496
        },
        {
            "text": "INCA:",
            "probability": 0.002184248880795213,
            "start_logit": 5.3273024559021,
            "end_logit": -1.170318603515625
        },
        {
            "text": "UNLABELLED: INteractive Codon usage Analysis (INCA)",
            "probability": 0.0020868656448859205,
            "start_logit": 1.101665735244751,
            "end_logit": 3.009709358215332
        },
        {
            "text": "UNLABELLED: INteractive Codon usage Analysis",
            "probability": 0.002000454150917193,
            "start_logit": 1.101665735244751,
            "end_logit": 2.9674203395843506
        },
        {
            "text": "INCA: synonymous codon usage analysis and clustering by means of self-organizing map. UNLABELLED: INteractive",
            "probability": 0.0015181086991832027,
            "start_logit": 5.3273024559021,
            "end_logit": -1.5341253280639648
        },
        {
            "text": "INteractive Codon usage",
            "probability": 0.0014923547379261583,
            "start_logit": 4.585039138793945,
            "end_logit": -0.8089720606803894
        },
        {
            "text": "self-organizing map. UNLABELLED: INteractive Codon usage Analysis (INCA",
            "probability": 0.0013981701584503022,
            "start_logit": -0.15746834874153137,
            "end_logit": 3.86834454536438
        },
        {
            "text": "INCA: synonymous codon usage analysis and clustering by means of self-organizing map",
            "probability": 0.0012659325469254665,
            "start_logit": 5.3273024559021,
            "end_logit": -1.715781569480896
        },
        {
            "text": "IN",
            "probability": 0.0011571576799153094,
            "start_logit": 5.3273024559021,
            "end_logit": -1.8056238889694214
        },
        {
            "text": "INCA: synonymous codon usage analysis",
            "probability": 0.0009308316024202008,
            "start_logit": 5.3273024559021,
            "end_logit": -2.0232675075531006
        },
        {
            "text": "inca",
            "probability": 0.0008761696708309712,
            "start_logit": 1.5947026014328003,
            "end_logit": 1.6488137245178223
        }
    ],
    "58a2ced760087bc10a000004_000": [
        {
            "text": "5p15.33",
            "probability": 0.9633848577834495,
            "start_logit": 6.377092361450195,
            "end_logit": 5.926222324371338
        },
        {
            "text": "5p15.33;",
            "probability": 0.014851854548581683,
            "start_logit": 6.377092361450195,
            "end_logit": 1.7538940906524658
        },
        {
            "text": "6A3 (SLC6A3; dopamine transporter 1; DAT1) localizes to 5p15.33",
            "probability": 0.005810697599779209,
            "start_logit": 1.2663400173187256,
            "end_logit": 5.926222324371338
        },
        {
            "text": "SLC6A3; dopamine transporter 1; DAT1) localizes to 5p15.33",
            "probability": 0.003522392786690803,
            "start_logit": 0.7657799124717712,
            "end_logit": 5.926222324371338
        },
        {
            "text": "5p15",
            "probability": 0.0025992916924048167,
            "start_logit": 6.377092361450195,
            "end_logit": 0.011008329689502716
        },
        {
            "text": "(SLC6A3; dopamine transporter 1; DAT1) localizes to 5p15.33",
            "probability": 0.0025092544027043432,
            "start_logit": 0.4266250431537628,
            "end_logit": 5.926222324371338
        },
        {
            "text": "dopamine transporter 1; DAT1) localizes to 5p15.33",
            "probability": 0.001981622875245848,
            "start_logit": 0.19055552780628204,
            "end_logit": 5.926222324371338
        },
        {
            "text": "DAT1) localizes to 5p15.33",
            "probability": 0.001665491742264827,
            "start_logit": 0.016759805381298065,
            "end_logit": 5.926222324371338
        },
        {
            "text": "5",
            "probability": 0.0008313793905973798,
            "start_logit": 6.377092361450195,
            "end_logit": -1.1288996934890747
        },
        {
            "text": "33",
            "probability": 0.0007211391565366824,
            "start_logit": -0.8202837705612183,
            "end_logit": 5.926222324371338
        },
        {
            "text": "to 5p15.33",
            "probability": 0.0004659158600575285,
            "start_logit": -1.257110834121704,
            "end_logit": 5.926222324371338
        },
        {
            "text": "5p15.",
            "probability": 0.00037325460020486454,
            "start_logit": 6.377092361450195,
            "end_logit": -1.929725170135498
        },
        {
            "text": "15.33",
            "probability": 0.0002069708461750813,
            "start_logit": -2.068537950515747,
            "end_logit": 5.926222324371338
        },
        {
            "text": "p15.33",
            "probability": 0.00019412998965143315,
            "start_logit": -2.1325879096984863,
            "end_logit": 5.926222324371338
        },
        {
            "text": "; DAT1) localizes to 5p15.33",
            "probability": 0.0001911973974125702,
            "start_logit": -2.1478095054626465,
            "end_logit": 5.926222324371338
        },
        {
            "text": "6A3; dopamine transporter 1; DAT1) localizes to 5p15.33",
            "probability": 0.0001825536104902138,
            "start_logit": -2.1940720081329346,
            "end_logit": 5.926222324371338
        },
        {
            "text": "; dopamine transporter 1; DAT1) localizes to 5p15.33",
            "probability": 0.00015937352754226235,
            "start_logit": -2.3298652172088623,
            "end_logit": 5.926222324371338
        },
        {
            "text": ".33",
            "probability": 0.00013758800043488662,
            "start_logit": -2.4768521785736084,
            "end_logit": 5.926222324371338
        },
        {
            "text": "chromosome 5p13",
            "probability": 0.00012145458420068694,
            "start_logit": 1.5831859111785889,
            "end_logit": 1.741460919380188
        },
        {
            "text": "6A3 (SLC6A3; dopamine transporter 1; DAT1) localizes to 5p15.33;",
            "probability": 8.957960557556532e-05,
            "start_logit": 1.2663400173187256,
            "end_logit": 1.7538940906524658
        }
    ],
    "58a2ced760087bc10a000004_001": [
        {
            "text": "5p15.32",
            "probability": 0.5079147761529175,
            "start_logit": 5.612752914428711,
            "end_logit": 6.04156494140625
        },
        {
            "text": "chromosome 5p15.32",
            "probability": 0.45211876485696295,
            "start_logit": 5.496384143829346,
            "end_logit": 6.04156494140625
        },
        {
            "text": "5p15.32.",
            "probability": 0.013471235957670183,
            "start_logit": 5.612752914428711,
            "end_logit": 2.4118080139160156
        },
        {
            "text": "chromosome 5p15.32.",
            "probability": 0.011991378964026947,
            "start_logit": 5.496384143829346,
            "end_logit": 2.4118080139160156
        },
        {
            "text": "5p15",
            "probability": 0.004447577871817218,
            "start_logit": 5.612752914428711,
            "end_logit": 1.303610920906067
        },
        {
            "text": "chromosome 5p15",
            "probability": 0.00395899766736804,
            "start_logit": 5.496384143829346,
            "end_logit": 1.303610920906067
        },
        {
            "text": "on chromosome 5p15.32",
            "probability": 0.0012507978488834454,
            "start_logit": -0.39377912878990173,
            "end_logit": 6.04156494140625
        },
        {
            "text": "p15.32",
            "probability": 0.001103543701689462,
            "start_logit": -0.519034206867218,
            "end_logit": 6.04156494140625
        },
        {
            "text": "5",
            "probability": 0.0009302362758336504,
            "start_logit": 5.612752914428711,
            "end_logit": -0.26106539368629456
        },
        {
            "text": "chromosome 5",
            "probability": 0.0008280469397653993,
            "start_logit": 5.496384143829346,
            "end_logit": -0.26106539368629456
        },
        {
            "text": "32",
            "probability": 0.0007093670197764977,
            "start_logit": -0.9609429836273193,
            "end_logit": 6.04156494140625
        },
        {
            "text": "DAT1 consists of 15 exons spanning 60 kb on chromosome 5p15.32",
            "probability": 0.00032766945303709584,
            "start_logit": -1.7333106994628906,
            "end_logit": 6.04156494140625
        },
        {
            "text": "5p15.",
            "probability": 0.00019124769094480053,
            "start_logit": 5.612752914428711,
            "end_logit": -1.8429346084594727
        },
        {
            "text": "chromosome 5p15.",
            "probability": 0.00017023853975391522,
            "start_logit": 5.496384143829346,
            "end_logit": -1.8429346084594727
        },
        {
            "text": "15.32",
            "probability": 0.00015997899426727986,
            "start_logit": -2.4502735137939453,
            "end_logit": 6.04156494140625
        },
        {
            "text": "60 kb on chromosome 5p15.32",
            "probability": 0.00013986043241925696,
            "start_logit": -2.5846710205078125,
            "end_logit": 6.04156494140625
        },
        {
            "text": ".32",
            "probability": 0.00013736705418138554,
            "start_logit": -2.6026594638824463,
            "end_logit": 6.04156494140625
        },
        {
            "text": "chromosome",
            "probability": 8.647124755583368e-05,
            "start_logit": 5.496384143829346,
            "end_logit": -2.5203232765197754
        },
        {
            "text": "on chromosome 5p15.32.",
            "probability": 3.317444923591322e-05,
            "start_logit": -0.39377912878990173,
            "end_logit": 2.4118080139160156
        },
        {
            "text": "p15.32.",
            "probability": 2.926888189325647e-05,
            "start_logit": -0.519034206867218,
            "end_logit": 2.4118080139160156
        }
    ],
    "58a2ced760087bc10a000004_002": [
        {
            "text": "chromosome 5p15.3",
            "probability": 0.504837728957171,
            "start_logit": 4.762047290802002,
            "end_logit": 4.7882208824157715
        },
        {
            "text": "5p15.3",
            "probability": 0.4203494043557218,
            "start_logit": 4.578896522521973,
            "end_logit": 4.7882208824157715
        },
        {
            "text": "chromosome 5p15.3.",
            "probability": 0.02975858052715167,
            "start_logit": 4.762047290802002,
            "end_logit": 1.9571013450622559
        },
        {
            "text": "5p15.3.",
            "probability": 0.02477826216534861,
            "start_logit": 4.578896522521973,
            "end_logit": 1.9571013450622559
        },
        {
            "text": "chromosome 5p15",
            "probability": 0.005694939667527717,
            "start_logit": 4.762047290802002,
            "end_logit": 0.30356183648109436
        },
        {
            "text": "5p15",
            "probability": 0.004741849429582027,
            "start_logit": 4.578896522521973,
            "end_logit": 0.30356183648109436
        },
        {
            "text": "chromosome 5",
            "probability": 0.0024077297867839053,
            "start_logit": 4.762047290802002,
            "end_logit": -0.5573318600654602
        },
        {
            "text": "on chromosome 5p15.3",
            "probability": 0.0021938432764653792,
            "start_logit": -0.6765348315238953,
            "end_logit": 4.7882208824157715
        },
        {
            "text": "5",
            "probability": 0.002004778414273404,
            "start_logit": 4.578896522521973,
            "end_logit": -0.5573318600654602
        },
        {
            "text": "3",
            "probability": 0.0006540013802420973,
            "start_logit": -1.8868355751037598,
            "end_logit": 4.7882208824157715
        },
        {
            "text": "DAT gene on chromosome 5p15.3",
            "probability": 0.0004190532284717618,
            "start_logit": -2.331947088241577,
            "end_logit": 4.7882208824157715
        },
        {
            "text": "p15.3",
            "probability": 0.0004033158832522534,
            "start_logit": -2.370224952697754,
            "end_logit": 4.7882208824157715
        },
        {
            "text": "chromosome 5p15.",
            "probability": 0.00035166725481683436,
            "start_logit": 4.762047290802002,
            "end_logit": -2.481086015701294
        },
        {
            "text": "chromosome",
            "probability": 0.00032218432586738846,
            "start_logit": 4.762047290802002,
            "end_logit": -2.568647623062134
        },
        {
            "text": "5p15.",
            "probability": 0.0002928131409651616,
            "start_logit": 4.578896522521973,
            "end_logit": -2.481086015701294
        },
        {
            "text": "15.3",
            "probability": 0.00026140346607142717,
            "start_logit": -2.803879976272583,
            "end_logit": 4.7882208824157715
        },
        {
            "text": "polymorphism of the DAT gene on chromosome 5p15.3",
            "probability": 0.00016396664236383718,
            "start_logit": -3.270282030105591,
            "end_logit": 4.7882208824157715
        },
        {
            "text": "on chromosome 5p15.3.",
            "probability": 0.00012932009250081998,
            "start_logit": -0.6765348315238953,
            "end_logit": 1.9571013450622559
        },
        {
            "text": "gene on chromosome 5p15.3",
            "probability": 0.0001273059049867375,
            "start_logit": -3.5233521461486816,
            "end_logit": 4.7882208824157715
        },
        {
            "text": ".3",
            "probability": 0.00010785210043616512,
            "start_logit": -3.6891841888427734,
            "end_logit": 4.7882208824157715
        }
    ]
}
